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Pharyngitis due to oropharyngeal infection with Streptococcus pyogenes is most
commonly treated by using penicillin-derived antibiotics.While treatment failure in
the 1950’s was reported in 4-8% of children, more recent studies have alarmingly
found antibiotic failure as high as 20-40% providing the impetus to study this
important pathogen. The contiguous mucosa along neighboring oropharyngeal
surfaces is classically unaffected during Strep ”Throat” suggesting pathogen
specificity for palatine tonsil epithelium. While recent studies are advancing the
premise of pathogen-host microenvironment effects on streptococcal virulence,
the specific interaction between S. pyogenes and the human tonsillar surface
relative to neighboring tissues remains insufficiently understood.
This thesis investigates the unique interaction between the Group A
Streptococcus, GrAS, and the human tonsil surface. We were particularly
interested in the transcriptional response exhibited by the bacterium during coculture with this tissue epithelium compared to epithelium from an anatomically
neighboring sight to determine if phenotype might be informed by the genotypic

profile. During the course of this work, we introduce new palatine tonsil tumorderived cell lines for their novel usefulness as a model for studying pharyngitis.
Using primary tonsil epithelial cells from non-malignant patient samples to
confirm our studies with the cancer cell line, we were successful in demonstrating
a tissue-specific phenotype and have begun the process of elucidating the
genotypic nuances that an M1 strain exhibited in direct response to the tonsillar
environment. These and further studies should allow us to better understand the
pathogenic adaptions exhibited by this bacterium at its preferred target niche for
infection.
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not a disgrace not to reach the stars, but it is a disgrace to have no stars to reach
for. Not failure, but low aim is sin."
Dr. Benjamin Elijah Mays – 6th President of Morehouse College
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§1. INTRODUCTION
1.1 Genus Streptococcus
Streptococcus is a genus of facultative anaerobic bacteria that consists of over
100 recognized species. Named for it’s morphology, “Strep” from the Greek word
στρεπτος "streptos" which translates to mean "twisted" or "chained", and the
word "kokhos" meaning a "berry" or "seed", it is among the most studied gram
positive pathogens. Early observations by such historic investigators as Van
Leeuwenhoek in the 17th century and Louis Pasteur in the 19th century identified
this pathogen in the context of its interaction with human host. Pasteur also
proposed that these “rounded granules (microorganisms) arranged in the form of
strings of beads” found in the bodies of diseased women in the maternity wards
as being the infective cause. In this regard, streptococcus served as one for the
first microbes identified as a contagious agent.

1.2 Classification System
Gram Positive bacteria are characterized by a thick cell wall matrix composed of
peptidoglycan (PG), teichoic acid, polysaccharides (PS), and a cadre of cell wall
associated proteins (CWPs) (Figure 1.1). Identification of unique cell surface
antigens have provided some of our earliest understanding of streptococcal
pathogenesis as well as providing a convenient means for organizing the genus
into classification schemes of related species.
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Cell wall associated
proteins (CWP)

Lipoteichoic
Acids

Polysaccharide (PS)

Peptidoglycan (PG)

Plasma membrane

Figure 1.1. Gram positive bacterial cell wall contains mainly peptidoglycan (PG), polysaccharide
(PS), and cell wall associated proteins (CWPs). The CWPs outside the PS and PG layers can be
removed by proteolytic enzymes, whereas the proteins inside the PG layer are difficult to remove
without breaking the PG structure. PS binds covalently to the PG layer, and protects PG polymers
from the degrading enzymes. PG consists of several of sugar chains composed of Nacetylglucosamine and N-acetylmuramic acid alternately linked each other. Short peptides bound to
the N-acetylmuramic acid (muramyl peptides) connect the sugar chains.

Image modified from Zhang et al 2001

2

1.2.1 Lancefield Classification
Despite Leeuwenhoek and Pasteur’s important morphologically descriptive
accounts on Streptococcal bacteria, a widely accepted classification system for
this historic bacterium was not adapted until hundreds of years later in the 20 th
century. Developed by Dr. Rebecca C Lancefield at the Rockefeller University,
this system of grouping related streptococcal species was based on serologically
active polysaccharides associated with the bacteria’s cell wall (Cunningham
2000). These aptly named “Lancefield Groups” were stratified by “group specific
antigens” or C –substances such as polysaccharides (ie. groups A, B, C, E, F,
and G), techoic acids (ie. groups D and N), and lipoteichoic acids (ie. group H).
Notably, Group A carbohydrate is composed of N-acetylglucosamine linked to a
rhamnose polymer backbone. The Lancefield typing system remains a
cornerstone of the diagnosis of many streptococcal diseases, including the
identification of S. agalactiae using rapid test kits for the detection of the
Lancefield Group B carbohydrate (GBC) (Sutcliffe 2008). Streptococcus spp,
may also be grouped using 16s rRNA gene sequence analysis to produce a
grouping scheme based on taxonomic relationship: Pyogenic, Bovis, Salivarius,
Mutans, Mitis, and Anginosus. These molecular-based groups in some instances
ungroup and regroup related members from disperate Lancefield Groups. For
instance, the “Pyogenic” group includes respective members representing
Lancefield Groups A, B, C, G, and L (Figure 1.1). Streptococcus pyogenes
constitutes the sole species in the Lancefield Group A of Streptococci. The

3

name “pyogenes” comes from the word pyogenic, which served to distinguish
this it’s association with pus formation.

Figure 1.2. Taxonomic relationship tree for Streptococcus based on 16S rRNA gene sequence
comparisons showing positions of selected species.
Nobbs et al 2009
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1.2.2 R and T typing
Further classification systems within this group have historically been delineated
by the surface antigen expressed by the streptococci, including the R, M and T
proteins.
R proteins were initially identified in S. pyogenes by Rebecca Lancefield in the
early1950’s (Lancefield 1952). Later, groups would identify, four immunologically
distinct R proteins (R1, R2, R3, and R4) occurring in various combinations in
streptococci of groups A, B, and C. The R protein sequence has yet to be
elucidated (Paoletti 2000).
The R, T and M antigens were found to uniquely participate in the serological
reactions of group A streptococci. In the laboratory, the T typing assay is
performed as an agglutination test. The T typing of group A streptococci has
been important in the investigation of epidemiology of group A streptococcal
infections and has identified strains associated with outbreaks when the M type
was not identifiable (Cummingham 2000). It was also found that strains
designated by M antigen may have serologically distinct T types (Lancefield
1946). Notably, the T protein was not present in streptococcal groups C and G
(Cunningham 2000). Falugi et al also indicte one of the major drawbacks of the
T-typing sera is that different centers have reported discrepant results This same
group has recently described that pili, and in particular the backbone protein (BP)
subunits, correspond to these Lancefield T antigens, and that the 15 BP variants
account for all but 4 of the 21 T serotypes (Falugi 2008).
5

1.2.3 M typing / emm sequencing
Most commonly, GrAS typing is based on M protein gene (emm) sequence. The
emm gene encodes streptococcal M protein, a surface exposed protein
considered the the primary virulence factor of the organism. Variation within this
gene’s unique 5’sequence enables researchers to determine distinct “emm-”or
"M-" types. Before this molecular approach was introduced, M protein serotyping
was based on M precipitin reactions in capillary pipettes (Swift 1943). More than
200 emm/M-types have been identified (Bessen 2011, Johnson 2006) among
Group A Streptococcal isolates.

1.3. Specialists vs Generalists
The primary ecological niches for GrAS are the epithelial surfaces of the upper
respiratory tract and skin of the human host, and the vast majority of GrAS
infections involve one of these two tissues, namely pharyngitis and impetigo, as
aforementioned. Robust historical epidemiological evidence has demonstrated
the causative strains for a respective tissue-specific infective phenotype have
discrete sets of M or emm types. Five major emm chromosomal patterns were
identified based on the number and arrangement of emm subfamily genes
(Bessen 2010). According to this system, emm pattern groups A–D, are
considered “specialist” and are all serum-opacity factor (SOF)-negative. S.
pyogenes strains preferentially isolated from throat (ie. M1, M3, M6, and M18)
belong to patterns A–C. Pattern D is composed of strains preferentially isolated
6

from skin sites. Bessen and colleagues provide a review of epidemiologic
surveys on population-based collections of GrAS causing superficial throat or
skin infections between1989 – 2009. Their robust analysis strongly supported the
conclusion that GrAS strains harboring the emm pattern A-C genotype are better
equipped to fill the superficial throat infection niche, as compared to emm pattern
D (Bessen 2011). Global molecular analysis between groups have also revealed
three accessory gene regions (AGR) may account for all statistical significant
difference in genotypic biomarkers separating the throat vs skin specialists.
Conversely, strains recovered readily from both tissues and are SOF-positive (ie.
M49) are considered “generalists” and belong to Pattern E. (Bessen 1996, Klenk
2007). Significantly, emm pattern A-C genotypes are highly diverse in AGR
content, suggestive of multiple genetic pathways associated with adaptation to
their narrow niche (Bessen 2011).

Table 1.1Chromosomal emm patterns and related serotypes
Chromosomal Infection
emm
M
Opacity
Pattern
gene
classb factor
subfamily
reaction
a
A
Pharyngitis
SF1
I
Negative
B
Pharyngitisa SF1-SF1
I
Negative
C
Pharyngitis
SF1-SF3
I
Negative
D
Impetigo
SF4-SF1I
Negative
E
Pharyngitis
SF3
II
Positive
or impetigo
SF4-SF2SF3

Usual tissue
site of
isolation
Throat
Throat
Throat
Skin
Throat or skin

Typical M
serotype(s)

1,3,6,12,17,19
,24
1,5,14
18
33,41,42,52,5
3,70
2,4,11,22,28,4
9,75
a
All of the studies conducted that will be discussed in this dissertation will be of Chromosomal
emm patterns A-B.
b
Class I M proteins were identified by reactivity with anti-M protein Mabs 10.B6 and 10.F5; class
II M proteins do not react with these Mabs.
Table contents originally modified from (Cunningham 2000)
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1.4 Virulence Factors
The pathogenicity of Group A Streptococci is exhibited by the structure and
function of proteins in their arsenal with such roles in virulence as adhesion to
host cells, stimulation of host responses, binding of soluble factors, and immune
evasion. The number of virulence factors that GrAS encodes varies, even
between strains of the same phenotype (Cunningham 2000).

1.4.1 Adhesins
A key characteristic expected for a tissue-specific GrAS adhesin is differential
binding to throat versus skin-derived cells or tissues of human origin (Bessen
2010). These microbial surface components recognizing adhesive matrix
molecules (MSCRAMMs) represent a particular class of proteins expressed on
the GrAS surface (Nobbs 2009). MSCRAMMs mediate bacterial binding to host
serum- and extracellular matrix proteins, leading to firm attachment and in some
cases also to internalization into host cells or paracellular translocation (as later
described). MSCRAMMs are usually anchored covalently to the peptidoglycan of
Gram-positive species by the transpeptidase activity of sortase enzymes
recognizing a specific LPXTG amino acid motif located at the C terminus of these
proteins (Nobbs 2009). Other important adhesin proteins, however, have been
found to be either anchorless at the cell surface or linked to the streptococcal

8

surface other non-LPXTG motifs. List 1.2 elaborates on the known adhesins
expressed by S. pyogenes.

1.4.1.1 M protein
M protein is one of the classical virulence determinants of S. pyogenes and is an
important adhesin, This abundant protein appears as hair-like fibrils at the
bacterial surface. Some of the 50 kDa α-helical coiled-coil M1 protein is
spontaneously shed from the surface but some is also actively released through
cysteine protease (SpeB) secreted by the bacteria. M1 protein contains
fibrinogen-, IgG- and albumin-binding regions, properties that are important for
adhesion and its overall virulence. In addition, M1 protein is important for the
adhesion of S. pyogenes to epithelial cells via glucosaminoglycans (GAGs) and
sialic acid containing cell surface proteins (Ryan 2001).

1.4.1.2 Pilli
The recent discovery of pili in gram-positive bacteria and their role as a major
factor in adherence to host cells have been proposed by numerous investigators
(Abbot 2007, Yeates 2007, Olsen 2008, Ryan 2007, Manetti 2007). Abbot and
colleagues have used apiliated mutants to demonstrate that early adherence
events are drastically impaired across multiple epithelial cell types if pili are not
present or produced (Abbot 2007). The genes for such pili are encoded by the
pathogenicity island known as the fibronection-binding, collagen-binding, Tantigen (FCT) region, which has been identified in all sequenced group A
9

streptococcal isolates to date (Manetti 2007, Falugi 2008). The pili are encoded
within this region by a multi-gene loci. Recently the actual pilus subunit t that
serves as the epithelial cell adhesin has been proposed to be encoded by locus
tag Spy0125, although recombinantly expressed minor pilus subunit Spy0130
has also been shown to adhere to human pharyngeal cells in vitro (Smith 2010).
Importantly, biofilm formation is a characteristic lifestyle feature of S. pyogenes
during colonization, and it has been suggested that pili mayplay and particularly
pivotal role in facilitating biofilm formation (Manetti 2007).

Table 1.2. Cell wall-anchored or surface-associated adhesins
Protein group
AgI/II family

Alp family

Pili / fimbriae / fibrils

Protein(s)

Cell surface
linkage

Function(s) and/or
substrate(s)

Spy1325

S. pyogenes

R28/Alp3

S. pyogenes, S.
agalactiae

LPxTz

Coaggregation; multiple
substrates
Multiple substrates

R proteins (R1–
R4)

S. pyogenes, S.
agalactiae, S.
dysgalactiae

LPxTz

Host glycosaminoglycans

PI

S. pyogenes

LPxTz

AgI/II family

S. mutans, S. sobrinus,
S.

LPxTz

Coaggregation, biofilm
formation,
phagocyte resistance;
multiple
substrates
Salivary components (gp340,

Saliva-binding proteins

Fn-binding proteins

Species

LPxTz

gordonii, S. oralis, S.

salivary glycoproteins,
proline-

intermedius

rich proteins)

Pili, fimbriae,
fibrils

S. pyogenes, S.
parasanguinis, S.
intermedius, S.
salivarius, S. gordonii

LPxTz

gp340

SfbI/PrtF1

S. pyogenes

LPxTz

Fn

FbaA

S. pyogenes

LPxTz

Fn

S. pyogenes

LPxTz

Fn

S. pyogenes

LPxTz

Fn

S. pyogenes

LPxTz

Fn

FbaB/PFBP/PrtF2
SOF/SfbII
SfbX
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Table 1.2 (continued)
Fbp54

S. pyogenes

Anchorless

Fn

ScpA (C5
peptidase)
GAPDH/SDH

S. pyogenes

LPxTz

Fn

S. pyogenes

Anchorless

Fn

M proteins

S. pyogenes

LPxTz

Fn

M-like proteins
Shr

S. pyogenes
S. pyogenes

LPxTz
Anchorless

Fn
Fn

Collagen-binding proteins

Cpa

S. pyogenes

LPxTz

Collagen

Enolase

S. pyogenes,
S.pneumoniae, S. oralis,
S. anginosus, S.
mutans, S. salivarius,
S. sanguinis

Anchorless

Plasminogen, plasmin

Plasminogen-binding
proteins

M protein

S. pyogenes

LPxTz

Plasminogen

PAM

S. pyogenes

LPxTz

Plasminogen

GAPDH/Plr

S. oralis, S. anginosus,
S. agalactiae, S.
pyogenes,
S. pneumoniae, S.
gordonii, S.
dysgalactiae
S. pyogenes

Anchorless

Plasminogen, plasmin

None

Plasminogen

Lbp

S. pyogenes

LXXC/XXGC

Laminin

Lsp

S. pyogenes

LXXC/XXGC

Laminin

SpeB

S. pyogenes

Lmb

LXXC/XXGC

Laminin

M protein

S. agalactiae, S.
pyogenes
S. pyogenes

LPxTz

Fibrinogen

SOF/SfbII

S. pyogenes

LPxTz

Fibrinogen

Fbp54

S. pyogenes

Anchorless

Fibrinogen

Mrp

S. pyogenes

LPxTz

Fibrinogen

SfbI/PrtF

S. pyogenes

LPxTz

IgG

Sib35

S. pyogenes

Anchorless

IgG

SibA

S. pyogenes

None

IgG, IgA, IgM

Protein H

S. pyogenes

LPxTz

IgG

Arp

S. pyogenes

LPxTz

IgA

Sir

S. pyogenes

LPxTz

IgA, IgG

Enn protein

S. pyogenes

LPxTz

IgA

M protein

S. pyogenes

LPxTz

IgG, IgA

M-like proteins

S. pyogenes

LPxTz

IgG, IgA

Mrp

S. pyogenes

LPxTz

IgG

FcRA

S. pyogenes

LPxTz

IgG

Streptokinase
(Ska)
Laminin-binding proteins

Fibrinogen-binding
proteins

Ig-binding proteins

Table 1.2 (continued)
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Anchorless/none

Laminin

Table 1.2 (continued)
Anchorless

IgG, IgA, IgM

M protein

S. pyogenes, S.
agalactiae
S. pyogenes

LPxTz

Factor H, factor H-like protein
1

M-like proteins

S. pyogenes

LPxTz

FbaA

S. pyogenes

LPxTz

ScpA

S. pyogenes

LPxTz

Factor H, factor H-like protein
1
Factor H, factor H-like protein
1
Complement C5a

Shr

S. pyogenes

Anchorless

Epithelial cells

ScpA

S. pyogenes

LPxTz

Epithelial cells

Lbp

S. pyogenes

LXXC/XXGC

Epithelial cells

R28

S. pyogenes

LPxTz

Epithelial cells

M protein

S. pyogenes

LPxTz

SfbI/PrtF

S. pyogenes

LPxTz

SclA, SclB (Scl1,
Scl2)

S. pyogenes

LPxTz

Epithelial/endothelial cells
(α5β1 integrin, Fn bridge)
Epithelial/endothelial cells
(α5β1 integrin, Fn bridge)
Epithelial cells (α2β1, α11β1
integrins)

Pili, fimbriae,
fibrils

S. agalactiae, S.
pyogenes, S.
pneumoniae, S.
salivarius
S. mutans, S.
pneumoniae, S.
pyogenes
S. pyogenes, S. oralis,
S. anginosus

LPxTz

Epithelial/endothelial cells

Anchorless

Serine protease

Anchorless

Glycolytic enzymes

S. pyogenes

Anchorless

Lysozyme, cytoskeletal
proteins, CD87/uPAR

PulA

S. pyogenes

LPxTz

Pullulanase

GRAB

S. pyogenes

LPxTz

α2-Macroglobulin; protects
against proteolysis

Lzp
Complement-binding
proteins

Host cell-binding proteins

HtrA
Enzymes

GAPDH, αenolase, PGK,
PGM, TPI
GAPDH/SDH

(Adadpted from Nobbs 2009)

1.4.2 Invasins
In order to cause invasive diseases as myositis and necrotizing fasciitis, S.
pyogenes must invade deep tissue through either a paracellular route between
adjacent cells, or by traversing epithelia through intracellular movement. It is now
established that the streptococcal M-protein and fibronectin-binding protein
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(Protein F) serve as invasins, since latex beads coated with either protein will
efficiently become internalized by epithelial cells (Fluckiger 1998, Jadoun 1998).

1.4.3 Secreted Factors
Secreted proteins can include degradative enzymes (SpeB, DNases,
hyaluronidases), toxins (streptolysins and superantigens), and proteins for
immune evasion (antibody-degrading factors) (Hynes 2004). The streptococcal
pyrogenic exotoxins (Spes) have likely been most studies of any of the
pathogen’s secreted products. Principally, Spes have been shown to induce
fever as its name implies, among a cadre of other symptoms of disease. The
Spes have been defined in four distinct antigenic groups, A to D. Types A, B, and
C are well defined, while type D is not well characterized (Cunningham 2000).

1.4.3.1 SpeA
The nucleotide sequence of the streptococcal pyrogenic exotoxin A gene was
reported by Weeks and Ferretti (Weeks 1986) and the gene has been found to
be expressed in most streptococcal strains isolated from cases of streptococcal
toxic shock syndrome (Hauser 1991). In this study, 85% of the patients who
manifested toxic streptococcal syndrome had strains which produced pyrogenic
exotoxin A. Nucleotide sequencing of the streptococcal pyrogenic exotoxin A
(speA) gene in strains associated with various outbreaks has revealed that there
are four naturally occurring alleles of speA (Cunningham 2000). The speA1,
speA2, and speA3 alleles encode toxins, which differ in a single amino acid,
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while speA4 encodes a toxin which is 9% divergent from the other three and has
26 amino acid substitutions. The speA2 and speA3 alleles are expressed in most
of the recent isolates from toxic streptococcal syndrome (Nelson 1991).

1.4.3.2 SpeB
SpeB (streptococcal cysteine protease, streptococcal exotoxin B) is a cardiotoxic
virulence factor of S. pyogenes). The speB gene is carried by all strains of S.
pyogenes, but the degree of expression varies from strain to strain. Its protease
activity has the ability to degrade the human extracellular matrix protein
fibronectin and vitronectin, release inflammatory mediators such as interleukin 1β
and bradykinin from their precursors, cleave or degrade immunoglobulins and
complement factors, and also bind to the human cell surface receptors integrins
(Cunningham 2000). Its expression is directly under the reglation of mg. In
addition to ropA, the presence of M-protein on the streptococcal surface is
needed for the maturation of SpeB. The secreted SpeB has an important role in
S. pyogenes virulence. It degrades host extracellular matrix proteins activates
interleukin-1β and releases fragments of proteins from the S. pyogenes surface
(Nelson 2011).

1.5 Genetics of Virulence
1.5.1 Chromosomal and Bacteriophage-encoded Virulence Factors
Streptococcal virulence factors can be encoded on the streptococcal
chromosome or located on lysogenic bacteriophage.
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Integrated phages not

only contribute to the genetic diversity of GrAS strains, but they can also
introduce virulence factors that alter the phenotype of a particular strain in the
infection setting. Although strain SF370 encodes for extracellular DNases,
hyaluronidases, and superantigens within its bacterial chromosome, additional
proteins from each category have been introduced by phage transduction as
evidenced by the four integrated prophage sequences in the SF370 genome
(Ferretti 2001). It is important to also note that these factors are often strain and
serotype-specific. For example, skin- tropic M type strains are often distinguished
from throat-tropic M type isolates by the presence of the chromosomally encoded
serum opacity factor (sof) on the former (Cunningham 2000, Bessen 2010).
Tables 1.2 and 1.3 provide the known annotated known virulence factors for the
M type 1 strain SF370 with accompanying locus tag and gene name. We
exclusively use this strain in all of microarray experiments presented later in
section 6.
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Table 1.3 Chromosomally Encoded Virulence Factors
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Table 1.3 (continued) Chromosomally Encoded Virulence Factors
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Table 1.3 (continued) Chromosomally Encoded Virulence Factors

Table 1.4 Phage Encoded Virulence Factors
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1.5.2 Regulation of Virulence
Regulation of virulence in S. pyogenes is widely considered to be executed at the
transcriptional level. Studies that have examined the correlation between mRNA
levels and protein production in S. pyogenes have found good agreement (Lyon
2001, Chaussee 2002, Ryan 2007, Juncosa 2012).

1.5.2.1Stand-alone Regulators
Stand-alone regulators can positively or negatively affect virulence factor
expression in response to environmental signals communicated by unknown
sensory elements (Kreikemeyer 2003). SF370 encodes over 40 stand-alone
regulators (Ferritti 2000).

1.5.2.1.1 Mga
Mga has been so named as the multiple gene regulator of group A
streptococcus. The mga gene lies immediately upstream of emm, which encodes
M protein. ga is ubiquitous in GrAS and, due to its regulation of a vast array of
genes implicated in GrAS pathogenesis, is often referred to as a global regulator
of virulence (Nobbs 2009). It is now established that Mga activates the
transcription of several additional genes, including those for C5a peptidase
(scpA), M-like proteins (mrp, enn, and fcR), serum opacity factor (sof), and
secreted inhibitor of complement (sic). Mga feeds back to positively regulate itself
and functions as a 62-kDa protein to bind to the promoter region of the genes
that it regulates (Cunningham 2000).
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1.5.2.1.2 amrA
The amrA locus corresponds to Spy0797 in the serotype M1 GrAS. Based on
mutation experimental screens, it received its name for activation of Mga regulon
expression locus A. As amrA is strongly conserved across the sequenced
streptococcal M types, and inactivation of amrA in an M3 serotype also resulted
in reduction of emm transcripts. Ribardo et al asserted that the original role the
noted during their screen identifying amrA does not appear to be serotype
specific. Although the specific function of AmrA is unknown, its putative
membrane localiza- tion and homology to transporters involved in cell wall
synthesis suggest a link between growth and virulence gene expression in GrAS
(Ribardo 2003).

1.5.2.2 Two-Component Systems
Working in conjunction with stand-alone regulators, two-component
systems (TCS) offer GrAS the ability to integrate extracellular signals directly into
regulatory circuits (Kreikemeyer 2003).The sequenced genomes of S. pyogenes
have been found to encode 13 two-component systems (Ferritti 2000).

1.5.2.2 .1 CovR / CovS
Levin and Wessels identified csrR / csrS (CovR / CovS), a pair of genes in group
A streptococci that encode a two-component regulatory system. It’s name stem
from “control of virulence” genes. Inactivation of CovR resulted in a striking
increase in transcription of the capsule synthesis genes of the has operon and a
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corresponding increase in hyaluronic acid capsule production (Cunningham
2000). The CovR / CovS is now know to be responsible for negative regulation of
capsule production, streptokinase, SpeB and streptolysin S, and appears to
influence the transcription of up to 15% of the genes in GrAS (Ribardo 2003).

1.5.2.2.2 SptR / SptS
Named for its role in Streptococcal persistence in Saliva, the SptR/SptS TCS
plays a crucial role during the host–pathogen interaction in saliva. It has been
proposed that SptR/S links central metabolic processes with the production of a
broad range of putative and known virulence factors Interestingly, one of the
major roles of the SptR/SptS is to coordinate expression of genes involved in
acquisition and processing of complex carbohydrates, with little to no effect on
the use of simple sugars like glucose (Shelburne 2005). SptR regulates 20% of
GrAS ORFs during growth in saliva including transcription of spd (DNase), spd3
(DNase), sic, speB, and hasA (capsule) (Shelburne 2008). These genes have
been associated with colonization and infection of the oropharynx. (Fig.1.3).
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Figure 1.3 Proposed mechanism for how the SptR/S TCS contributes (directly or indirectly) to

persistence of GrAS in human saliva.

Adapted from Shelburne et al 2005
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1.6 Pathogenesis
1.6.1 Adhesion
The dominant theory describing streptococcal colonization of pharyngeal and
dermal epithelia is via a two-step adherence mechanism (Hasty 1999, Nobbs
2009). The first step involves a weak electrostatic interaction likely mediated by
lipotechoic acid (LTA) in the bacterial cell wall. This amphipathic molecule
contains a lipid moiety attached to a negatively (-) charged polyglycerol
phosphate backbone, which reacts with positively (+) charged residues on host
epithelial surface proteins, such as fibronectin. This electrostatic attraction may
account for up to 60% of the pathogen’s adhesion to epithelial cells (Cunningham
2000).

The second stage of adherence occurs by a mechanism that confers tissue
specificity (Bessen 2010) and involves high-avidity binding that is mediated by
multiple bacterial adhesins and their associated host cell epitopes, often
extracellular matrix proteins (Cunningham 2000, Nobbs 2009).

1.6.2 Invasion
In order to cause invasive diseases as myositis and necrotizing fasciitis, S.
pyogenes must invade deep tissue through either a paracellular route between
adjacent cells, or by traversing epithelia through intracellular movement. LaPenta
et al. were the first to demonstrate in vitro that group A streptococci are able to
invade (or become internalized by) immortalized cells (LaPenta 1994). These
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initial findings have been confirmed and expanded by other groups
demonstrating that streptococci can invade certain cell lines as efficiently as
certain obligate intracellular pathogens such as Listeria and Salmonella (Greco
1995, Cunningham 2000). It is now established that the streptococcal M-protein
and fibronectin-binding protein (Protein F) serve as invasins, since latex beads
coated with either protein will efficiently become internalized by epithelial cells
(Fluckiger 1998, Jadoun 1998). The mechanism for fibronectin-mediated invasion
has been extensively studied. A leading theory proposes streptococci bind host
serum fibronectin with one of multiple fibronectin-binding proteins (e.g. FnBP,
Sfb1) and is subsequently engaged by the α5β1 integrin as a consequence of it
being the host cell fibronectin receptor. Once bound to the integrin, propagation
of phosphoinositide 3-kinase and integrin-linked kinase-dependent intracellular
signals induce cytoskeletal rearrangement and internalization of the streptococci
(Wang 2006a, Wang 2006b). Integrin ligands frequently posses the tripeptide
sequence RGD, which serves as the integrin recognition or binding site. Other
peptides with RGD amino acid sequences appear to stimulate uptake without
either M-protein or serum. Another factor potentially important for invasion is
laminin, which binds group A streptococci and induce epithelial internalization
also without serum (Cunningham 2000).

The evolution of presumably many routes to the interior of human epithelial cells
implies that this otherwise extracellular bacterium might be able to survive, at
least transiently, intracellularly. Osterlund et al were among the first to
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convincingly demonstrate that streptococcal internalization may not be an in vitro
laboratory artifact when they recognized that excised tonsil tissue contained
viable intra- and extracellular streptococci (Osterlund 1997). This observation led
to the suggestion that the tonsil may contain an intracellular reservoir of S.
pyogenes that mediates recurrent infection (Osterlund 1997). Mammalian
epithelial cells are not well penetrated by β-lactam antibiotics. Multiple groups
propose that streptococci may persist intracellularly and evading killing by
antibiotics prescribed to treat pharyngotonsillits. (Cue 2000, Osterlund 1997). We
further explore the mechanisms of epithelial internalization as well as it’s
consequence to the host and bacterium in section 7.

1.7 Streptococcal Disease Burden
This pathogen causes a wide variety of diseases including acute pharyngitis,
impetigo, scarlet fever, and puerperal sepsis. In many cases, these diseases
have been attributed to particular M serotypes. For example, M types 2, 49, 57,
59, 60, and 61, are associated with pyoderma and acute glomerulonephritis while
M types 1, 3, 5, 6, 14, 18, 19, and 24 arep found associated with throat infection
and rheumatic fever. More recently, studies have also linked post-streptococcal
infection sequelae to such neurologic conditions as Tourette’s syndrome, Tics,
Attention Deficit Disorder (ADD), and Pediatric Autoimmune Neurosychiatric
Disorders Associated with Streptococcal infections (PANDAS) (Cunningham
2000, Pavone 2006, Hahn 2005). Significant outbreaks of streptococcal
infections and their sequelae have historically occurred in densely populated
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settings, such as schools and in the military (Kaplan 2009). The annual global
burden of S. pyogenes related diseases is staggering and includes greater than
100 million cases of pyoderma, and over 600 million cases of pharyngitis (Bisno
2000). An increased global incidence of severe invasive diseases due to S.
pyogenes has been observed over past decades (Kaplan 1996), often associated
with bacteremia, streptococcal toxic shock syndrome (STSS), and high mortality.
It was estimated that nearly 500,000 deaths due to invasive diseases occurred in
2005 (Carapetis 2005).

1.7.1 Acute Rheumatic Disease and Sydenham Chorea
Molecular mimicry is proposed to be an important mechanism in the
pathogenesis of Acute Rheumatic Fever (ARF). Human monoclonal antibodies
derived from rheumatic heart disease have provided evidence supporting the
hypothesis that crossreactive autoantibodies that target the dominant group A
streptococcal epitope of the group A carbohydrate, N-acetyl-beta-D-glucosamine
(GlcNAc), and heart valve endothelium, laminin and laminar basement
membrane. This cross reactivity may then lead to the initiation of carditis and
rheumatic heart. Similarly, Antineuronal antibodies in Sydenham chorea may
cross the blood–brain barrier and trigger antibody-mediated neuronal cell
signaling induction of calcium calmodulin- dependent protein kinase II (CaMKII)
and subsequent dopamine release in the caudate putamen region of the brain,
which may lead to the movement disorder (Cunningham 2012).
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1.7.2 Pharyngitis
1.7.2.1 Healthcare Burden
The superficial infection of the pharyngeal mucosa is among the important
primary infections of the throat specialist streptococcal serotypes. M type 1 has
been of particular importance as it remains the most commonly isolated serotype
associated with pharyngeal and invasive disease (Bessen 2010). Notably,
however, there have been an increasing number of adults and children
hospitalized annually for throat infections over the past decade in the
industrialized world. In Australia, 4% of all symptomatic presentations to general
practitioners from 2000 – 2001 were for throat complaints, second only to cough
at 7%. Sore throat consultations resulted in an antibiotic prescription in 89% of
cases (WHO 2005). In England from 2000 – 2001, there were 30,942 tonsil
related admissions for medical treatments. By 2008 – 2009, the figure had risen
to 43,641 medical admissions for throat symptoms, an increase of over 41%
(12,700 admissions) in 8 years [http://www.hesonline.nhs.uk], (Vincent 2004).
The Ambulatory Medical Care Utilization in the United States (AMCUS),
estimates for 2007 found that acute pharyngitis accounts for 1.1 percent of visits
in the primary care setting and is ranked in the top 25 reported primary
diagnoses resulting in office visits (Schappert 2011).

1.7.2.2 Antibiotic Failure
While treatment failure in the 1950’s was reported in 4-8% of children, more
recent studies have alarmingly found antibiotic failure as high as 20-40%
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(Pichichero 1991, 2007). Treatment failure has been attributed to reasons
inlcluding: 1) carrier state, 2) lack of compliance, 3) recurrent exposure, 4) in vivo
copathogenicity of beta-lactamase–producing normal pharyngeal flora, 5) in vivo
bacterial coaggregation, 6) poor antibiotic penetration to tonsillopharyngeal
tissue, 7) in vivo eradication of normal protective flora, 8) early initiation of
antibiotic therapy resulting in suppression of an adequate host immune response,
9) intracellular localization of GrAS, 10) GrAS tolerance to penicillin, 11)
contaminated toothbrushes or orthodontic appliances, and 12) transmission from
the family pet (Pichichero 2007).

1.7.2.3 GrAS Pharyngitis Clinical Appearance
The clinical presentation for group a streptococcal pharyngotonsillits on physical
examination may be atypical with non-descript physical symptoms or more
commonly reveals well confined pharyngeal erythema with palatine tonsil
swelling, an edematous uvula, and anterior cervical lymphadenopathy (figure
1.4). Ebell and colleagues’ literature review of physical exam findings in strep
throat cases concluded the signs and symptoms that help rule in GABHS
pharyngitis include tonsillar exudates (positive likelihood ratio [LR+]: 3.4),
pharyngeal exudates (LR+: 2.1), and exposure to strep throat in the previous two
weeks (LR+: 1.9) (Ebell 2000). The presence of a scarlatiniform rash or palatine
petechiae is uncommon but very specific for the diagnosis of GABHS pharyngitis
As previously described, more outspread symptoms may increase the likelihood
of an alternative pathogen (Ebell 2000).
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1.7.2.4 Differential Diagnosis of Non-GrAS Pharyngitis
Group A streptococcus remains the most common bacterial cause and is
estimated to account for 15-30% of cases of pharyngitis in children (<18 y.o.) and
5-10% of cases in adults. The differential diagnosis is generally a distinction
between bacterial and viral, since the treatment course between bacterial
etiologies may not differ dramatically. Among the other bacterial causes,
Neisseria gonorrhea pharyngitis occurs in sexually active patients18 presents
with fever, severe sore throat, dysuria, and a characteristic greenish exudate.
Corynebacterium diphtheria pharyngitis is assumed if examination reveals a
serosanguineous nasal discharge. Other diphtheria related symptoms may
include a grayish-white pharyngeal membrane where exudative and extending to
the uvula and soft palate in association with the pharyngitis, tonsillitis, and
cervical lymphadenopathy Table 1.5 provides a non-exhaustive review of the
alternate causes of pharyngitis (Vincent 2004, Bisno 2001).
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Table 1.5 Viral versus bacterial causes of pharyngeal infection
PATHOGEN
Viral
Rhinovirus (100 types and
1 subtype)
Coronavirus (3 or more
types)
Adenovirus (types
3,4,7,14, and 21)
Herpes simplex virus
(types 1 and 2)
Parainfluenza virus (types
1 and 4)
Influenza virus (types A
and B)
Coxsackie virus A (types
2, 4-6, 8, and 10)
Epstein-Barr virus
Cytomegalovirus
HIV virus type 1
Bacterial
Streptococcus pyrogenes
(group A B-hemolytic
streptococci)
Group C B-hemolytic
streptococci
Neisseria gonorrhea
Corynebacterium
diphtheria
Arcanobacterium
haemolyticum
Chlamydial
Chlamydial pneumonia
Mycoplasmal
Mycoplasma pneumonia

SYNDROME OR
DISEASE

ESTIMATED
PERCENTAGE OF
CASES

Common cold

20

Common cold

>5

Pharyngoconjunctival
fever, acute respiratory
disease
Gingivitis, stomatitis,
pharyngitis
Common cold, croup

5

Influenza

2

Herpangina

<1

Infectious mononucleosis
Infectious mononucleosis
Primary human deficiency
virus infection

<1
<1
<1

Pharyngitis and tonsillitis,
scarlet fever

15-30

Pharyngitis and tonsillitis

5

Pharyngitis
Diphtheria

<1
<1

Pharyngitis, scarlatiniform
rash

<1

4
2

Pneumonia, bronchitis,
and pharyngitis

Unknown

Pneumonia, bronchitis,
and pharyngitis

<1

The list is not exhaustive.Estimates are of the percentage of cases of pharyngitis in persons
of all ages that are due to the indicated organism.
(Adapted from Bisno 2001)

30

1.7.2.5 Surgical Indications
Tonsillectomy remains the most common operation in Ear, Nose and Throat units
(Little 1996). While hypertrophy increasingly has become the most common
indication for this procedure in recent years, recurring tonsillitis continues to be
an important predisposing factor, creating a significant financial burden with
potential complications, especially in the very young (Spencer 2012). Indication
for tonsillectomy relates to surgeon preference as well as effect on the overall
quality of life for the patient. One longstanding recommendation shared by the
American Medical Association and the American Academy of Pediatrics, is that
tonsillectomy be indicated for patients who have four or more documented cases
of pharyngitis over one year (Gates 1986).
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Figure 1.4. Clinical presentation of “Strep Throat”.

*Arrows indicate white exudate on the palatine tonsil. Patient was
cultured to be positive for Group A Streptococci and was treated with
1.2 million units of penicillin G benzathine intramuscularly with
benzocaine spray for topical analgesia.

Image adapted from Nimishikavi et al 2005.
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1.8 Human Oropharynx anatomy
The tonsils are secondary lymphoid organs that form a first line of defense in
protecting the oropharyngeal isthmus. Collectively referred to as Waldeyer’s
Ring (Figure 1.5), humans uniquely have numerous “tonsils”, namely: palatine,
nasopharyngeal (or adenoids), lingual, and tubal tonsils.). Similar to Peyers
patches and the vermiform appendix, the tonsils belong to the mucosaassociated lymphoid tissue (MALT) system and are constantly exposed to
antigens. In contrast to the material in contact with the intestinal MALTs,
however, these antigens are in their native form having not been modified by
gastric acid or digestive enzymes. An additional unique quality is that unlike
most lymphoid organs/nodes (with the exception of the spleen), tonsils do not
have afferent lymph vessels (Perry 1998). The palatine tonsils’ anatomic
placement within Waldeyer’s ring is ideally situated for antigen sampling but are
themselves more vulnerable to damage and infection than many of the less
exposed members of this lymphoidal network. Accordingly, tonsillitis caused by
bacterial and viral infections is usually localized to the palatine tonsils (Clark
2000), with occasional involvement of the adenoids. Diseased tonsils are
associated with decreased antigen transport, decreased antibody production
above baseline levels, and chronic bacterial infection.
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Figure 1.5 Waldeyer’s Ring. Pharyngeal lymphoid tissue of Waldeyer’s ring comprises the
nasopharyngeal tonsil or adenoid (NT), the paired tubal tonsils (TT), the paired palatine
tonsils (PT) and the lingual tonsil (LT). All four micrographs show that the surface of the
tonsils is in each case covered with pharyngeal epithelium. Note the branching crypt
arrangement in the NT and the PT, and the single crypt in the LT. The intimate
relationship of tonsils with salivary glands is especially obvious in the TT.

Adapted from Perry et al 1998
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Although healthy tonsils offer immune protection, diseased tonsils are less
effective at serving their immune functions. Diseased tonsils are associated with
decreased antigen transport, decreased antibody production above baseline
levels, and chronic bacterial infection.

Of note, the pharyngeal surface of the nasopharyngeal tonsil is covered mainly
with a ciliated respiratory epithelium. The surface epithelium (or outer capsule)
of the palatine tonsils, however, is essentially a continuation of the nonkeratinized or parakeratinized stratified squamous of the surrounding
oropharyngeal mucosa (Perry 1998). Heterogeneity within both the
nasopharyngeal and palatine tonsil architectures becomes apparent at the tonsil
crypts as epithelia becomes increasingly reticulated and often desquamated
(Perry 1994). In an average adult, it has been estimated that the stratified
squamous epithelium of the superficial oropharyngeal aspect accounts for
45cm2 of total palatine tonsil surface area while the morphologically non-uniform
epithelium of the tonsillar crypts accounts for 295cm 2 of total surface area (Perry
1994, 1998).

Antigen sampling in this lymphoepithelial organ occurs at specialized tonsillar
crypts either through direct contact with infiltrated immune cells or via follicleassociated epithelium (FAE). FAE refers to the epithelium lining the crypts, and
includes reticulated specialized M-cells, which are able to sample antigen and
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translocate them to underlying lymphoid tissue (Perry 1994, Perry 1998). (Figure
1.6)

Figure 1.6. The lymphoepithelium of the palatine tonsil. The nonepithelial cells, mainly
lymphocytes, can enter the reticulated epithelium either via vascular (1 and 2) or nonvascular
routes (3). Routes 1 and 2 involve direct homing into the lymphoepithelium through the walls of

capillaries and high endothelial venules (HEVs), whereas route 3 involves entry from the
subepithelial lymphoid compartments through the disrupted basement membrane.

Image adapted from Perry et al 1998
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While the uniqueness of the specialized epithelium of the palatine tonsil provides
a functional capacity to sample antigens for immunoprotection, it is well
documented that this organ is a prudent area for pathogen entry. Various
investigators have shown a pathogenic focus for oral HIV transmission, EBV
transmission, and a putative route for prion entry concentrated in tonsillar crypt
reticulated epithelium (Perry 1998, Pegtal 2004, Maher 2005, Moutsopoulos
2007).

1.9 Experimental Models of Pharyngitis
In an animal model, rabbits infected with aerosolized group A streptococci
revealed streptococci and cell debris-like masses mainly within the micropores of
the palatine tonsillar crypt while the pharynx, larynx, trachea, bronchi, and lungs
appeared mostly resistant (Hokonohara 1988).

The rabbit model offers insight that is likely applicable to humans, but potentially
significant anatomic and pathologic inconsistencies exist between the two
species. Rabbit palatine tonsils are monocryptic, as compared to polycryptic
tonsils of humans (Effat 2006). Infected rabbits also do not present symptoms of
pharyngitis as do infected humans. Tissues equivalent to those of Waldeyer’s
ring are actually present in all mammals (except rodents), but tonsil crypt
distribution and epithelial lining differs greatly amongst mammals. These
differences include the few short wide-tonsil crypts of camels, the few deep
crypts of the cow, and the many deep crypts of dogs (Effat 2006). Interestingly,
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the clinical features of acute pharyngitis is absent in all aforementioned
mammals, and are even not seen in baboons and rhesus macaques that are
infected with group a streptococci. Cynomolgus macaques however, do reliably
mimic the clinical features of the human infection (Sumby 2008), but this model is
prohibitively expensive and therefore could not be used in routine studies.
Additionally, while numerous studies have used nonhuman primate models for
pharyngeal colonization and/or infection by GrAS, high inoculating doses of
bacteria are consistently employed, ranging from more than 3 × 105 to 108 CFU.
Nonetheless, transcription of several GrAS genes that are upregulated in
organisms recovered from pharyngitis patients are also expressed at elevated
levels during infection in the macaque model (Virtaneva 2003, Shumby 2008,
Shea 2010).

In vitro studies remain a useful alternative to animal models for elucidating basic
features of complex infection mechanisms. We discuss existing epithelial cell in
vitro models along with some of their benefits and set backs in section 4.
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§2.0 OBJECTIVES
As more is understood about Streptococcus pyogenes pathogenesis, the
complexity of its adaptive capacity is further revealed. The anatomical
predisposition of the tonsil makes it an organ prone to streptococcal infections
although this phenomenon is not well understood from a mechanistic
perspective. Putative virulence factors appear to guide S. pyogenes infective
capacity in a serotype specific and environment-dependent manner. The growing
appreciation of the relationship between streptococcal virulence factors,
environmental conditions, and surface anatomic architecture necessitate the
development of systems that better mimic the natural host. Additionally, our
current ability to investigate mechanisms of pathogenesis by cellular and genetic
tools may further allow us to understand a simple clinical observation that Group
A streptococci appears to preferentially infect tonsillar tissue in the oropharynx
leading to acute tonsillitis.
The overarching aim of this study was to better understand the tissue-/nichespecificity that has been attributed to “throat specialists” strains of Group A
streptococci, GrAS. While during the process of this investigation, however, we
successfully established techniques for cultivating primary tonsil epithelial cells,
as well as characterized two palatine tonsil-derived tumor cell lines for their novel
use as an in vitro model for tonsillitis. Armed with these new tools, we were able
to specifically test the bacterium’s ability to discern from its proximate
environment: tonsil vs non-tonsil epithelium. Using established measures of
pathogenesis, we observed epithelial cell type-specific phenotypic and genotypic
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responses by our representative M type 1 strain, SF370, a member of the earlier
ascribed “throat tropic” group of streptococci. This study has extended our lab’s
continued work on the transcription shifts observable in S. pyogenes from initial
contact with host factors in suspension (conditioned media), to transient contact /
association with neighboring epithelial cells (Detroit 562), to transient contact /
association with palatine tonsil epithelium (UT-SCC-60B), to adherence with
nasopharyngeal (Detroit 562) surface. It is clear that, in vivo, the GrAS must
experience to some extent every step within our model’s continuum. The bacteria
also may adhere to non-tonsil tissues in the pharynx, particularly during
asymptomatic carriage of the pathogen in the nasopharynx. While we have
observed unique qualities that are stage-specific throughout the course of an
infection, improvements in models and annotation will only produce even greater
opportunities to ask more precise questions. Our UT-SCC-60A and UT-SCC-60B
tonsil epithelial model mirrored many of the in vitro effects exhibited by the more
precious HPTE cells, offering an affective surrogate for determining anatomically
significant mechanisms underlying streptococcal pharyngotonsillitis.
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§3.0 MATERIALS AND METHODS

3.1 Bacterial Strains and Growth Conditions. Group A Streptococcus (GrAS)
strain SF370 (M type 1) was provided by J. Ferretti, University of Oklahoma
Health Sciences Center. Unless otherwise stated, the spontaneous streptomycinresistant derivative of SF370 will be referred to as SF370 Wild Type or
SF370SMR. The isogenic KO mutant SF3700129 was derived from this GrAS
background. GrAS strain D471 (M type 6), and the isogenic M-negative mutant
JRS75 were from the Rockefeller University culture collection. All GrAS strains
were grown at 37°C supplemented with 5% C02 in Todd Hewitt broth + 1%Yeast
Extract (BD, Becton, Dickinson and Company) and on protease peptone blood
agar (ie. supplemented with 4% defribinated sheep blood (Cleveland Scientific))
or Columbia Blood Agar plates (Thermo Scientific). When required, media was
supplemented with antibiotics at the following concentrations: erythromycin at15
μg/ml or streptomycin at 200 μg/ml. E. coli strain One Shot DH5α (Invitrogen)
was cultured in Luria-Bertani (LB) broth and on LB agar supplemented with
erythromycin at 200 μg/ml at 37°C.

3.2 Human Immortalized Epithelial Cell Lines and Growth Conditions Detroit
562 (ATCC CCL-138) human nasopharyngeal epithelial cell line obtained from
the American Type Culture Collection (Manassas, Va.) was maintained at 37°C
in minimal essential medium (MEM) (Gibco-BRL, Life Technologies, Grand
Island, NY) supplemented with 10% fetal bovine serum (FBS), 5 mM L41

Glutamine, and 1mM Na pyruvate. Human immortalized epithelial cell lines UTSCC-60A (palatine tonsil primary tumor-derived) and UT-SCC-60B (donor paired
secondary / metastatic tumor-derived) were generously provided to us for this
study by Dr. Reidar Grenman (University of Turku, Turku, Finland) (Lange, et al
2009) (Takebayashi 2004). UT-SCC cell types were maintained at 37°C in
Dulbecco’s Modified Essential Medium (DMEM) (Gibco-BRL) supplemented with
5% fetal bovine serum (FBS) 2 mM L-glutamate.

3.3 Adherence and invasion assay GrAS strains SF370, SF3700129, D471
and JRS75 cultures were grown to early log phase (OD600 ~0.6) in THY,
washed twice with 0.1 M Phosphate Buffered Saline (PBS, pH 7.4), collected by
centrifugation (3000 g, 10 min), and resuspended in Minimum Essential Medium
(MEM, Invitrogen, Carlsbad, CA) at a concentration of ~1x108 CFU/mL and
incubated for 1 h at 37°C. Glycerol (10% vol/vol) was added and cultures were
flash frozen in liquid N2. Culture suspensions were kept at -80°C until the day of
assay experiment when frozen suspensions were thawed in a 37°C waterbath for
1h. Thawed bacterial suspensions were diluted with warm MEM (without serum).
A Falcon® 24-well tissue culture plate with respective human epithelial cell
type(s) grown as a monolayer to approximately 90% confluency was washed
twice with PBS. Approximately 106 bacteria were added per well and plates
were infected for 2 h at 37°C in a 5% CO2 atmosphere. The wells were then
washed twice with PBS, and parallel tests were performed to assess bacterial
adherence and internalization.
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The presence of intracellular viable intracellular bacteria was quantified by
the standard antibiotic protection assay as previously described (Ryan 2007).
Briefly, the extracellular bacteria after 2 h of infection were killed by adding
prewarmed MEM without serum containing 600mg l−1 penicillin (Sigma) and 100
mg l−1 gentamicin (Sigma). After 1 h of further incubation, the monolayers were
rinsed twice with PBS. Purified phage lytic enzyme, PlyC (0.05U / well) (Fischetti
1971, Nelson 2001) was then added to monolayers and incubated for 5 min at
37° and washed three times with PBS. Cells were detached from the plate by
treatment with 100µl of 0.25% trypsin−0.02% EDTA (Life Technologies) and then
lysed by the addition of 400µl of Triton X-100 (0.025% in H2O). Appropriate
dilutions were plated on blood agar to determine the number of viable bacteria.
Antibiotic sensitivity was demonstrated in control experiments with equivalents
numbers of bacteria and under the same conditions as in the invasion assay
except that no epithelial cells were present in the well. Internalization results
were expressed as the average number of bacteria recovered per well for three
independent determinations in a single assay and the invasion efficiency (%
invasion) was calculated using the following equation: bacteria recovered (cfu
ml−1) time 3 hrs in the presence of antibiotics/bacteria inoculated (cfu ml−1) × 100.
To measure bacterial adherence the monolayers were further incubated
with fresh media for 1 h. Then, cells were dispersed and lysed, and bacteria were
plated for enumeration. The numbers of cfu recovered from these wells represent
total associated bacteria (attached plus internalized), and for simplicity named as
adherence. Adherence results were expressed as the average number of
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bacteria recovered per well for three independent determinations in a single
assay and the percentage of adherence was calculated using the following
equation: bacteria recovered (cfu ml−1) after 3 h (2 h infection + 1 h incubation) /
bacteria inoculated (cfu ml−1) × 100.
Tests were repeated four times and results are expressed as the averages
+ SD for a representative experiment performed in triplicate.

3.4 Bacterial Intracellular Viability. Mid- late log phase (O.D.600 ~0.6) bacteria
were co-cultured with human epithelial monolayers as described previously for
the Invasion Assay. After extracellular bacteria were killed by antibiotic solution
(600mg/mL penicillin and 100 mg/mL gentamicin) with subsequent PlyC
treatment (0.05U / well), monolayers were overlaid with anti-reemergence
medium consisting of DMEM with 10% FBS, diluted PlyC solution (0.005U/mL),
and Tannic acid) (Nakagawa 2004). At specified time intervals, post initial
antibiotic treatment (T0= 0hrs, T2=2hrs, T3= 16hrs, and T4=24hrs), designated
monolayers were enzymatically detached and lysed to quantify viable
intracellular bacteria by cfu counts on blood agar plates as previously described

3.5 Human Primary Tonsil Epithelium At the present time, there remains no
ATCC deposited human tonsil epithelial cell line. Human palatine tonsils were
obtained from otherwise healthy patients undergoing routine tonsillectomy by
surgeons affiliated with NewYork-Presbyterian (NYP) Department of
Otorhinolaryngology or the National Cancer Institute’s Cooperative Human
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Tissue Network (CHTN) Eastern, Midwestern, and Western Divisions. Only
specimens from traditional “full” tonsillectomy (FT) performed either by cold
dissection (conventional scalpel), electrocautery, laser, the harmonic scalpel, or
coblation was used for culturing. Specimens from “partial” tonsillectomy
techniques such as Powered Intracapsular Tonsillectomy with Adenoidectomy
(PITA) were rejected due to the procedure’s inherent tissue pre-masceration.
The experimental protocol received Institutional Review Board approvals
from both the Rockefeller University (VAF-0621-1207) and the Weill Cornell
Medical College [nos. 0803009695 and 0806009857and individual patient
consent for the use of tissue in research applications was obtained prior to the
surgical procedure. Other investigators may have received specimens from the
same subjects. Specimens were never refrigerated and unless otherwise noted,
all subsequent processing was performed using reagents pre-warmed to 37° C.
Tonsils were transported within 6 h of surgery at room temperature (RT) in
“transport antibiotic solution” consisting of sterile 0.1M phosphate-buffered saline
(PBS) (pH 7.4) supplemented with 0.5% bovine serum albumin (SIGMA) and
antibiotic / anti-mycotic cocktail (Gentamicin [50 µg mL-1], Penicillin [1000 U mL1

], Streptomycin [10 mg mL-1], Fungizone [25 μg mL-1], and Nystatin [240 U mL-

1

])(SIGMA) or shipped overnight at ambient temperature in DMEM supplemented

with fetal bovine serum (10%) and antibiotic / anti-mycotic cocktail (Penicillin
[100µg mL-1], Streptomycin [100µg mL-1], Amphotericin B [2.5µg mL-1].
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Acquired tonsil specimens were carefully dissected about the surface of
the tonsil capsule under a sterile cell culture hood using surgical tools in a glass
Petri dish. Investigator visual inspection was used to separate the exterior
(epithelial) tissues from underlying follicular lymphocytes and connective tissues
as best as possible and resulting capsular tissues were further cut into small
explants measuring ~1-3 mm3. Explants were transferred to a conical tube
containing fresh, pre-warmed transport antibiotic solution and washed twice by
briefly vortexing to liberate potentially associated non-epithelial cell types
(including lymphocytes, innate immune cells, and low density fat), allowing the
explants to settle by gravity at the bottom of the tube and aspirating off resulting
supernatant. Explants were then washed an additional two times in pre-warmed
“high Ca++ media” consisting of Dulbecco's modified Eagle's medium (DMEM)
supplemented with 10% fetal bovine serum, F12, 0.1mM Na Pyruvate, 1mM
calcium, and antibiotic / anti-mycotic cocktail (Gentamicin [50 µg mL-1], Penicillin
(1000 U mL-1], Streptomycin [10 mg mL-1], Fungizone [25 μg mL-1], and Nystatin
[240U mg mL-1]). After final wash, explants were placed in a 100-mm-diameter
petri dish, submerged in high Ca++ media, and incubated overnight at 37° C in 5%
CO2. The next day, explants were washed twice with transport antibiotic solution
before being transferred to a Costar 100-mm-diameter tissue culture plate
(Figure 3.1).

Culturing the explants was done in three phases. In the first phase,
Costar® 24-mm-diameter transwell devices (3 per culture plate) was placed on
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top of tissue explants (~10 pieces) with high calcium media added into and
around each transwell. Inert sterile glass beads were (~5-8) were added inside of
each transwell to provide a weight to aid explants adhere to the tissue culture
dish and stimulate the outward migration of epithelial cells from the tissue.
Explants with weighted transwells were incubated at 37° C in 5% CO2 for
approximately 8 days with daily media changes. In the second phase, the
transwells were removed and the remaining adherent explants were assessed for
migrating epithelial colonies extending from the tissue. Keratinocyte serum-free
medium with keratinocyte growth factor (KGF) (Invitrogen) supplemented with 0.1
mM Ca++ and antibiotic / anti-mycotic cocktail (Gentamicin [50 µg mL-1], Penicillin
[1000 UmL-1], Streptomycin [240 μg mL-1], Fungizone [240 μg mL-1], and Nystatin
[240 U mL-1]). The low calcium "keratinocyte medium" supported outgrowth of
epithelial cells, and kill both fibroblasts and lingering lymphocytes. Keratinocyte
media was changed daily for 10 days. For the third phase, the explants were
gently removed leaving only attached epithelial cells. Subsequent epithelial cells
were then transferred to Falcon PRIMARIA® tissue culture flasks (BD) at ~60%
confluency in the UT-SCC cell media (MEM).
Tonsil media was switched to a basal media with serum 5-12 hrs before human
primary tonsil epithelial cell monolayers were used for co-culturing experiments
with bacterial pathogen.
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Figure 3.1. Schematic of Human Primary Tonsil Epithelial Cell Culture technique

Protocol modified from Pegtal et al 2004

3.6 Recombinant M- protein preparation
E. coli bearing plasmid pJRS42.13 (Coli M6) was cultured to amplify recombinant
M type 6 protein in the host bacteria’s periplasmic space. This material was
extracted and purified essentially as described by Fischetti et al 1984.

3.7 Bacterial cell wall preparation S. pyogenes cells were fractionated by two
separate methodological protocols as indicated in the results. The first method is
modified from a protocol described by Linke et al 2009. S. pyogenes serotype
strain SF370 was grown in Todd-Hewitt broth supplemented with 1% yeast
extract (THY) overnight at 37°C and harvested by centrifugation at 4000 rpm for
5 min. The cell pellet was resuspended in cold lysis buffer (100mM KH2PO4, pH
6.2, 40% sucrose, 10mM MgCl2) supplemented with Complete EDTA-free
protease inhibitor cocktail tablets (Roche), 4 mg/ml lysozyme, and 5U/ml
amidase enzyme, PlyC, and incubated at 37°C for 2.5 h with gentle rotation.
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Cells and debris were sedimented by centrifugation at 12,900 × g for 15 min at
4°C); the supernatant containing proteins covalently attached to the cell wall such
as the pili was kept as the cell wall fraction.
As second method for extracting the bacterial cell fraction, a 50mL culture
of S. pyogenes SF370 was grown overnight in THY media at 37°C, and
harvested by centrigugation at 3000 rpm. The pellet was washed three times in
PBS and resuspended to 1/50 (v/v) in lysis buffer (30% raffinose, 5mM DTT,
EDTA-free protease Inhibitor [Roche®] in PBS, pH 6.1). PlyC stock (5.0 U/mL)
was added to the buffer solution at 1/100 (v/v) and the mixture was incubated at
37°C for 1.5h. Following incubation, lysed material was centrifuged 10 min at
3000rpm separating protoplasts, membrane, cytoplasmic proteins. The
supernatant, containing cell wall proteins, was then dialyzed against 50mM TrisHCl, pH7.5 for 24h at 4°C. Resulting dialysate was concentrated using
Centricon® filter devices (Millipore Corp, Bedford, MA).

3.8 Conditioned media extraction and LC/MS Fresh DMEM was applied to
Detroit 562, UT-SCC-60A, UT-SCC-60B, or HPTE cell monolayers for 3h (37C
at 5% CO2). After 3h, the cells were removed from the media by centrifugation
and filtration. This supernatant or control media (20mL) was then extracted with
30mL of chloroform:methanol (7:3). The resulting emulsion was resolved by
centrifugation (3200G, 15min), the aqueous layer was aspirated and the organic
layer was dried down in a speed vac. This crude organic extract was
resuspended in methanol (100mL) and analyzed by analytical LC/MS (XBridge
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C-18, 20min linear gradient from 20:80 methanol/water with 0.1% formic acid to
100% methanol).

3.9 Co-Immunoprecipatation (whole bug) S. pyogenes grown to mid-log phase
were Mitomycin C-killed using [25g/mL] in THY for 2h at 37°C. These cells were
then washed twice in PBS and used to capture natural binding partners from
fractionated epithelial cell membrane proteins in suspension. Briefly, human
epithelial cell monolayers were seeded to approximately 60% confluency.
Adherent cells were then briefly washed of serum with pre-warmed PBS, and fed
methionine-free / serum-free DMEM (Gibco) for 60 min to deplete monolayer
epithelial cell methionine reserves. Cells were then l fed methionine free - MEM
supplemented with ~40M L-Azidohomoalanine (AHA), a synthetic amino acid,
as well as for ~4 – 8 h to incorporate AHA in newly synthesized mammalian
surface proteins. Epithelial cells were fractionated as previously described (Linke
2009) to achieve a final suspension of mammalian cell membrane associated
surface proteins. Using fractionation and ultracentrifugation techniques to isolate
epithelial membrane fractions, this protein suspension was exposed to killed
bacteria, treated with a cross-linker, dithiobis[succinimidylpropionate] (DSP)
(Pierce Biotechnology, Rockford, IL) to create a covalent bond between the
human protein and pathogen, then washed to eliminate unbound debris. The
pathogen-host binding partners will be un-cross-linked with dithiothreitol (DTT)
(Hoefer Inc., San Francisco, CA) and the liberated human proteins will be eluted
off in RIPA buffer and salt. Subsequently, the bacteria were lysed and the S.
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pyogenes cell membrane protein fractions were collected. Bacterial fractionation
was performed by method described by Linke et al mentioned above. Both eluted
and membrane associated protein samples were then reacted to alkalineRhodamine using Cu1-catalyzed azide-alkyne cycloaddition (CuAAC) or “Click
Chemistry” reaction as described previously by (Grammel 2010). Proteins were
separated by SDS PAGE and bands containing human epithelial proteins crosslinked to bacterial cell wall fractions were identified by in gel fluorescence directly
by scanning the gel on a GE Healthcare Typhoon 9400 variable-mode imager.
Rhodamine-associated signal was detected at excitation 532 nm / emission
580nm.

3.10 Phase contrast microscopy Detroit 562, UT-SCC-60A, UT-SCC-60B, and
human primary tonsil epithelial cell monolayers were grown to > 90% confluence
in Falcon® or Falcon PRIMARIA® 24-well tissue culture plates. Entire plate
visualized at room temperature using an Olympus IX71 inverted microscope with
phase contrast optics using 20X and 40X objectives. Images were captured
using a Hamamatsu Orca ER B/W digital camera with MetaMorph acquisition
software (Molecular Devices, Sunnyvale, CA).

3.11 Streptococcal transformation with GFP expression plasmid pCM18).
The pCM18 plasmid vector (Figure 3.2) was a generous gift from Michael Kehoe
(University of Newcastle, UK). A transformation procedure described by Hansen,
et al 2001 was performed with minor modification. The plasmid pCM18 was
51

amplified and purified by adding 5μL of pCM18 [3ng/μL] to 80μL E. coli One Shot
TOP10 and subjected to one freeze / thaw cycle (1h on ice, then 40 seconds at
42°C, and 2min on ice) immediately followed by adding 1mL SAC media and
incubation for 2 h at 37°C. After transformed E. coli was plated onto selective
Luria-Bertani agar and incubated overnight, resistant colonies were selected and
used to inoculate a 2mL culture in LB for 8h. The purification was then completed
using the Qiagen HiSpeedTM Plasmid Purification Midi Kit (QIAGEN, Valencia,
CA) as described by the manufacturer’s protocol, finally eluting in 200μl TE. An
overnight culture of S. pyogenes strain SF370 grown in Todd–Hewitt broth
supplemented with 1% yeast extract was diluted 33 fold and incubated for 3h at
37°C until when an OD600 = 0.3 was reached. The culture harvested by
centrifugation and washed five times in chilled electroporation medium (10%
glycerol) for 15 min, rendering the streptococci competent. The pellet was then
suspended in 1mL of electroporation medium to the mixture and incubated at
37°C for 2.5h. The cells were then spread on protease peptone blood agar plates
with 5 μg/mL erythromycin, and transformants were scored after 2d incubation at
37°C.

Figure 3.2 Genetic and physical map of pCM18.
Adapted from Hansen et al 2001
52

3.12 PlyCB purification and Alexa Fluor labeling. PlyCB purification and
labeling was performed as previously described by Nelson et al 2006. Briefly,
PlyCB was induced with 0.5% arabinose overnight from E. coli XL-1 blue
(Stratagene) transformed with pBAD24 vector containing plyCB gene construct.
Cells were washed in 20 mM phosphate buffer at pH 7.0 and lysed with 20% wt /
vol chloroform to yield crude PlyCB. Lysate was then run over a hydroxyapatite
(MacroPrep Typell 40μm, BioRad) column, undergoing a stepwise elution from
200mM to 1M phosphate buffer to elute PlyCB. The enzyme was then dialyzed
extensively against phosphate buffer with 1mM DTT and 50mM NaCl. Protein
quantification was determined with the BCA method (Sigma, St. Louis, MO).
Five hundred micrograms of purified PlyCB was reacted with the carboxylic acid,
succinimidyl ester of Alexa Fluor 568, or Alexa Fluor 488 (Molecular Probes)
according to the manufacturer’s instructions. Unreacted dye was removed from
the labeled protein by application to a 5-ml HiTrap Desalting column (GE
Healthcare), equilibrated with PBS.

3.13 Fluorescence microscopy Bacterial cultures were grown overnight,
washed in PBS, mixed with 50 μg of labeled PlyCB (PlyCB-Alexa568), washed
two times in PBS, and wet mounted on a glass microscope slide. For
experiments to differentiate internalized from adherent bacteria on human
epithelial monolayers, Detroit 562, UT-SCC-60B, and UT-SCC-60B cells were
seeded onto coverslips placed at the bottom of wells in Falcon® 24-well plates
and grown to 90% confluence. The adherence and internalization assays were
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performed on coverslips as described. Wells were co-cultured with streptococci
constitutively expressing GFP for 1.5h. After final wash of the ascribed assay, the
monolayer wells were inoculated with 1mL vol MEM supplemented with PlyCBAlexa568 for 5 minutes at 37°C. The wells were then washed an additional 2
times with PBS. The streptococci and pharyngeal monolayers were fixed in 4%
paraformaldehyde at room temperature for 15 min, washed 3 times in PBS for 5
min each wash, and inverted onto 10µL of Prolong® Antifade (Molecular Probes,
Eugene, OR) mounting media on a glass microscope slide. An Eclipse E400
microscope with a Plan Apo -100 objective (both from Nikon) was used to
visualize all fluorescence samples, and digital images were obtained by using a
Retiga Exi camera with Q CAPTURE PRO® software (both from QImaging,
Burnaby, BC, Canada)
3.14 Immunofluorescence microscopy Cell lines (Detroit 562, UT-SCC-60A,
UT-SCC-60B, and THP-1) were seeded onto coverslips placed at the bottom of
wells in Falcon® 24-well plates and grown to 90% confluence. For HPTE and
THP-1 cells, coverslips were pre-treated with 0.1% poly-L-lysine solution (Sigma)
for 10 minutes at room temperature, washed one time in sterile water, and
allowed to completely air dry before seeding. For Streptococcal internalization
fate experiments, monolayers were co-cultured with S. pyogenes in MEM
supplemented with PlyCB-Alexa568 for 1hr.

All monolayers were fixed in 4% paraformaldehyde at room temperature for 15
minutes, washed 3 times in PBS for 5 minutes each wash. For intracellular
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immunolabeling, monolayers were permeabilized with 0.05% Tween in PBSsolution for 1 minute, then washed 3 times in PBS for 5 min each wash.
Antibodies were diluted in 5% Normal goat serum (in PBS-) as shown in table3.1.
The coverslips were then distributed 200μL of their appropriate primary
antibody(s) and incubated at room temperature for 1 hr or overnight at 4°C.
Following incubation, excess antibiotic solution was aspirated off and coverslips
were washed 3 times in PBS for 5 minutes each wash. Secondary antibodies
diluted in 5% Normal goat serum (in PBS-) as described (Table 3.1) were
distributed to appropriate coverslips if indicated for 1h at room temperature,
followed by 3 washes in PBS for 5 minutes each wash. The coverslips were then
inverted onto 10µL of Prolong® Antifade (Molecular Probes, Eugene, OR)
mounting media on a glass microscope slide.
Fluorescence microscope, camera, and image software was used as described
earlier.
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Table 3.1 Primary and secondary antibodies used for immunofluorescence
Name/Target
Epitope

Host

Species
Reactivity

Antibody
concentration

Dilution of
Antibody in
a
%5 NGS

Fluorophore
label

Clone

Source

Primary Ab’s
Anti-Vimentin

Mouse

Human, Pig,
Rat, Chicken,
Cow, Cat, Dog

1.0mg mL

-1

1:100

N/A

Abcam

AntiCytokeratin
19

Rabbit

Human,
Mouse

0.2mg mL

-1

1:200

N/A

Abcam

Keratin 8 /18
Ab-1

Mouse

Humans

Unavailable

1:50

N/A

5D3

NeoMarkers

Keratin, Pan
Ab-1

Mouse

Human,
Monkey, Cow,
Rabbit,
Mouse, Rat,
Chicken

0.2mg mL

-1

1:50

N/A

AE1/AE3

NeoMarkers

Human CD44

Mouse

Human

0.1mg mL

-1

1:100

Fluorescein
(FITC)

F10-44-2

Southern
Biotech

Early
Endosome
Antigen-1

Mouse

Human

0.25mg mL

1:100

Fluorescein
(FITC)

14/EEA1

BD Biosciences

N/A

N/A

~6.6µM

1:200

Alexa Fluor
555

Invitrogen /
Molecular
Probes

F(ab’)2
fragment of
goat antirabbit IgG

Goat

Rabbit

2.0mg mL

-1

1:200

Alexa Fluor
488

Invitrogen /
Molecular
Probes

Goat AntiMouse IgG
(H+L)

Goat

Mouse

2.0mg mL

-1

1:200

Rhodamine
Red™-X

Invitrogen /
Molecular
Probes

Phalloidin

b

-1

Secondary
Ab’s

a

Normal Goat Serum (Vector Laboratories, Burlington, CA)
Not an Antibody, but rather a fuorophore-conjugated water soluble “toxin” that is extremely used to stain F-actin at nanomolar
concentrations. Unlike antibodies, the binding affinity does not change appreciably with actin from different species or sources.
b
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3.15 Spotted oligonucleotide microarrays Sense strand oligonucleotides
(primarily 55-mers), representing the 1769 open reading frames (ORF) in the
genome of Streptococcus pyogenes strain SF370 were designed by Invitrogen
and produced by Eurofins MWG Operon (Huntsville, AL) . Oligonucleotides were
spotted onto Corning Epoxide Coated Slides (Corning Inc., Life Sciences, Acton,
MA) by Microarrays Inc (Huntsville, AL). Slides were post-processed by
Microarrays Inc, and adequate oligonucleotide deposition was verified using their
quantitative Veriprobe QC assay (http://www.microarrays.com/mi-quality.php).
Each oligonucleotide was spotted six times in a well-spaced configuration to
generate in-slide replicates.

3.16 Epithelial cell association assay (for microarray). Assays on
streptococcal association with the human pharyngeal cells were performed, as
described previously (Ryan 2007), with the following modifications. Human
Pharyngeal (Detroit 562) and palatine tonsil-derived (UT-SCC-60B) epithelial cell
lines were grown to confluence (5 x 106 cells/well) in 6-well Falcon® plates.
Intact monolayers were washed three times with 2ml PBS to remove serum.
Streptococcal stock cultures in MEM and glycerol were pre-incubated at 37°C for
1 hour, and aliquots (1mL) were added to each well of 6-well plates containing
confluent monolayers at a multiplicity of infection (MOI) of 100 (5 x 10 8 CFU/well).
Streptococci in co-culture with their respective epithelial cell line in MEM were
incubated for 2.5 hours at 37°C in 5% CO2. Associated (non-adherent)
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streptococci were harvested from the monolayer wells by aspiration. One PBS
wash (1ml volume) was performed to ensure collection of all associated bacteria.

3.17 RNA isolation. Streptococci from the pharyngeal association assays were
washed twice in PBS, resuspended in 0.1X TE (pH 6.0), and flash frozen in a
bath of ethanol and dry ice. Bacteria were lysed with the amidase enzyme lysin
PlyC (Fischetti 1971, Nelson 2001). Lysin was added to the bacterial samples
(2U/108 cfu) and incubated for 1 minute at room temperature, which was
determined to be optimum for complete streptococcal lysis in preliminary
experiments. RNA was isolated immediately after lysis with a modified phenolchloroform protocol, as described previously (Juncosa 2012), substituting acid
phenol (Invitrogen) to reduce genomic DNA contamination.
RNA was digested with DNase I (TURBO DNA-free, Invitrogen). Removal
of contaminating genomic DNA was confirmed by the absence of any PCR
product using ethidium-bromide gel visualization following 40 cycles of PCR.
Primers specific for the ORF spy0930 were used as this gene was previously
reported in our laboratory to be constitutively expressed in the host cell
environment (unpublished observations). RNA quantity was determined with the
NanoDrop 1000 spectrophotometer (Thermo Scientific, Wilmington, DE), and
RNA quality was assessed with the Nucleic Acid Bioanalyzer 2100 (Agilent
Tech., Palo Alto, CA).
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3.18 Synthesis of cDNA and labeling. DNase-treated streptococcal total RNA
(2.5 μg) was reverse transcribed using the Superscript Indirect cDNA Labeling
System (Invitrogen). Random hexamers (Invitrogen) primed the reverse
transcription reaction that incorporated a 5-(3-aminoallyl)-dUTP into the first
synthesized cDNA strand. cDNAs from experimental streptococci and control
streptococci were indirectly labeled with the N-hydroxysuccinimide activated
fluorescent dyes cyanine 3 (Cy3) and cyanine 5 (Cy5), respectively, as outlined
in the Superscript kit. Amersham CyDyes were purchased for this use from GE
Healthcare Life Sciences (Piscataway, NJ). Labeled cDNA samples were
purified following Superscript kit instructions. cDNA yield and dye incorporation
rates were assessed using the NanoDrop 1000 spectrophotometer to ensure
high-quality labeled probes.

3.19 Microarray hybridization and image acquisition. Biological replicate
experiments incorporating dye swaps were performed to account for both
biological and technical variability (Yang & Speed 2002). To determine
transcriptional differences between streptococci co-cultured with human
pharyngeal versus tonsillar epithelial cells, eight biological replicate experiments
were prepared for both Detroit 562 and UT-SCC-60B cell lines. For microarray
analysis, 4 replicates for each data set were labeled in the standard dye
orientation, and 4 replicates were labeled in the flip orientation (total of 16
separate hybridizations).
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Microarray slides were blocked with a prehybridization solution containing
10 mg/ml bovine serum albumin (Sigma). Labeled cDNA samples were
hybridized to the arrays under standard glass microscope coverslips in a
hybridization buffer containing 50% deionized formamide (Sigma), 10X SSC, and
0.2% SDS for 16 h at 55°C in a stationary hybridization oven. Slides were
washed with agitation as follows: one wash with 0.2X SSC, 0.1% SDS at 55C
for 15 minutes and two washes with 0.1X SSC at room temperature for 15
minutes.
Slides were dried via centrifugation (1000 rpm, 3 minutes) and then
scanned with the Agilent High-Resolution C Microarray Scanner (Agilent
Technologies, Santa Clara, CA) at 5 μm per pixel resolution. The resulting
images were processed using the GenePix Pro program (version 4.0, Axon,
Union City, CA).

3.20 Data filtering, normalization, statistical significance analysis, and
calculation of P values for individual genes Following image analysis, low
level processing of microarray data included probe and array quality filtering to
remove probes that were saturated, displayed a low signal to noise ratio, and/or
produced signal in only one dye channel. Lowess standardization was performed
for data normalization, and a modified t-test (based on CyberT software) was
implemented to calculate a P value of the log2-fold change (expression ratio in
the experimental sample to the appropriate control) for each gene, as previously
described (Ryan 2007).
60

The t-test statistics and P values generated in this analysis were used to
rank genes undergoing statistically significant changes in expression (P < 0.05)
during association with UT-SCC-60B tonsil as compared to Detroit 562
monolayers in MEM.
No cutoff values were set for the magnitude of the expression change
necessary to be included in the set of genes undergoing statistically significant
fold changes. Although researchers often disregard expression changes that are
less than 2-fold (log2 value of 1) between the experimental and control
conditions, gene expression changes as low as 1.5-fold (log2 value of 0.6) have
been demonstrated to be physiologically relevant (Hughes 2000).
The GenomeCrawler algorithm, written in the statistical language R
(http://www.R-project.org), stepped through the expression date and identified
adjacent gene grouping s that exhibited similar expression fold changes. The
algorithm then calculated statistical significance of all putative resulting neighbor
clusters using a permutation algorithm with the sum of the t-test statistics
(generated by Cyber-T) from each gene within a given cluster as the metric for
comparison. The output was then inspected visually and groupings were
disqualified that violate the neighbor cluster definition based on established
guidelines for functionally coupled gene pairs: (1) genes occur on the same DNA
strand and (2) adjacent genes are separated by ≤300 bp.
Since a specified gene could be a member of many different clusters, only
the cluster that generated the lowest PK value < 0.05 and met all of the defined
conditions of a neighbor cluster (as detailed in the text) was reported. The
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GenomeSpyer algorithm, also written in R, provides a method to view the
GenomeCrawler output and to visualize clusters and their respective gene
members (Ryan 2007).
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§4.0 CULTIVATION AND CHARACTERIZATION OF HUMAN PALATINE
TONSIL-DERIVED EPITEHELIAL CELLS
4.1.0 Introduction:
Epithelial cell monolayers remain the standard in vivo model of pharyngitis for the
study of basic pathology and mechanisms for infection. Group A Streptococci
strains belonging to emm pattern groups A-C are referred to as “throat
specialists”, as epidemiologic evidence demonstrate their collective predilection
for this specific ecologic niche (Bessen 2009).

4.1.1 Relevant clinical anatomy at times incongruent with cell type of
convenience
As the throat specialists GrAS strains come in contact with oramucosa, they must
come in contact and may even adhere to surface along the way. Indeed, it has
been reported that S. pyogenes can be found to bind buccal, tongue and other
non-tonsillar surfaces in vivo (Ellen1974). Clinically, however, the sites of typical
streptococcal disease during acute infection tend to occur posterior to the hard
palate within the pharynx. Thus, clinically informed in vitro models should reflect
disease pathology with anatomic context. For instance, A549 cells are derived
from carcinomatous tissue of human alveoli (Lieber 1976), and have been used
in numerous studies modeling GrAS infections of the oropharynx despite it not
being an anatomic site that is normally colonized by this bacterium outside the
the extraordinary rare cases of S. pyogenes pneumonia. Furthermore, most
cases of GrAS pneumonia are not associated with concurrent or recent
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pharyngitis infections, drawing into question sebseqent conjecture regarding
oropharyngeal disease processes from these cells (Barnham 1999).

Another important example of an existing epithelial monolayer model that has
been revisited recently is the commonly utilized HEp-2 cells to model laryngeal
disease. Despite previous reports, this line was not derived from an epidermoid
carcinoma of the larynx, but rather originated from a HeLa cell contamination
[American Type Culture Collection (ATCC) website: http://www.atcc.org] (Abbot
2007). Additionally, many cell lines in common use for in vitro studies contain an
undefined set of mutations and chromosomal abnormalities of undetermined
effect on cell physiologic properties.

Detroit 562 is a permanent heteroploid human cell line that is similar to HeLa and
other heteroploid cell lines in morphology, growth, and virus infectibility (Peterson
1971). The cell line was derived from a metastatic pleural lesion of an adult
female with nasopharyngeal carcinoma (Brock 2002). It differs from similar
permanent human cell lines in having G-6-PD type B isozyme (Peterson 1971).
The Detroit 562 naspharyngeal cell line has been reported to more faithfully
display the carbohydrate epitopes, however, which are more representative of
the native nasopharyngeal cell than certain other transformed cell lines (Ryan
2001). The well characterized nature of this cell type, along with it’s relative
proximity to the normal site of clinically observed pharyngotonsillitis has made
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the Detroit 562 an attractive cell line to model GrAS pathogenesis (Bartelt 1978,
Ryan 2001, Pancholi 2003).

The extent to which the in vivo microenvironment can be reproduced in vitro may
likely be of particular importance when modeling tissue-tropic or niche specific
disease processes. There are currently no “commercially” available immortalized
tonsil epithelial cell lines.

4.1.2 UT-SCC-60A / B Epithelial Cell Lines
Palatine tonsil squamous cell carcinoma tumor explants were recently dissected
and cultivated from a 59 year old male patient in Finland who presented with
stage IV primary disease to Dr. Reidar Grenman and colleagues from the
Department of Otolaryngology and Medical Biochemistry at the University of
Turku (Turku, Finland). A cell line was established using a technique whereby
malignant outgrowing epithelial cells were harvested from 1 x 1 mm tissue
explants attached to tissue culture flasks in DMEM supplemented with NEAA,
FBS and antibiotics as previously described (Grenman 1992). The resulting cells
were designated University of Turku Squamous Cell Carcinoma line 60A (UTSCC-60A). The same patient donor had a metachronous tumor (relative to the
primary) 3 months later following the onset of radiation treatment. This welldifferentiated secondary tumor was surgically resected from the patient’s neck
lymph node, also underwent subsequent culturing, and is designated UT-SCC60B. The UT-SCC-60B cell line exhibited a loss of heterozygosity in an allele on
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chromosome arm 18, which has been hypothesized as a common marker for
growth regulation and enhanced cancer cell survivor in head and neck malignant
disease (Takebayashi 2004). Pries and colleagues further noted a constitutive
expression of CD44 on the cell surface of these cells as they noted of nearly all
head and neck cancers reviewed in their study to differences between tumor
lines and non-malignant epithelia (Pries 2008).

4.1.3 Tumor derived cell lines and Toll-Like Receptors expression
Lange et al demonstrated that UT-SCC-60A and UT-SCC-60B cell lines are
similar to primary tonsil epithelial cells in Toll Like Receptor (TLR) expression. Of
note, while primary and UT-SCC-60A/B lines all express mRNA for TLR and
TLR-4, neither the primary or UT-SCC-60A cells were observed to actually
exhibit TLR2 protein expression. UT-SCC-60B, however, was found to produce
TLR2 protein following Poly I:C stimulation (Lange 2009). UT-SCC-60B’s
inducibility is significant as TLR-2 has been previously shown to mediate
intracellular NF-KB activation in epithelial cells following stimulation by soluble
peptidoglycan and lipoteichoic acid derived from oral pathogens like grampositive streptococci (Schwandner 1999). M-protein is also recognized by TLR-2,
which has been shown by oral epithelia. TLR-2 is also detected on the surface of
resting Detroit 562 cells and can be further induced to increased expression after
stimulation with IFN-γ (Eliasson 2007).
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Relatively few protocols are available in the literature from investigators who
have attempted to recreate the heterogeneous palatine tonsil epithelial cell
population in vitro (Cue 2000, Pegtal 2004, Maher 2005, Abbot 2007). The
heterogeneity in vivo was underscored by visual inspection of tonsillar epithelium
as reported by Clark et al (Clark 2000). They observed localized irregularities,
including lymphocyte invasion of the stratified squamous epithelium covering the
external surface of the palatine tonsil in 10 of 11 randomly selected tonsils.
Furthermore, in examining tonsil pieces by SEM, they recognized abrupt
transition in the topographical structure of the surface. One shortcoming of many
early primary tonsil epithelial cell culturing protocols is the potential mesenchymal
influence that may inform the differentiating of epithelial cells to be representative
of the in vivo heterogeneity (Pegtal 2004),

Work on protocols for harvesting and culturing epithelial cells from human
palatine tonsils continues to be necessary given the growing evidence for the
niche specificity of pathogenesis (Wannamaker 1970, Bessen 2010, Bessen
2011). Developing a standardized method becomes further complicated by the
variety of tonsillectomy procedural techniques, which can alter the quality of
organ samples.

In this chapter, four pharyngo-tonsillar epithelial cell monolayers are described
and compared for the purpose of contributing to the existing repertoire of in vitro
model systems for tonsillitis. A cell culturing method was implemented to isolate
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and culture human primary tonsil epithelial cells (HPTEC) from fresh human
palatine tonsil specimens. The HPTEC culture method utilized a staged strategy,
employing both serum-containing and serum-free media to preferentially
stimulate epithelial growth while mitigating contamination by fibroblast and
lymphoid organ-associated immune cell types. Preliminary comparative
characterization studies include visualizing relative cellular morphology,
confirming epithelial nature of cell cultures, identifying surface expression of a
known binging receptor, and gross comparison of surface protein banding
patterns on gel electrophoresis.
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4.2 Results:
4.2.1Human primary epithelial (HPTE) cell cultivation
Human primary tonsil epithelial cells were cultivated from fresh clinical patient
samples post-tonsillectomy. Patients ranged in age and disease indication for the
surgical procedure, although the majority (>90%) of the de-identified patient
reports list hypertrophy and disordered breathing (i.e., Obstructive Sleep Apnea)
as the primary complaint. Using a three-phase primary culturing system switching
between serum-containing and serum-free media, primary epithelial cell
populations were proliferated outwards from the edges of tonsil tissue explants.

At approximately 15-18 days after receiving the tonsil, the epithelial cells usually
will have expanded adequately, such that the cells can be split and cultured into
new tissue flasks or petri dishes. The stability of our attained monolayer was not
as robust as reported by other researchers creating primary epithelial cell
systems (Ropke 1997, Pegtal 2004), exhibiting stability only up to a maximum of
3 – 4 trypsin treatments before significant apoptosis would ensue as observed by
light microscopy and cell viability staining (not shown).

In general, epithelial cells spread out from the tonsil explants as a carpet mainly
consisting of flattened cells. The resulting cell populations were often not
homogeneous in shape and size. As has been reported, it was typical to see both
small (10-20µm) and large (20-100µm) cells from the start of the culture.
Additionally, cytoplasmic extensions were frequently observed between adjacent
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cells (Figure 4.1F). Previous researchers have linked this morphologic
presentation in ex vivo tonsil cultures to the secretion of lymphokines and
mediators from infiltrating lymphocytes. Perry et al purports that secretions are
made that may induce neighboring epithelium to undergo changes specifically in
cytokeratin expression (Perry 1998). Whether cytokeratin-mediated
rearrangements or by some other mechanisms, a subpopulation of the stratified
squamous epithelia in the tonsil appears to undergo this unique morphologic
transition of undetermined purpose. Based on a similar protocol and their
observations, Pegtal et al suggested that by virtue of the achieved proliferative
cells stemming from tissue explants, these tonsil epithelial cells are likely to be
derived from the basal epithelial layer and/or tonsillar reticulated epithelium
(Pegtal 2004).
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Figure 4.1 Human Primary Tonsil Epitheliium
A-F Light photomicrograph of tissue explants (T) on Day 7 post tonsillectomy. A.
“Low” magnification (10X objective) view of tonsil explant surrounded by outgrowth of
migrating epithelial cells. B-E. “High” magnification (25X objective) view of adherent
primary epithelial cells. F. Image E was digitally zoomed an additional x4 on area
demarcated in E by white box. White arrow indicates a representative cytoplasmic
extension
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4.2.2 Comparative light microscopy of confluent monolayers
Epithelial cell monolayers could be distinguished based on morphology by visual
inspection using microscopy. The Detroit 562 and the UT-SCC-60B cells appear
similar in size when visualized as a confluent monolayer on a tissue culture flask.
When compared with UT-SCC-60A and HPTE cells, the Detriot 562 and UTSCC-60B cells are smaller. Notably, the cultured UT-SCC-60B cells grow with a
distinctly dichotomous morphologic distribution throughout the monolayer. Soon
after seeding these cells to ~40% confluence, patches of cells quickly adhere to
the tissue culture surface and assume a flattened morphology. As the remaining
“late” cells in suspension settle to fill in the patches, their adherent morphology
assume a more columnar shape on visual inspection. The appearance of these
“early” adhering patches seems independent of their starting cell concentration.
To test this, wells were seeded heavily. While the size of the gaps between
patches declined, excess cells tended to grow on top of one another at the
patches rather than necessarily filling open areas remaining on the flask surface
(not shown). No obvious differences were detected in cytokeratin expression (or
in any of the other markers) stained for in our study between the “early” adhering
flat cells and columnar “late” cells. This growth pattern was UT-SCC-60B-specific
as it was not observed in the UT-SCC-60A monolayer.

Since the UT-SCC-60A tumor line was originally cultivated from a tissue explant
taken from the primary site of the squamous cell palatine tonsillar cancer, soon
after diagnosis (and in advance of chemotherapeutic treatments), there is likely
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significant similarities between this and our cultured HPTC. By extension, it may
not be surprising that similar characteristics are shared between these cells in
culture. The relative size similarities between the lines were additionally relevant
when determining the multiplicity of infection calculations for our in vitro studies.
Detroit 562 and UT-SCC-60B monolayers both reached 100% confluency on
Falcon 24-well plates at ~ 1.2 x 106 cells / well, while UT-SCC-60A and HPTEC
reached confluence at ~2.8 x 105 cells / well and ~1.1 x 105 cell / well,
respectively.
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Figur4.2. Morphology of human oropharyngeal epithelial cells as a monolayer
Phase contrast microscopy images of non-fixed (A) Detroit 562, (B) UT-SCC-60A, (C) UT-SCC60B, and (D) Human Primary Tonsil Epithelial Cell [HPTE] monolayers. Cells were grown to
~95% confluence as previously described (see methods). Images taken at original
magnification 100X.
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100X

4.2.3 Immunofluorescence staining for epithelial and fibroblast markers
In order to verify tonsil derived cell cultures were free of non-epithelial cell types,
Immunofluorescence (IF) staining for epithelial (pankeratin, keratins 8 [K8], K18,
and K19) and fibroblast (vimentin) markers was performed on Detroit 562, UTSCC-60A, UT-SCC-60B, and HPTEC lines. Tonsil epithelium is comprised of
stratified surface and reticulated crypt epithelia. Clark et al determined panepithelial tonsil markers and demonstrated that surface and reticular crypt
epithelia may be differentiated by the expression of particular cytokeratins. Their
in situ staining of tonsil epithelium demonstrated expression of the simple
epithelial keratins K8 and K18 were mostly limited to the crypt epithelial cells,
along with K19 (Clark 2000). Pancytokeratins represent a much broader staining
pattern that captures numerous cytokeratin markers for both simple keratins
(including K8/18) as well as complex. In this this study, variable pankeratin, K8,
K18, and K19 (not shown) expression was detected in the HPTE and UT-SCC60A, UT-SCC-60B monolayers. Interestingly, the Detroit 562 cells stained
uniformly across the monolayer for the simple epithelial markers, likely indicative
of cell type homogeneity. In contrast, the HPTEC cells were more heterogeneous
with some cells staining significantly brighter than neighboring cells. This was
less true for UT-SCC-60B cells, which suggests the presence of subpopulations
of cells, which may be of crypt epithelial lineage (in appendix A4.1) (Table 4.1).
A non-epithelial cell type of monocyte lineage was used as a negative control
and demonstrated the appearance of no keratin staining.
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Table 4.1 Summary of Epithelial Cell Markers from ImmunoFluorescence Studies

Cell Marker
Epithelial Cell
Type

K8 / K18

K19

Pan-Keratin

Vimentin

Detroit 562

XXX

XXX

XXX

0

UT-SCC-60A

XXX

XXX

XXX

0

UT-SCC-60B

XXX

XXX

XX

0

HPTE

XX / XXX

XXX

XXX

0/X

XXX – highly expressing marker
XX – mildly expressing marker
X – lighty expressing marker
0 – Not expressing marker
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4.2.4 Secreted metabolites by human epithelial monolayers
As with all living cells, the epithelial surfaces of human tissue require nutrients for
energy production during growth and maintenance of homeostasis. Adherent cell
types grown in vitro as a model of tissue undergo periods of enhanced
proliferation soon after being passaged to artificially stimulate cell turnover using
enzymes to detach them from specially treated plastic or glass to then be re“seeded” at sub-confluent concentrations. Cells become increasingly crowded
until complete monolayer confluence is reached. Environmental limitations such
as nutrients and dissolved oxygen will decrease the rate of expansion until finally
reaching a state of senescence. The senescent cell phenotype is characterized
by a decrease in cellular energy expenditure and subsequent metabolite
production. The tonsil epithelial surface in vivo is constantly undergoing cell
turnover, since this site is subject to injury by inhaling antigens. This is a
consequence of its anatomic placement at the isthmus of the digestive and upper
respiratory tracts. Given the dynamic state of tonsil epithelium in vivo, we have
designed an in vitro model physiologically reflective of mostly senescent cells
with an allowed subpopulation undergoing proliferative growth (~90%
confluence). Using this model, we sought to perform a liquid chromatography
mass spectrometry (LC/MS)-based metabolomic investigation (Siuzdak 2005) to
compare the intrinsic differences in metabolite production between our
experimental human pharyngeal epithelial monolayers under pre-infection
conditions. Our lab has previously shown how sensing pharyngeal cell soluble
factors that are secreted into the mileu may augment bacterial pathogenesis
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(Broudy 2001). This screen aimed to establish a baseline for any such
differences, which may direct future characterization efforts.
Fresh DMEM was applied to Detroit 562, UT-SCC-60A, UT-SCC-60B, and HPTE
cell monolayers and was collected following 3h of unstimulated, bacteria-free, coculture. The supernatant from each cell line was then extracted with
chloroform:methanol (7:3) and the crude extract was analyzed by LC/MS. The
LC/MS analysis of the crude extracts revealed few differences between the four
tested cell lines and the experimental background when compared to fresh
media. Not seeing differences between the cells lines and control media
suggests that either the performed LC/MS experiment was not sensitive enough
to detect the low titer metabolites produced by cells or that the relatively clean
chloroform:methanol extraction does not accurately represent the entire
metabolome of the cell line. However, two peaks at 789.03 and 703.87 m/z were
observed in the HPTE crude extract that were not seen in the extracts of the
other cells lines (Figure 4.3).
To further interrogate the identity of these putative metabolites differentially
produced by our primary tonsil epithelia, we performed a preliminary search of
the Human Metabolome Database, HMDB (available at www.hmbd.ca) (Wishart
2009. Briefly, the HMDB is designed as a comprehensive, web-accessible
metabolomics database that brings together quantitative chemical, physical,
clinical and biological data about 7,900 experimentally ‘proven’ or experimentally
detected human metabolites. Inputting our spectra informed measurements on
molecular weight (789.03 +/- 0.5 m/z) (Table 4.2) yielded 210 matches where
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80% were either glycerophospholipids (138/210) or diglycerides (22/210). After
ruling out unlikely ionization adducts and Diguanosine triphosphate, which is
likely too polar to be consistent with the observed hydrophobic retention time, the
remaining compounds in the search queue were glycerophospholipids. A
hydrophobic glycerophospholipid or diglyceride compound would be consistent
with the retention time of the 789.03 m/z peak. A diglyceride structure, as
suggested from a similar speculative HMDB search, would be consistent with the
more polar retention time of the 703.87 m/z peak. Phospholipids are ubiquitous in
cells and are key components of the lipid bilayer of cells. They are also available
to be metabolized as an energy source or as well as signaling intermediates.
Diacylglycerols are precursors to triglyceride and, biochemically, function as a
2nd messenger-signaling lipid that directly activates protein kinase C during
numerous intracellular signaling pathways.
While particularly crude and speculative, these results demonstrate the potential
for differences in metabolites excreted into the conditioned media between our
cell lines. For the HPTE monolayer, these differences appear most prominently in
liberated lipid products. This finding may have some implications on
streptococcal colonization, however, as was observed by Ellen and Gibbson in
1974. Using a throat isolated, M type 12 reference strain STAT628, they noted a
relative increase in adherence to oral epithelium by 9% and 25%, respectively,
after adding 80µl phosphatidyl serine or phosphatidyl ethanolamine to bacterial
suspension (Ellen 1974). A role relating free phospholipids to virulence or
persistence at the tonsil has not been previously established, however, so our
81

“interesting” putative metabolite hit will require much greater context to have
meaning, if any.
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Figure 4.3. Conditioned “spent” media from primary epithelial cells exhibit unique
metabolite production. Detroit 562, UT-SCC-60A, UT-SCC-60B and HPTE cells
were grown to near 90% confluency, and subsequently co-cultured with fresh
MEM media for 3h. Crude extraction by a chloroform methanol precipitation was
performed and analyzed by Liquid Chromatography and Mass Spectrometry.
Peak of interest at 789.03 m/z circled on bottom panel.
Note: 2nd Peak at 703 m/z NOT SHOWN
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DMEM – media only

UT-SCC-60A
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Table 4.2. Summary of preliminary metabolite profile potential biomarkers based on
molecular weight
HMDB ID

Common Name

Chemical Formula

HMDB01379

Diguanosine triphosphate

C20H27N10O18P3

HMDB09741

PE(24:0/P-16:0)

C45H90NO7P

HMDB09511

PE(22:0/P-18:0)

C45H90NO7P

HMDB11388

PE(P-18:0/22:0)

C45H90NO7P

HMDB11362

PE(P-16:0/24:0)

C45H90NO7P

HMDB08266

PC(20:0/16:1(9Z))

C44H86NO8P

HMDB08102

PC(18:1(9Z)/18:0)

C44H86NO8P

HMDB08069

PC(18:1(11Z)/18:0)

C44H86NO8P

HMDB08038

PC(18:0/18:1(9Z))

C44H86NO8P

HMDB08037

PC(18:0/18:1(11Z))

C44H86NO8P

HMDB08010

PC(16:1(9Z)/20:0)

C44H86NO8P

HMDB09747

PE(24:1(15Z)/15:0)

C44H86NO8P

HMDB08915

PE(15:0/24:1(15Z))

C44H86NO8P

HMDB08558

PC(22:1(13Z)/14:0)

C44H86NO8P

HMDB08526

PC(22:0/14:1(9Z))

C44H86NO8P

HMDB07978

PC(16:0/20:1(11Z))

C44H86NO8P

HMDB07919

PC(14:1(9Z)/22:0)

C44H86NO8P

HMDB07887

PC(14:0/22:1(13Z))

C44H86NO8P

HMDB08298

PC(20:1(11Z)/16:0)

C44H86NO8P

HMDB12400

PS(18:2(9Z,12Z)/18:0)

C42H78NO10P

HMDB12390

PS(18:1(9Z)/18:1(9Z))

C42H78NO10P

HMDB12380

PS(18:0/18:2(9Z,12Z))

C42H78NO10P

HMDB11933

Ganglioside GQ1c (d18:0/14:0)
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:
1(9Z)/18:1(9Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:
1(9Z)/18:1(11Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:
1(11Z)/18:1(9Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:
1(11Z)/18:1(11Z))

C103H177N5O55

HMDB10243
HMDB10242
HMDB10239
HMDB10238

C81H146O17P2
C81H146O17P2
C81H146O17P2
C81H146O17P2
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Adduct MW
(Da)
[Matching
HMDB MW]
789.079041
[788.071777]
788.652771
[787.645508]
788.652771
[787.645508]
788.652771
[787.645508]
788.652771
[787.645508]
788.616394
[787.609131]
788.616394
[787.609131]
788.616394
[787.609131]
788.616394
[787.609131]
788.616394
[787.609131]
788.616394
[787.609131]
788.616394
[787.609131]
788.616394
[787.609131]
788.616394
[787.609131]
788.616394
[787.609131]
788.616394
[787.609131]
788.616394
[787.609131]
788.616394
[787.609131]
788.616394
[787.609131]
788.543579
[787.536316]
788.543579
[787.536316]
788.543579
[787.536316]
789.047485
[2364.120605]
789.048889
[1453.003540]
789.048889
[1453.003540]
789.048889
[1453.003540]
789.048889
[1453.003540]

MW Difference (Da)
/ [QueryMass AdductMass]

Adduct

0.049011

M+H [1+]

0.377258

M+H [1+]

0.377258

M+H [1+]

0.377258

M+H [1+]

0.377258

M+H [1+]

0.413635

M+H [1+]

0.413635

M+H [1+]

0.413635

M+H [1+]

0.413635

M+H [1+]

0.413635

M+H [1+]

0.413635

M+H [1+]

0.413635

M+H [1+]

0.413635

M+H [1+]

0.413635

M+H [1+]

0.413635

M+H [1+]

0.413635

M+H [1+]

0.413635

M+H [1+]

0.413635

M+H [1+]

0.413635

M+H [1+]

0.48645

M+H [1+]

0.48645

M+H [1+]

0.48645

M+H [1+]

0.017456

M+3H [3+]

0.01886

M+3ACN+2H [2+]

0.01886

M+3ACN+2H [2+]

0.01886

M+3ACN+2H [2+]

0.01886

M+3ACN+2H [2+]

HMDB00217

NADP

C21H29N7O17P3

HMDB11912

C73H132N2O26

HMDB11867

Ganglioside GM2 (d18:1/23:0)
Ganglioside GM2
(d18:1/26:1(17Z))
Ganglioside GD3
(d18:1/24:1(15Z))
Ganglioside GD3
(d18:0/24:1(15Z))

HMDB01155

Diadenosine triphosphate

C20H27N10O16P3

HMDB05017

Pantoprazole

C16H15F2N3O4S

HMDB00912

Succinyladenosine

C14H17N5O8

HMDB06583

Poly-N-acetyllactosamine

C14H25NO11

HMDB06575

C14H25NO11

HMDB06535

Lacto-N-biose I
Beta-1,4-mannose-Nacetylglucosamine

HMDB01542

N-Acetyllactosamine

C14H25NO11

HMDB05021

Quetiapine

C21H25N3O2S

HMDB12214

Dihydrozeatin-O-glucoside

C16H25N5O6

HMDB12213

Dihydrozeatin-9-N-glucoside

C16H25N5O6

HMDB12211

Dihydrozeatin-7-N-dihydrozeatin

C16H25N5O6

HMDB06737

CE(22:2(13Z,16Z))

C49H84O2

HMDB07799

DG(24:0/18:2(9Z,12Z)/0:0)

C45H84O5

HMDB07658

DG(22:2(13Z,16Z)/20:0/0:0)

C45H84O5

HMDB07630

DG(22:1(13Z)/20:1(11Z)/0:0)

C45H84O5

HMDB07602

DG(22:0/20:2(11Z,14Z)/0:0)

C45H84O5

HMDB07434

DG(20:2(11Z,14Z)/22:0/0:0)

C45H84O5

HMDB07406

DG(20:1(11Z)/22:1(13Z)/0:0)

C45H84O5

HMDB07378

DG(20:0/22:2(13Z,16Z)/0:0)

C45H84O5

HMDB07267

DG(18:2(9Z,12Z)/24:0/0:0)

C45H84O5

HMDB07239

DG(18:1(9Z)/24:1(15Z)/0:0)

C45H84O5

HMDB07210

DG(18:1(11Z)/24:1(15Z)/0:0)

C45H84O5

HMDB07827

DG(24:1(15Z)/18:1(9Z)/0:0)

C45H84O5

HMDB07826

DG(24:1(15Z)/18:1(11Z)/0:0)

C45H84O5

HMDB12638

20-hydroxy-E4-neuroprostane

C22H31O5

HMDB12601

17-hydroxy-E4-neuroprostane

C22H31O5

HMDB04943
HMDB04917

C75H135N3O26
C76H135N3O29
C76H135N3O29

C14H25NO11

86

789.054443
[744.083252]
789.000549
[1452.906860]
789.000488
[1493.933350]
788.957275
[1553.918091]
788.957275
[1553.918091]
789.115417
[756.081909]
789.139465
[383.075134]
789.204651
[383.107727]
789.274719
[383.142761]
789.274719
[383.142761]
789.274719
[383.142761]
789.274719
[383.142761]
789.322693
[383.166748]
789.350159
[383.180481]
789.350159
[383.180481]
789.350159
[383.180481]
788.702271
[704.647156]
788.687012
[704.631897]
788.687012
[704.631897]
788.687012
[704.631897]
788.687012
[704.631897]
788.687012
[704.631897]
788.687012
[704.631897]
788.687012
[704.631897]
788.687012
[704.631897]
788.687012
[704.631897]
788.687012
[704.631897]
788.687012
[704.631897]
788.687012
[704.631897]
789.397461
[375.217163]
789.397461
[375.217163]

0.024414

M+2Na-H [1+]

0.02948

M+3ACN+2H [2+]

0.029541

M+2ACN+2H [2+]

0.072754

M+H+Na [2+]

0.072754

M+H+Na [2+]

0.085388

M+CH3OH+H [1+]

0.109436

2M+Na [1+]

0.174622

2M+Na [1+]

0.24469

2M+Na [1+]

0.24469

2M+Na [1+]

0.24469

2M+Na [1+]

0.24469

2M+Na [1+]

0.292664

2M+Na [1+]

0.320129

2M+Na [1+]

0.320129

2M+Na [1+]

0.320129

0.343018

2M+Na [1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]

0.367432

2M+K [1+]

0.367432

2M+K [1+]

0.327759
0.343018
0.343018
0.343018
0.343018
0.343018
0.343018
0.343018
0.343018
0.343018
0.343018
0.343018

HMDB12580

14-hydroxy-E4-neuroprostane

C22H31O5

HMDB12855

7-hydroxy-D4-neuroprostane

C22H31O5

HMDB12777

4-hydroxy-D4-neuroprostane

C22H31O5

HMDB04972

Glucosylceramide (d18:1/18:0)

C42H81NO8

HMDB10709

Galactosylceramide (d18:1/18:0)

C42H81NO8

HMDB04973

Glucosylceramide (d18:1/20:0)

C44H85NO8

HMDB10710

Galactosylceramide (d18:1/20:0)

C44H85NO8

HMDB12643

20-Trihydroxy-leukotriene-B4

C20H31O7

HMDB10705

CerP(d18:1/24:1(15Z))

C42H82NO6P

HMDB10168

C39H82N2O6P

HMDB07788

SM(d18:0/16:0)
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/
22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)

HMDB09312

PE(20:2(11Z,14Z)/P-16:0)

C41H78NO7P

HMDB11441

PE(P-18:1(9Z)/18:1(9Z))

C41H78NO7P

HMDB11440

PE(P-18:1(9Z)/18:1(11Z))

C41H78NO7P

HMDB09115

PE(18:2(9Z,12Z)/P-18:0)

C41H78NO7P

HMDB11408

PE(P-18:1(11Z)/18:1(9Z))

C41H78NO7P

HMDB11407

PE(P-18:1(11Z)/18:1(11Z))

C41H78NO7P

HMDB09084

PE(18:1(9Z)/P-18:1(9Z))

C41H78NO7P

HMDB09083

PE(18:1(9Z)/P-18:1(11Z))

C41H78NO7P

HMDB11376

PE(P-18:0/18:2(9Z,12Z))

C41H78NO7P

HMDB09051

PE(18:1(11Z)/P-18:1(9Z))

C41H78NO7P

HMDB09050

PE(18:1(11Z)/P-18:1(11Z))

C41H78NO7P

HMDB11349

PE(P-16:0/20:2(11Z,14Z))

C41H78NO7P

HMDB09576

PE(22:2(13Z,16Z)/P-16:0)

C43H82NO7P

HMDB09313

PE(20:2(11Z,14Z)/P-18:0)

C43H82NO7P

HMDB09282

PE(20:1(11Z)/P-18:1(9Z))

C43H82NO7P

HMDB09281

PE(20:1(11Z)/P-18:1(11Z))

C43H82NO7P

HMDB11447

PE(P-18:1(9Z)/20:1(11Z))

C43H82NO7P

HMDB11414

PE(P-18:1(11Z)/20:1(11Z))

C43H82NO7P

HMDB11382

PE(P-18:0/20:2(11Z,14Z))

C43H82NO7P

HMDB11357

PE(P-16:0/22:2(13Z,16Z))

C43H82NO7P

C47H68O5

87

789.397461
[375.217163]
789.397461
[375.217163]
789.397461
[375.217163]
788.661499
[727.596191]
788.661499
[727.596191]
788.661011
[755.627502]
788.661011
[755.627502]
789.403137
[383.206970]
788.653320
[727.587952]
788.651428
[705.591064]
789.425659
[712.506653]
788.616943
[727.551575]
788.616943
[727.551575]
788.616943
[727.551575]
788.616943
[727.551575]
788.616943
[727.551575]
788.616943
[727.551575]
788.616943
[727.551575]
788.616943
[727.551575]
788.616943
[727.551575]
788.616943
[727.551575]
788.616943
[727.551575]
788.616943
[727.551575]
788.616394
[755.582886]
788.616394
[755.582886]
788.616394
[755.582886]
788.616394
[755.582886]
788.616394
[755.582886]
788.616394
[755.582886]
788.616394
[755.582886]
788.616394
[755.582886]

0.367432

2M+K [1+]

0.367432

2M+K [1+]

0.367432

2M+K [1+]

0.36853

M+IsoProp+H [1+]

0.36853

M+IsoProp+H [1+]

0.369019

M+CH3OH+H [1+]

0.369019

M+CH3OH+H [1+]

0.373108

2M+Na [1+]

0.376709

M+IsoProp+H [1+]

0.378601

M+2ACN+H [1+]

0.39563

M+2K+H [1+]

0.413086

M+IsoProp+H [1+]

0.413086

M+IsoProp+H [1+]

0.413086

M+IsoProp+H [1+]

0.413086

M+IsoProp+H [1+]

0.413086

M+IsoProp+H [1+]

0.413086

M+IsoProp+H [1+]

0.413086

M+IsoProp+H [1+]

0.413086

M+IsoProp+H [1+]

0.413086

M+IsoProp+H [1+]

0.413086

M+IsoProp+H [1+]

0.413086

M+IsoProp+H [1+]

0.413086

M+IsoProp+H [1+]

0.413635

M+CH3OH+H [1+]

0.413635

M+CH3OH+H [1+]

0.413635

M+CH3OH+H [1+]

0.413635

M+CH3OH+H [1+]

0.413635

M+CH3OH+H [1+]

0.413635

M+CH3OH+H [1+]

0.413635

M+CH3OH+H [1+]

0.413635

M+CH3OH+H [1+]

HMDB07839

DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/
22:0/0:0)
DG(22:5(7Z,10Z,13Z,16Z,19Z)/22:
1(13Z)/0:0)
DG(22:5(4Z,7Z,10Z,13Z,16Z)/22:1
(13Z)/0:0)
DG(22:4(7Z,10Z,13Z,16Z)/22:2(13
Z,16Z)/0:0)
DG(22:2(13Z,16Z)/22:4(7Z,10Z,13
Z,16Z)/0:0)
DG(22:1(13Z)/22:5(7Z,10Z,13Z,16
Z,19Z)/0:0)
DG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z
,16Z)/0:0)
DG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,
19Z)/0:0)
DG(20:5(5Z,8Z,11Z,14Z,17Z)/24:1
(15Z)/0:0)
DG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z
,17Z)/0:0)

HMDB11577

MG(20:3(8Z,11Z,14Z)/0:0/0:0)

C23H40O4

HMDB11576

MG(20:3(5Z,8Z,11Z)/0:0/0:0)

C23H40O4

HMDB11575

MG(20:3(11Z,14Z,17Z)/0:0/0:0)

C23H40O4

HMDB11547

MG(0:0/20:3(8Z,11Z,14Z)/0:0)

C23H40O4

HMDB11546

MG(0:0/20:3(5Z,8Z,11Z)/0:0)

C23H40O4

HMDB11545

C23H40O4

HMDB13330

MG(0:0/20:3(11Z,14Z,17Z)/0:0)
3-Hydroxy-cis-5tetradecenoylcarnitine

HMDB00770

N-Glycoloylganglioside GM2

C43H85NO8

HMDB10577

PG(16:0/18:3(9Z,12Z,15Z))

C40H73O10P

HMDB10576

PG(16:0/18:3(6Z,9Z,12Z))

C40H73O10P

HMDB10675

PG(18:3(9Z,12Z,15Z)/16:0)

C40H73O10P

HMDB10660

PG(18:3(6Z,9Z,12Z)/16:0)

C40H73O10P

HMDB10646

PG(18:2(9Z,12Z)/16:1(9Z))

C40H73O10P

HMDB10590

C40H73O10P

HMDB10666

PG(16:1(9Z)/18:2(9Z,12Z))
PG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z
,15Z))
PG(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,
12Z))
PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,
15Z))
PG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,1
2Z))

HMDB10567

PE-NMe(16:0/16:0)

C38H76NO8P

HMDB08988

PE(18:0/15:0)

C38H76NO8P

HMDB08892

PE(15:0/18:0)

C38H76NO8P

HMDB07782
HMDB07754
HMDB07725
HMDB07697
HMDB07669
HMDB07642
HMDB07641
HMDB07614
HMDB07587

HMDB10682
HMDB10681
HMDB10667

C47H80O5
C47H80O5
C47H80O5
C47H80O5
C47H80O5
C47H80O5
C47H80O5
C47H80O5
C47H80O5
C47H80O5

C21H39NO5

C42H71O10P
C42H71O10P
C42H71O10P
C42H71O10P

88

788.616333
[724.600586]
788.616333
[724.600586]
788.616333
[724.600586]
788.616333
[724.600586]
788.616333
[724.600586]
788.616333
[724.600586]
788.616333
[724.600586]
788.616333
[724.600586]
788.616333
[724.600586]
788.616333
[724.600586]
788.608459
[380.292664]
788.608459
[380.292664]
788.608459
[380.292664]
788.608459
[380.292664]
788.608459
[380.292664]
788.608459
[380.292664]
788.599487
[385.282837]
788.598633
[743.627502]
789.465332
[744.494141]
789.465332
[744.494141]
789.465332
[744.494141]
789.465332
[744.494141]
789.465332
[744.494141]
789.465332
[744.494141]
789.467651
[766.478455]
789.467651
[766.478455]
789.467651
[766.478455]
789.467651
[766.478455]
788.591248
[705.530884]
788.591248
[705.530884]
788.591248
[705.530884]

0.413696

M+ACN+Na [1+]

0.413696

M+ACN+Na [1+]

0.413696

M+ACN+Na [1+]

0.413696

M+ACN+Na [1+]

0.413696

M+ACN+Na [1+]

0.413696

M+ACN+Na [1+]

0.413696

M+ACN+Na [1+]

0.413696

M+ACN+Na [1+]

0.413696

M+ACN+Na [1+]

0.413696

M+ACN+Na [1+]
2M+3H2O+2H
[2+]
2M+3H2O+2H
[2+]
2M+3H2O+2H
[2+]
2M+3H2O+2H
[2+]
2M+3H2O+2H
[2+]
2M+3H2O+2H
[2+]

0.42157
0.42157
0.42157
0.42157
0.42157
0.42157
0.430542

2M+NH4 [1+]

0.431396

M+2Na-H [1+]

0.435303

M+2Na-H [1+]

0.435303

M+2Na-H [1+]

0.435303

M+2Na-H [1+]

0.435303

M+2Na-H [1+]

0.435303

M+2Na-H [1+]

0.435303

M+2Na-H [1+]

0.437622

M+Na [1+]

0.437622

M+Na [1+]

0.437622

M+Na [1+]

0.437622

M+Na [1+]

0.438782

M+2ACN+H [1+]

0.438782

M+2ACN+H [1+]

0.438782

M+2ACN+H [1+]

HMDB07965

PC(16:0/14:0)

C38H76NO8P

HMDB07934

PC(15:0/15:0)

C38H76NO8P

HMDB07869

PC(14:0/16:0)

C38H76NO8P

HMDB12868

9'-Carboxy-gamma-chromanol

C23H35O4

HMDB08196

PC(18:3(9Z,12Z,15Z)/14:0)

C40H74NO8P

HMDB08163

PC(18:3(6Z,9Z,12Z)/14:0)

C40H74NO8P

HMDB08131

PC(18:2(9Z,12Z)/14:1(9Z))

C40H74NO8P

HMDB08903

PE(15:0/20:3(8Z,11Z,14Z))

C40H74NO8P

HMDB08902

PE(15:0/20:3(5Z,8Z,11Z))

C40H74NO8P

HMDB09351

PE(20:3(8Z,11Z,14Z)/15:0)

C40H74NO8P

HMDB09318

PE(20:3(5Z,8Z,11Z)/15:0)

C40H74NO8P

HMDB07907

PC(14:1(9Z)/18:2(9Z,12Z))

C40H74NO8P

HMDB07876

PC(14:0/18:3(9Z,12Z,15Z))

C40H74NO8P

HMDB07875

PC(14:0/18:3(6Z,9Z,12Z))

C40H74NO8P

HMDB08199

PC(18:3(9Z,12Z,15Z)/16:0)

C42H78NO8P

HMDB08166

PC(18:3(6Z,9Z,12Z)/16:0)

C42H78NO8P

HMDB08134

PC(18:2(9Z,12Z)/16:1(9Z))

C42H78NO8P

HMDB08006

PC(16:1(9Z)/18:2(9Z,12Z))

C42H78NO8P

HMDB07975

PC(16:0/18:3(9Z,12Z,15Z))

C42H78NO8P

HMDB07974

PC(16:0/18:3(6Z,9Z,12Z))

C42H78NO8P

HMDB07913

PC(14:1(9Z)/20:2(11Z,14Z))

C42H78NO8P

HMDB08394

PC(20:3(8Z,11Z,14Z)/14:0)

C42H78NO8P

HMDB08361

PC(20:3(5Z,8Z,11Z)/14:0)

C42H78NO8P

HMDB08329

PC(20:2(11Z,14Z)/14:1(9Z))

C42H78NO8P

HMDB07882

PC(14:0/20:3(8Z,11Z,14Z))

C42H78NO8P

HMDB07881

PC(14:0/20:3(5Z,8Z,11Z))

C42H78NO8P

HMDB08259

PC(18:4(6Z,9Z,12Z,15Z)/dm18:0)

C44H80NO7P

HMDB08228

PC(18:3(9Z,12Z,15Z)/P-18:1(9Z))

C44H80NO7P

HMDB08227

PC(18:3(9Z,12Z,15Z)/P-18:1(11Z))

C44H80NO7P

HMDB08195

PC(18:3(6Z,9Z,12Z)/P-18:1(9Z))

C44H80NO7P

HMDB08194

PC(18:3(6Z,9Z,12Z)/P-18:1(11Z))

C44H80NO7P
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788.591248
[705.530884]
788.591248
[705.530884]
788.591248
[705.530884]
789.470215
[375.253540]
788.580566
[727.515198]
788.580566
[727.515198]
788.580566
[727.515198]
788.580566
[727.515198]
788.580566
[727.515198]
788.580566
[727.515198]
788.580566
[727.515198]
788.580566
[727.515198]
788.580566
[727.515198]
788.580566
[727.515198]
788.580017
[755.546509]
788.580017
[755.546509]
788.580017
[755.546509]
788.580017
[755.546509]
788.580017
[755.546509]
788.580017
[755.546509]
788.580017
[755.546509]
788.580017
[755.546509]
788.580017
[755.546509]
788.580017
[755.546509]
788.580017
[755.546509]
788.580017
[755.546509]
788.556458
[765.567261]
788.556458
[765.567261]
788.556458
[765.567261]
788.556458
[765.567261]
788.556458
[765.567261]

0.438782

M+2ACN+H [1+]

0.438782

M+2ACN+H [1+]

0.438782

M+2ACN+H [1+]

0.440186

2M+K [1+]

0.449463

M+IsoProp+H [1+]

0.449463

M+IsoProp+H [1+]

0.449463

M+IsoProp+H [1+]

0.449463

M+IsoProp+H [1+]

0.449463

M+IsoProp+H [1+]

0.449463

M+IsoProp+H [1+]

0.449463

M+IsoProp+H [1+]

0.449463

M+IsoProp+H [1+]

0.449463

M+IsoProp+H [1+]

0.449463

M+IsoProp+H [1+]

0.450012

M+CH3OH+H [1+]

0.450012

M+CH3OH+H [1+]

0.450012

M+CH3OH+H [1+]

0.450012

M+CH3OH+H [1+]

0.450012

M+CH3OH+H [1+]

0.450012

M+CH3OH+H [1+]

0.450012

M+CH3OH+H [1+]

0.450012

M+CH3OH+H [1+]

0.450012

M+CH3OH+H [1+]

0.450012

M+CH3OH+H [1+]

0.450012

M+CH3OH+H [1+]

0.450012

M+CH3OH+H [1+]

0.473572

M+Na [1+]

0.473572

M+Na [1+]

0.473572

M+Na [1+]

0.473572

M+Na [1+]

0.473572

M+Na [1+]

HMDB11312

PC(P-18:1(9Z)/18:3(9Z,12Z,15Z))

C44H80NO7P

HMDB11311

PC(P-18:1(9Z)/18:3(6Z,9Z,12Z))

C44H80NO7P

HMDB11279

PC(P-18:1(11Z)/18:3(9Z,12Z,15Z))

C44H80NO7P

HMDB11278

PC(P-18:1(11Z)/18:3(6Z,9Z,12Z))

C44H80NO7P

HMDB11247

C44H80NO7P

HMDB13415

PC(P-18:0/18:4(6Z,9Z,12Z,15Z))
PC(o16:1(9Z)/20:4(8Z,11Z,14Z,17Z))

HMDB11221

PC(P-16:0/20:4(8Z,11Z,14Z,17Z))

C44H80NO7P

HMDB11220

PC(P-16:0/20:4(5Z,8Z,11Z,14Z))

C44H80NO7P

HMDB08488

PC(20:4(8Z,11Z,14Z,17Z)/P-16:0)

C44H80NO7P

HMDB08455

PC(20:4(5Z,8Z,11Z,14Z)/P-16:0)

C44H80NO7P

HMDB11154

LPA(P-16:0e/0:0)

C19H39O6P

HMDB10572

PG(16:0/18:0)

C40H79O10P

HMDB10600

PG(18:0/16:0)

C40H79O10P

HMDB08126

PC(18:1(9Z)/P-16:0)

C42H82NO7P

HMDB08093

PC(18:1(11Z)/P-16:0)

C42H82NO7P

HMDB08028

PC(16:1(9Z)/P-18:0)

C42H82NO7P

HMDB11305

PC(P-18:1(9Z)/16:0)

C42H82NO7P

HMDB11272

PC(P-18:1(11Z)/16:0)

C42H82NO7P

HMDB11240

PC(P-18:0/16:1(9Z))

C42H82NO7P

HMDB11210

PC(P-16:0/18:1(9Z))

C42H82NO7P

HMDB11209

PC(P-16:0/18:1(11Z))

C42H82NO7P

HMDB07997

PC(16:0/P-18:1(9Z))

C42H82NO7P

HMDB07996

PC(16:0/P-18:1(11Z))

C42H82NO7P

HMDB11151

C42H82NO7P

HMDB11908

PC(O-16:0/18:2(9Z,12Z))
Ganglioside GM2
(d18:0/26:1(17Z))

HMDB12363

PS(16:1(9Z)/14:0)

C36H68NO10P

HMDB12353

PS(16:0/14:1(9Z))

C36H68NO10P

HMDB12343

PS(14:1(9Z)/16:0)

C36H68NO10P

HMDB12333

PS(14:0/16:1(9Z))

C36H68NO10P

HMDB08229

PC(18:4(6Z,9Z,12Z,15Z)/14:0)

C40H72NO8P

HMDB08197

PC(18:3(9Z,12Z,15Z)/14:1(9Z))

C40H72NO8P

C44H80NO7P

C76H138N2O26
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788.556458
[765.567261]
788.556458
[765.567261]
788.556458
[765.567261]
788.556458
[765.567261]
788.556458
[765.567261]
788.556458
[765.567261]
788.556458
[765.567261]
788.556458
[765.567261]
788.556458
[765.567261]
788.556458
[765.567261]
789.504089
[394.248413]
789.504211
[750.541077]
789.504211
[750.541077]
788.554077
[743.582886]
788.554077
[743.582886]
788.554077
[743.582886]
788.554077
[743.582886]
788.554077
[743.582886]
788.554077
[743.582886]
788.554077
[743.582886]
788.554077
[743.582886]
788.554077
[743.582886]
788.554077
[743.582886]
788.554077
[743.582886]
789.510681
[1494.953735]
789.513184
[705.458069]
789.513184
[705.458069]
789.513184
[705.458069]
789.513184
[705.458069]
789.515320
[725.499573]
789.515320
[725.499573]

0.473572

M+Na [1+]

0.473572

M+Na [1+]

0.473572

M+Na [1+]

0.473572

M+Na [1+]

0.473572

M+Na [1+]

0.473572

M+Na [1+]

0.473572

M+Na [1+]

0.473572

M+Na [1+]

0.473572

M+Na [1+]

0.473572

M+Na [1+]

0.47406

2M+H [1+]

0.474182

M+K [1+]

0.474182

M+K [1+]

0.475952

M+2Na-H [1+]

0.475952

M+2Na-H [1+]

0.475952

M+2Na-H [1+]

0.475952

M+2Na-H [1+]

0.475952

M+2Na-H [1+]

0.475952

M+2Na-H [1+]

0.475952

M+2Na-H [1+]

0.475952

M+2Na-H [1+]

0.475952

M+2Na-H [1+]

0.475952

M+2Na-H [1+]

0.475952

M+2Na-H [1+]

0.480652

0.483154

M+2ACN+2H [2+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]
M+IsoProp+Na+H
[1+]

0.485291

M+ACN+Na [1+]

0.485291

M+ACN+Na [1+]

0.483154
0.483154
0.483154

HMDB08164

PC(18:3(6Z,9Z,12Z)/14:1(9Z))

C40H72NO8P

HMDB09417

PE(20:4(8Z,11Z,14Z,17Z)/15:0)

C40H72NO8P

HMDB08905

PE(15:0/20:4(8Z,11Z,14Z,17Z))

C40H72NO8P

HMDB08904

PE(15:0/20:4(5Z,8Z,11Z,14Z))

C40H72NO8P

HMDB09384

PE(20:4(5Z,8Z,11Z,14Z)/15:0)

C40H72NO8P

HMDB07909

PC(14:1(9Z)/18:3(9Z,12Z,15Z))

C40H72NO8P

HMDB07908

PC(14:1(9Z)/18:3(6Z,9Z,12Z))

C40H72NO8P

HMDB07877

PC(14:0/18:4(6Z,9Z,12Z,15Z))

C40H72NO8P

HMDB10580

PG(16:0/20:4(5Z,8Z,11Z,14Z))

C42H75O10P

HMDB10575

PG(16:0/18:2(9Z,12Z))

C40H75O10P

HMDB10679

PG(18:3(9Z,12Z,15Z)/18:1(9Z))

C42H75O10P

HMDB10678

PG(18:3(9Z,12Z,15Z)/18:1(11Z))

C42H75O10P

HMDB10664

PG(18:3(6Z,9Z,12Z)/18:1(9Z))

C42H75O10P

HMDB10663

PG(18:3(6Z,9Z,12Z)/18:1(11Z))

C42H75O10P

HMDB10650

PG(18:2(9Z,12Z)/18:2(9Z,12Z))

C42H75O10P

HMDB10645

PG(18:2(9Z,12Z)/16:0)

C40H75O10P

HMDB10637

PG(18:1(9Z)/18:3(9Z,12Z,15Z))

C42H75O10P

HMDB10636

PG(18:1(9Z)/18:3(6Z,9Z,12Z))

C42H75O10P

HMDB10631

PG(18:1(9Z)/16:1(9Z))

C40H75O10P

HMDB10622

PG(18:1(11Z)/18:3(9Z,12Z,15Z))

C42H75O10P

HMDB10621

PG(18:1(11Z)/18:3(6Z,9Z,12Z))

C42H75O10P

HMDB10616

PG(18:1(11Z)/16:1(9Z))

C40H75O10P

HMDB10594

PG(16:1(9Z)/20:3(8Z,11Z,14Z))

C42H75O10P

HMDB10593

PG(16:1(9Z)/20:3(5Z,8Z,11Z))

C42H75O10P

HMDB10589

PG(16:1(9Z)/18:1(9Z))

C40H75O10P

HMDB10588

C40H75O10P

HMDB13332

PG(16:1(9Z)/18:1(11Z))
3-Hydroxy-5, 8tetradecadiencarnitine

HMDB02082

Bisnorcholic acid

C22H36O5

C21H37NO5

789.515320
[725.499573]
789.515320
[725.499573]
789.515320
[725.499573]
789.515320
[725.499573]
789.515320
[725.499573]
789.515320
[725.499573]
789.515320
[725.499573]
789.515320
[725.499573]
788.543579
[770.509766]
788.543579
[746.509766]
788.543579
[770.509766]
788.543579
[770.509766]
788.543579
[770.509766]
788.543579
[770.509766]
788.543579
[770.509766]
788.543579
[746.509766]
788.543579
[770.509766]
788.543579
[770.509766]
788.543579
[746.509766]
788.543579
[770.509766]
788.543579
[770.509766]
788.543579
[746.509766]
788.543579
[770.509766]
788.543579
[770.509766]
788.543579
[746.509766]
788.543579
[746.509766]
789.523560
[383.267181]
788.535706
[380.256287]

0.485291

M+ACN+Na [1+]

0.485291

M+ACN+Na [1+]

0.485291

M+ACN+Na [1+]

0.485291

M+ACN+Na [1+]

0.485291

M+ACN+Na [1+]

0.485291

M+ACN+Na [1+]

0.485291

M+ACN+Na [1+]

0.485291

M+ACN+Na [1+]

0.48645

M+NH4 [1+]

0.48645

M+ACN+H [1+]

0.48645

M+NH4 [1+]

0.48645

M+NH4 [1+]

0.48645

M+NH4 [1+]

0.48645

M+NH4 [1+]

0.48645

M+NH4 [1+]

0.48645

M+ACN+H [1+]

0.48645

M+NH4 [1+]

0.48645

M+NH4 [1+]

0.48645

M+ACN+H [1+]

0.48645

M+NH4 [1+]

0.48645

M+NH4 [1+]

0.48645

M+ACN+H [1+]

0.48645

M+NH4 [1+]

0.48645

M+NH4 [1+]

0.48645

M+ACN+H [1+]

0.48645

M+ACN+H [1+]

0.49353

2M+Na [1+]
2M+3H2O+2H
[2+]

0.494324

* Glycerophospholipids are highlighted yellow. Diglycerides are highlighted green.
Abbreviations: PC = Phosphatidylcholine, PG = Phosphatidylglycine, PS = Phosphatidylserine,
DG = Diacylglycerol (Diglyceride)
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4.3 Discussion:
The specificity of all cell types within the palatine tonsil niche is not yet fully
understood, functionally or anatomically, as recent studies regularly describe new
information on the substructure of the lymphoepithelium (Clark 2000), the
possible existence of M cells (Park 2003), and the production of surface antimicrobial peptides (Ball 2007, Schwaab 2010). The need for reliable in vitro
models to model niche-specific disease remains an important impetus to explore
the utility of primary organ sources and tumor-derived lines. Lange and
colleagues concluded that their own preliminary characterization of UT-SCC-60A
and UT-SCC-60B cell lines with respect to Toll-Like receptor expression “justify
the use of the [UT-SCC-60A and UT-SCC-60B] cell lines as a model system to
examine…tonsillar epithelial cells” (Lange 2009).

As was recently shown by Pegtal et al using a similar primary cell cultivation
scheme, we established a reasonably clean population of HPTE using
commercially available serum-containing and serum-free media supplemented
with growth factors (Pegtal 2004). In our current study, Detroit 562, UT-SCC-60A,
UT-SCC-60B, and HPTE cells on visual inspection all stained positive for
keratins k8, k18, k19 and pankeratin markers but were negative for the fibroblast
marker, ant-vimentin. These data suggest that the cultures were principally of
epithelial lineage (Clark 2000).
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Most epithelial tissues are complex, and therefore simple keratin protein
expression may be useful in probing the origin of epithelial cells. While Clark et
al described pan-tonsillar markers in their in situ analysis of tonsil biopsies, their
ascribed specificity for simple keratins to identify crypt cells are likely most
significant with the support of anatomical orientation and within context of an
intact tissue. Notably, the same three keratins identified within the tonsil to
designate crypt cells are also typical of adenocarcinomas, and are present in
certain other carcinomas (Omary 2009). Non-specificity was seen in our study
with epithelial monolayers since all keratins tested were present in all of our cell
types with similar staining intensities as determined solely by visual inspection.
Detroit 562 cells derived from a nasopharyngeal squamous cell carcinoma do not
likely contain crypt cell epithelia, so simple keratin distribution may not be the
most effective means for distinguishing our cell types. Our findings are consistent
with Weber et al, who in 1984 also verified that Detroit 562 cells expressed
keratin K8, K18, and K19 in their analysis of the relationship between these
proteins and a human tumor marker, tissue polypeptide antigen (TPA). Keratin
distribution differences may, however, provide a crude visual assessment of
heterogeneity in tonsil-derived epithelial monolayers that thus far remain poorly
characterized in the literature. A more rigorous analysis of our primary epithelial
cells versus the Detroit 562 line may be able to better resolve this difference than
the techniques described above.
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Challenges and benefits to culturing primary epithelial cells

Several intrinsic challenges exist when relying on human samples, such as
tissue availability, incomplete medical history, and inter-sample variability. Our
IRB-approved protocol did not provide us the ability to further acquire patient
records to confirm patient history of culture-positive (rather than “suspected”)
GrAS infection. As the first step of our culturing procedure, tonsil samples were
immediately placed in an antibiotic / anti-mycotic solution. This solution greatly
mitigated inappropriate bacterial growth, but fungal contamination continued as a
significant problem that sporadically confounded our primary culture. Multiple
anti-fungals across differing concentrations were used with similar apparent
inefficiency in completely eliminating this fungal threat. The extended length of
time our cells were in culture surely served as a contributor to this propensity for
eventual fungal contamination.

In her Methods in Molecular Medicine protocol entry on culturing primary cells,
Louise Donnelly underscored the importance of recognizing that cell lines are
only models of human primary epithelial cells. To her point, she compares
responses of A549 cells, BEAS-2B and passaged human primary epithelium to
stimulation with “cytomix” (interleukin-1β, tumor necrosis factor-α, and interferonγ). A significantly higher level of granulocyte macrophage-colony stimulation
factor (GM-CSF) was produced by the primary cells relative to the immortalized
cell lines by up to a 4-fold differential (Donelly 2001). In our present study, the
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use of LC-MS in ESI positive mode detected 3 potential metabolite biomarkers
found uniquely in primary tonsil epithelial cell spent media versus our three tumor
cell lines. Further investigation suggested that one of these markers is likely a
phospholipid or diglyceride.

Due to the constraints of primary culturing, Donnelly concluded that cell lines
remain of critical importance and contends that they be used to interrogate
mechanistic pathways, requiring the use of many expendable cells. She warns
that data should not necessarily be extrapolated to in vivo conditions, or even to
the activity of in vitro primary cells. Indeed, it is undetermined the effect that our
findings from our metabolome investigation might have on experiments remains
undetermined but it represents an important reminder about the limitations of
assertions made solely based on immortalized cell date. She concludes that
more definitive conformational experiments may be performed using primary
cells as the presumably more relevant model (Donnelly 2001). It is with this latter
premise in mid that we have moved forward with performing many of our larger
experiments with our UT-SCC-60B and UT-SCC-60B cell to follow up with
primary cells, when available. We report in our subsequent studies, whenever
possible, the results from both the immortalized and HPTE cells to demonstrate
confirmatory or disparate findings
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§5.0 M1 STREPTOCOCCUS ADHERENCE AND INVASION PHENOTYPES
SUGGESTIVE OF TISSUE-SPECIFIC TROPISM FOR TONSIL EPITHELIUM
5.1 Introduction:

Our understanding of how S. pyogenes can asymptomatically colonize its human
host and/or cause disease has revealed a cadre of virulence factors that are M
type and strain-specific conferring the pattern specificity between the so
classified specialists and generalists. Transmission of the “throat tropic” M types
is largely mediated through respiratory droplets or secretions and direct contact
with host mucus surfaces. Onset of a group A streptococcal infection requires
that this immotile pathogen not only avoid clearance by opposing mucociliary
flow by the upper respiratory tract, but while so doing, traverse over much of the
oropharyngeal mucosal surface before finally adhering to- and then colonizing its
target epithelium (Beachey 1987). Clinical observations convincingly indicate that
group A streptococci have a pronounced predilection for colonizing tonsillar
epithelium in vivo (Ellen 1974, Hokonohara 1988, Lija 1999, Roberts 2012). The
number of in vitro studies described in the literature demonstrative of human
pharyngeal tissue adherence tropism is surprisingly few (Ellen 1974).

Park and colleagues’ murine intranasal infection model confirmed that GrAS has
a tropism towards an ascribed tonsil-homolog of paired lymphoid lobes along the
animal’s lateral nasopharyngeal wall (nasal-associated lymphoid tissue, NALT)
(Park 2003). The mechanism of the latter model rests greatly on M cell-specific
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adherence properties, which has subsequently not been reliably extended to
human or primate tonsillitis models. This example reveals a major shortcoming of
experimental animal models to accurately represent diseases caused by this
human-specific pathogen and the challenge to studying GrAS tissue tropisms.
Bessen et al also notes that extensive genetic diversity among strains often give
rise to strain-dependent phenotypes in various in vitro and in vivo models
(Bessen, Lizano 2010)

The Detroit 562 human nasopharyngeal cell line is a well-characterized epithelial
line that has been used extensively by many groups to model streptococcal
infection and to specifically explore GrAS pharyngeal adherence properties
(Duncan 1978, Fluckiger 1998, Ryan 2001, Pancholi 2003, Hong 2005, Ryan
2007, Manetti 2007). Our laboratory in particular has used this as an important
tool for understanding characteristics of the early host-pathogen colonization
process, which may help explain the clinically observed tropism exhibited by this
pathogen. Our studies with this cell type have recently revealed novel receptors
for M protein - sialic acid- mediated host-pathogen interactions as well as
important global transcriptional data on GrAS gene expression upon adhering to
Detroit 562 cells (Ryan 2001, 2007).

Morphologic heterogeneity of our human primary tonsil epithelial (HPTE)
monolayer has demonstrated characteristics in shape and keratin staining
suggestive of a subpopulation of cultured crypt – like lymphoepithelia cells. While
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we continue to characterize this subtype, the effect the tonsil has already shown
to have on its local microenvironment, as evidenced by the monolayer’s distinct
metabolite production, may prove significant in our ability to more reliably
recreate an in vitro system more closely resembling the in vivo
microenvironment. The palatine tonsil tumor-derived UT-SCC-60A and UT-SCC60B epithelial cell lines may contribute an additional model to study tonsil-specific
disease pathogenesis. The reliability of these tumor lines to mimic primary tonsil
epithelial cells and, by extension intact tonsil, during streptococcal infection has
yet to be explored.

In this chapter, we revisit the widely used Detroit 562 nasopharyngeal cell based
in vitro co-culture assay to observe streptococcal colonization and infection
phenotype of a clinically isolated M type 1 strain of Group A streptococcus,
SF370. We then explore the relative differences in streptococcal adherence
predilection during co-culture with Detroit 562, UT-SCC-60A, UT-SCC-60B, and
human primary tonsil epithelial cells. Following a brief update on a modification to
the classically described standard internalization assay, we immediately employ
this method to compare GrAS internalization across respective epithelia.
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5.2 Results
5.2.1 Streptococci are heterogeneously distributed along monolayers

Early observations of the interaction between S. pyogenes and our pharyngeal
cell monolayers revealed a non-homogeneous distribution of the bacterium
following co-culture with Detroit-562. When monolayers with adherent bacteria
were examined under the microscope, it appeared that not all Detroit 562 cells
were alike in their ability to allow streptococcal adherence. While some cells had
many bacteria adhering to them, no bacteria were associated with other epithelial
cells in the same area (Figure 5.1). Viewed under lower magnification (wider
view), it becomes apparent that the bacteria consistently attach as clumps
occupying patches along the monolayer (Figure 5.1). Sonication did not appear
to affect this tendency towards irregular distribution (unpublished observation).
UT-SCC-60A, UT-SCC-60B, and HPTE cell monolayers infected with S.
pyogenes demonstrated a less pronounced heterogeneity between bound and
unbound epithelia as compared to Detroit-562 cells (not show). In summary,
there was some degree of aggregation exhibited by GrAS during association with
the surface of all epithelial monolayers examined. Notably, our observation on
cell surface streptococcal aggregation is consistent with previously reported
accounts of this phenomenon by other investigators co-culturing streptococci with
Detroit 562 cells. (Bartelt 1978, Manetti 2007). The implications from the
numerous speculative mechanisms proposed by different groups will be
discussed later in this section.
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Figure 5.1. Distribution of S. pyogenes along epithelial monolayer
S. pyogenes strain SF370SMR was transformed with pCM18 (see Methods) to
constitutively express GFP (green). SF370-pCM18 in serum-free DMEM (~5 x 107 cfu /
ml) was co-cultured with Detroit 562 (A-C) and UT-SCC-60B (D) epithelial cell
monolayers on glass coverslips for 30 minutes at 37ºC, supplemented with 5% CO2.
Associated bacteria were removed by vigorous washing with PBS and monolayers were
briefly fixed with 4% paraformaldehyde. Fluorescence micrographs of representative
monolayers are presented, visualized with phase contrast and / or FITC filter (480nm).
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5.2.2 Persistent adherent GrAS exhibit biofilm-like growth possibly refractory to
treatement with antibiotics

Mannetti and colleagues recently described a link between the streptococcal
aggregation phenotype, GrAS pili and biofilm formation on Detroit 562
nasopharyngeal cells. Employing a similar experimental set up, their team
showed S. pyogenes strain SF370 adhered to Detroit 562 monolayers
following15 minutes of being co-cultured and formed extensive clumps of cells
typical of biofilm microcolonies by 2hrs. The clumped microcolonies extended
into 3D space, a characteristic arguably pathognomonic of biofilms, as was
confirmed by three-dimensional immunofluorescence imaging. It is well
established that biofilm formation, via matrixes of secreted proteins,
polysaccharides, and nucleic acids, offer a means of protection for member
bacteria against host antimicrobial peptides and antibiotic therapies. Recently,
Ogawa et al showed a hyper-biofilm forming M type 1 GrAS strain produced fully
matured biofilms, where penicillin, erythromycin, and clindamycin, either
individually or in combination, could not inhibit growth / viability even when the
concentration of each antibiotic was greater than the 10-fold minimum inhibitory
concentration (MIC) for planktonic bacteria (Ogawa2011).
Consistent with these finding, we have verified that a subpopulation of adherent
SF370 remain visible microscopically on the surface of Detroit 562 cells following
1h of antibiotic treatment with Penicillin and Gentamycin, as indicated by the
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standard invasion assay (Figure 5.2A,B). Given this observation, we first sought
to determine the effectiveness of using the amidase lytic enzyme, PlyC (Fischetti,
1971, Nelson 2001) at a modest concentration of 0.05U per well, to more
effectively eliminate persistent adherent bacteria. Our study consistently
demonstrated a marked decrease in visibly attached bacteria following PlyC
treatement, although monolayer surface sterilization was infrequently achieved.
We decided against increasing the concentration of PlyC or the increasing the
length of incubations since Nelson et al have recently shown that PlyC may
become internalized by epithelial cells when applied at high concentrations
(Nelson DC, unpublished). Incubating the monolayers with antibiotics for 1h
followed by PlyC treatment proved to consistently sterilize the monolayer surface
as was confirmed microscopically (Figure 5.2), which suggests a synergistic
effect between the two therapies on our in vitro assay.

Significantly, the viability of the persisting adherent streptococci was never
confirmed. Invasion viability and invaded-streptococci re-emergence experiments
rely on accurate removal of extracellular bacteria. We performed experiments
where aliquots of antibiotics from infected-wells during invasion assays were
plated on blood agar plates. Our results from these tests were usually negative
but they notably do not account for adherent bacteria that are alive but dormant
within a biofilm.
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Figure 5.2. Efficacy of using amidase lysin, PlyC, on persisting adherent S. pyogenes
versus antibiotics alone during in vitro assay
SF370-pCM18 (green) in serum-free DMEM (~5 x 107 cfu / ml) was co-cultured with
Detroit 562 (ATCC, CCL-138) epithelial cell monolayers on glass coverslips for 120 min at
37ºC, supplemented with 5% CO2. Associated bacteria were removed by vigorous
washing with PBS and subsequently treated with Antibiotics cocktail (Penicillin 100ng /
µL+ Gentamicin 100ng / µL) and /or PlyC (0.05U / well) for 60min. Monolayers were
washed with PBS and briefly fixed with 4% paraformaldehyde. Fluorescence micrographs
of representative monolayers are presented, visualized under phase contrast and / or
FITC filter (480nm).
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5.2.3 Streptococcal tonsil-specific phenotype suggests apparent tissue tropism
Clinical observations demonstrate a generally confined presentation during
Group A Streptococcal induced pharyngo-tonsillitis, or “Strep Throat”. One of the
major symptoms distinguishing this from non-streptococcal infection is a localized
inflammation and erythema at the palatine tonsil with or without exudate (Dajani
1995). Extended pharyngeal membrane discoloration involving the soft palate is
not seen in GrAS disease, but rather is indicative of other etiologies of
pharyngitis such as gonococcus spp (Vincent 2004).

Ellen et al established almost 40 years ago tonsil tissue specificity in a virulent
strain of streptococci. In their study, tonsil epithelial cells scraped from a healthy
male patient, along with a panel of epithelia from other sites, were cultured with
GrAS and Escherichia coli (Ellen 1974). They demonstrated greater adherence
of GrAs to tonsillar cells as compared to the other cell types, a finding
incongruent with observed E. coli adherence predilections. The disparate
locations from which they tested the streptococcal tropism limits the implications
of their finding between other neighboring oral mucosa, normally spared during
streptococcal disease. While numerous investigators have identified
streptococci’s ability to adhere to oral tissues including tongue and buccal
surfaces, comparisons between these surfaces have not convincingly
demonstrated tropism towards the tonsil in man, either in vivo or in vitro.
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In order to preliminarily explore whether streptococci exhibit higher affinity to
palatine tonsil-derived epithelial cells compared with anatomically proximate
nasopharyngeal-derived cells, a representative cell lines and a throat-tropic
(emm pattern A-C) strain, M type 1 SF370, were chosen for our model system.
We conducted a mixed cell infection experiment in which Detroit 562, UT-SCC60A, UT-SCC-60B, and Human Primary Tonsil Epithelial cells were infected
simultaneously in the same well (Amelung 2011).

Consistent with the apparent clinical presentation, our M1 strain exhibited a
strong preference for all three palatine tonsil cell lines over the Detroit 562
(nasopharyngeal) cells as assessed by visual comparison of infected cells
(Figure5.3. We quantitatively verified this observation by conducting an
adherence assay comparing all four (4) cell types using established standard
techniques as previously described (Romero 2003, Ryan 2001, Manetti 2007,
Ryan 2007). Our assays demonstrated that adherence was greater than 5-times
more efficient in tonsil cell lines, consistent with our observations by microscopy
(Figure 5.4). This enhanced adherence efficiency was reproducible and
calculated to be very significant (p < 0.001) demonstrating a clear difference
between tonsil versus non-tonsil monolayers when simultaneously infected with
the same inoculum. A similar epithelial cell type-specific response was
observable when measuring invasion efficiency (Figure 5.5).
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Figure 5.3 Visualization of apparent streptococcal tissue-specific tropism toward
tonsil epithelial cell types. Cultured epithelial cells were seeded to ~90%
confluency*, respectively, on glass coverslips. Coverslips were placed adjacent
to one another in the same well of a Falcon® 6-well tissue culture plate and
simultaneously inoculated with M type 1 S. pyogenes (~5 x 107). (A) Diagram of
experimental set up for a single well containing coverslips with the four epithelial
cell types. Fluorescence micrographs of infected (B) Detroit 562, (C) UT-SCC60A, (D) UT-SCC-60B, and (E) Human Primary Tonsil Epithelial [HPTE] cells are
presented. GrAS was labeled with PlyCB conjugated with Alexa 554 (red).
Epithelial nuclei were stained with DAPI (blue). All images captured at 20X
magnification.
*Note: Size and morphology differences between epithelial cell types influence
cell density of confluent monolayers. At 95% confluence: Detroit 562 = 1.2 x 10 6,
UT-SCC-60A = 5.0 x 105, UT-SCC-60B = 1.3 x 106, and HPTE = 4.5 x 105 (see
Section §4.0 for additional description)
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Figure 5.4 M type 1 streptococci exhibit greater adherence efficiency towards
tonsil-derived epithelium.
S. pyogenes strain SF370SMR was co-cultured with nasopharyngeal-derived
(Detroit 562- grey bar) and tonsil-derived (UT-SCC-60A, and HPTE – black bars)
epithelial monolayers, respectively at multiplicity of infection (MOI) ~100:1.
Associated bacteria were removed with PBS and cfu’s were counted on blood
agar as described in the methods. Results are the mean  standard deviation of
at least three independent experiments performed on separate days in triplicate.
Statistical significance (reported as p value) was determined by Student’s t-test.
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Figure 5.5. M type 1 streptococci are internalized more efficiently by tonsilderived epithelium
S. pyogenes strain SF370SMR was co-cultured with nasopharyngeal-derived
(Detroit 562- grey bar) and tonsil-derived (UT-SCC-60A, and HPTE – black bars)
epithelial monolayers, respectively at multiplicity of infection (MOI) ~100:1.
Adherent bacteria were killed with antibiotics and treatment with amidase lysin,
PlyC, as described in the methods. Results are the mean  standard deviation of
two to four independent experiments performed on separate days in triplicate.
Statistical significance (reported as p value) was determined by Student’s t-test.

112

p < 0.0001

Internalized GrAS (as % of inoculum)

0.70%

0.60%

0.50%

0.40%

0.30%

0.20%

0.10%

0.00%

Detroit 562

UT-SCC-60A

113

HPTE

5.3 Discussion:
In vitro assays were used to investigate a key early event in streptococcal
infections, initial adherence to mucosal surfaces of the human oropharynx. This
approach may mimic a child inhaling aerosolized droplets of S. pyogenes and
effectively inoculating their upper airway. Our in vitro investigations demonstrate
clear differences in adherence phenotypes between streptococcal strain-matched
assays and epithelial monolayers derived from two neighboring sites in the
human oropharynx. These findings are consistent with the clinical observation
that group A streptococcal infection appears to occur preferentially at the palatine
tonsil.

Our monolayer model system revealed thought provoking findings that have
been previously noted by other researchers, but remain unclear or otherwise
poorly explained. Among these observations is the non-homogeneous
distribution of GrAS, especially across our Detroit 562 monolayer. Bartelt et al
were the first to document the heterogeneity of streptococcal distribution on a
Detroit 562 monolayer nearly 30 yrs ago. Furthermore, they also reported that
the percentage of the bacterial inoculum followed an inverse relationship with
concentration as adherence percentage decreased as more bacteria was
applied. In cell cultures “saturated” with GrAS, they observed using microscopy
that only about 50% of the Detroit epithelial cells contained adherent
streptococci.
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In our current study, we used a multiplicity of infection of ~100:1 as an
inoculumdose that has been published in numerous streptococcal adherence
assays with Detroit 562 cells (Pancholi, 2003, Edwards 2008) as we sought to
identify streptococcal binding preferences between these and tonsil derived cell
types. We also regularly performed repeat experiments at 10 times our reported
MOI (1000:1) and also noted a decrease in the percentage of inoculum that
adhered (unpublished observations). Interestingly, we see an apparent maximum
to the number of absolute number of bacteria that can bind a monolayer. Based
on hemocytometer counts of confluent monolayers and CFU calculations on
blood agar, we found a maximum streptococcal saturation that was cell typespecific, ranging from 100:1 CFU (per Detroit 562 cell) to >350:1 CFU (per UTSCC-60B cell). Numbers no longer increased in our assays repeated in duplicate
on consecutive independent days at MOI’s 1000 - 3000:1 (data not shown).
Higher MOI’s were not attempted based on visual inspection of compromised
monolayer integrity.

The heterogeneous distribution observed in our study as well as by others may
be indicative of the well-established phenomena of oral streptococcal
aggregation. Numerous investigators have purported that GrAS bind human
salivary components, which in turns induces bacterial aggregation (Edwards
2008, Courtney 1991). While some of the described binding ligands responsible
for this process are unique to saliva (ie. gp340), other components such as
albumin and fibronectin can be readily found in standard growth media and along
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the surface of our epithelial cells. These components are known to provide a
“bridge” that facilitates enhanced epithelial adherence by the bacterium. Though
unlikely, it is possible that serum or epithelial surface matrix components not
evenly removed during washing steps might account for areas of localized
aggregation. Since this is a recurring observation seen specifically during Detroit
562 cell adherence assays, however, we reject the plausibility that this is the
case.

Another more intriguing explanation might be that there is heterogeneity within
the epithelial cell cultures. It may be that "receptor sites" on the epithelial cells
are present only during certain stages of the cell division cycle or that the
epithelial cells consist of subpopulations that differ in their ability to allow
streptococcal adherence. Since our in vitro assay uses epithelial monolayers at
nearly complete confluence (~90-95%), we make an assumption that the
respective cell types being compared (nasopharyngeal versus tonsil-derived), are
at similar stages of senescence with minimal proliferate subpopulations. This
may indeed be a more likely difference between Detroit 562 cells and other types
if their surface topography is exceptionally more affected by cell cycle stage.
Further analysis of the Detroit 562 cell surface in vitro is needed to continuously
revisit the implications for how this reflects the in vivo pharyngeal surface
whether this serves as a reliable model in vitro for streptococcal
pharyngotonsillitis.

116

In summary, using epithelia from an anatomically relevant, clinically – derived
source, the palatine tonsil, has allowed us to reproduce an appreciable “tropism”
in vitro. These observations, however, have many caveats that require further
investigation regarding the precarious difference in distribution patterns across
these anatomically related cell types, possibly alluding to tissue-specific
differences. The novel tonsil tumor lines UT-SCC-60A and UT-SCC-60B may
provide a powerful tool as a reliable system to investigate mechanisms for these
phenotypes and establish a basis for eventual confirmation by primary cells and
in vivo screens.
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§6.0 STREPTOCOCCAL TRANSCRIPTIONAL CHANGES UPON
ASSOCIATION WITH EPITHELIAL CELLS FROM HUMAN NASOPHARYNX
VERSUS PALATINE TONSIL

6.1 Introduction:
The arsenal of extracellular proteins and secreted virulence factors wielded by
Group A Streptococci GrAS have been extensively studied for the past 70 years,
which is a testament to the impact this bacterium has had on human disease.
While the extracellular presentation of these proteins is well studied, their
regulation and connectedness with other bacterial responses has only recently
become better understood. Advances in genome wide analysis over the last 1520 years has ushered in an enhanced appreciation of GrAS virulence by studying
the underlying molecular causes of disease pathogenesis. Since the first
complete sequence of the Streptococcus pyogenes genome was reported in
2001 by Ferretti et al, numerous laboratories have developed in vitro systems
using microarrays to capture snapshots of transcriptome –level shifts within the
pathogen in response to specific environmental stresses and conditions (Ferretti
2000, Shelburne, Sumby 2005) Sitkiewicz & Musser 2006). Studies have also
been performed in vivo using sample isolates from infected primates (Virtaneva
2005, Shea 2010) and humans (Livezey 2011). These studies have offered new
insights while bringing forth new questions. Previously described virulence
factors have been elaborated in a more genome-wide context while no fewer
than 13 new proteins involved in pathogenesis were found within the first ten
years of the advent of genome wide microarray (Musser 2009). Insight provided
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from studies using these molecular tools has already aided the design of
potential therapeutic and vaccine approaches to combatting streptococcal
disease (Ferretti 2001).
There are now 14 completed GrAS genome sequences (Table 6.1). Each
genome is approximately 1.9 Mb in size, with approximately 10% of the overall
gene content encoded on variably present exogenous genetic elements such as
prophages and integrated conjugative elements (ICE). It has been shown that
even among GrAS of the same M type, there is considerable variation in
prophage content and overall prophage-associated virulence factor profile
(Musser 2009). While phage represent only a minor fraction of the total GrAS
genome, they may account for up to 74% of the variation between strains
(Banks, Beres 2002).
Towards the effort of exploiting this new sequenced information and molecular
tools, our lab has recently developed novel oligonucleotide microarrays, which
represent every identified unique open reading frame from published group A
streptococcal serotypes. Moreover we have designed a suite of statistical
algorithms to extract biologically meaningful data generated from microarray
experiments that explore various streptococcal-host interactions. Uniquely, this
novel software suite provides analysis that incorporates the physical position of
genes on the bacterial chromosome to identify groupings of potentially related
genes and speculative operons. This powerful tool named GenomeCrawler
(www.rockefeller.edu/vaf/streparray.php) has been applied to investigate
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transcriptional changes in streptococci during various environmental conditions
and stages of infection (Ryan 2007, Aziz 2010, Juncosa 2012).

Table6.1. Sequenced S. pyogenes genomes

S. pyogenes
strain

M-type

Genome
Size (bp)

CDS
Count

SF370
MGAS5005
MGAS10270
MGAS315
SSI-1
MGAS10750
Manfredo
MGAS10394
MGAS2096
MGAS9429
MGAS8232
MGAS6180
NZ131
Alab49

1
1
2
3
3
4
5
6
12
12
18
28
49
53

1,852,441
1,838,554
1,928,252
1,900,521
1,894,275
1,937,111
1,841,271
1,899,877
1,860,355
1,836,467
1,895,017
1,897,573
1,815,724
1,827,308

1,697
1,865
1,987
1,865
1,861
1,979
1,803
1,886
1,898
1,878
1,845
1,894
1,699
1,773

% of CDS
with no
assigned
funtion
37.1
16.6
17.2
35.5
37.17
17.2
28.4
22.7
17.3
16.7
38.6
18
25.7

No. of
prophages
4
3
5
6
6
4
5
8
2
3
5
4
3
4

Reference
Ferretti, et al. 2001
Sumby, et al. 2005
Beres, et al. 2006
Beres, et al. 2002
Nakagawa, et al. 2003
Beres, et al. 2006
Holden, et al. 2007
Banks, et al. 2004
Beres, et al. 2006
Beres, et al. 2006
Smoot, et al. 2002
Green, et al. 2005
Mcshan, et al. 2008
Bessen, et al. 2011

The pathogen adapts transcriptionally to the host environment

While much of the earlier work on pathogen response to the host were focused
on changes in pH, temperature, carbohydrate sources, and superoxide
availability, our laboratory recently reported that streptococci actively responded
to a host cell small molecule, named SPIF, leading to phage induction and phage
encoded virulence expression (Broudy 2001, Broudy 2002). In order to cause
infection, the bacteria must first enter the oral cavity, generally via a low-glucose
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saliva aerosol, or by hand contact with nasal discharge from an infected
individual. This early inoculum then mixes with the oral milieu of the new host
eliciting adaptive transcriptional modifications appropriate to their new
environment.

An attempt to contextualize streptococcal adaptation to its host with respect to its
global effect transcriptionally has been recently undertaken by numerous groups.
Our lab has investigated the adaptive dynamics of the initial infection sequence
in an in vitro epithelial model measuring streptococcal transcriptome shifts during
co-culture with epithelial cell-free conditioned media (prepared from Detroit 562
cells). In comparison to bacteria cultured in freshly MEM as a control, GrAS
elaborated a global transcriptional response where over 430 individual genes
were differentially expressed. Similarly, after transient contact or “association”
with pharyngeal monolayers + conditioned media, streptococci differentially
expressed over 490 genes in comparison again to bacteria only cultured in fresh
MEM. Significantly, there was found to be a great deal of overlap in the genes
affected (337 genes) by the two experimental conditions (Juncosa 2012). The
bacterial transcriptome was sampled at various times post-exposure to host cells,
which revealed that streptococcal gene expression is dramatically remodeled
following initial exposure to the host environment but generally maintains its
directional change (up- or downregulated) through loose association with the
host cell surface (Juncosa 2012).
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Following the continuum of stages that lead to infection and disease, our lab
identified 79 genes differentially expressed by S. pyogenes upon adherence with
Detroit 562 monolayers in comparison to those bacteria only loosely associated
with this epithelium (Ryan 2007). The relatively few genes that were differentially
expressed in Ryan’s analysis points to a noteworthy distinction between this and
Juncosa et al’s experimental design. The bacterial group being compared for
relative “differences” in expression (adherent versus associated bacteria) has
presumably undergone the same large-scale transcriptome shifts upon initial
adaption to the host-modified environment. Differences in expression for
streptococci that have tightly bound to host cells (versus those only loosely
associated) may represent additional fine-tuning of the transcriptional program
necessary to initiate and maintain close contact with target epithelial cells (Ryan
2007, Juncosa 2012). These sets of experiments represent the first reported
account of transcriptional changes following S. pyogenes adaptive responses
from initial infection to adherence on the pharyngeal epithelial cell surface.

While we have shown that a single streptococcal strain may alter its adaptation
and colonization mechanisms based on host environment and stage of infection,
it has yet to be demonstrated whether this pathogen elicits a unique and
transcriptionally discernable response to different mucosal epithelial cells types
associated with the human pharynx following mere transient contact as might
naturally occur in vivo during infection. Due to anatomical proximity, comparing
the bacteria’s response to the related epithelia of the nasopharynx and palatine
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tonsil may offer a unique appreciation for the extent to which a “throat selective”
GrAS M type strain might distinguish between two host cells within their only
natural reservoir. Developing an in vivo system would likely prove irreconcilably
challenging to sufficiently control for the expected dispersal of the inoculum
throughout the pharyngeal mucosa by the action of host mucocilliary secretions.
Furthermore, bacterial sampling post-inoculation would be limited to only
adherent bacteria, which misses the important transcriptional status following
introduction to the oropharynx likely important for determining tropism. As
reported earlier, we have observed significant phenotypic differences in adhesion
and invasion of host cells by streptococci following co-culture with tonsil-derived
epithelial cells versus nasopharyngeal cells. Informed by these observations, we
hypothesize that there are dynamic transcriptional shifts elaborated by the
bacteria during co-culture, which may differ significantly between the respective
epithelial cell types.

In the following chapter, we describe our study capturing the relative changes in
S. pyogenes transcriptional responses to co-culture with a newly described
human palatine tonsil tumor cell line, UT-SCC-60B, as compared to the Detroit
562 nasopharyngeal epithelial cell line. Using a custom microarray platform and
novel clustering algorithms, our results revealed the upregulated operons that we
then test to further confirm our novel cell line’s ability to model a previously
described response to human primary tonsil epithelial cells
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§6.2 Results

§6.2.1 Differential expression of individual genes during association with human
tonsil epithelial cell monolayers
Streptococcus pyogenes M type 1 strain SF370 was co-cultured in vitro with
epithelial tumor lines derived from two anatomically proximate locations often
regarded indistinguishably as parts of the human “throat”: the nasopharynx
(Detroit 562) and palatine tonsil (UT-SCC-60B), respectively. We employed an
established association assay (Ryan 2007) (Juncosa 2012), as previously
described. Associated bacteria were recovered and RNA was immediately
extracted for analysis of transcript expression, capturing a snapshot of the
streptococcal transcriptional profiles following 2.5h co-culture with their
respective monolayers. We performed 8 independent experimental replicates on
separate days to incorporate biological variation into our experimental design.

Our control for this experiment was the cDNA isolated from bacteria co-cultured
with Detroit 562 cells. Accordingly, our “standard” color configuration
incorporated Cy3 (green) to control Detroit 562 cDNA, while Cy5 (red) was
incorporated into UT-SCC-60B cDNA. Dye swap experiments were included to
account for technical variability in dye incorporation. (Appendix 6.1)
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Using robust summary statistics and permutation algorithms, our analysis of the
replicate arrays identified 78 individual genes (4.4% of the total SF370 genome)
differentially expressed when streptococci are exposed to palatine tonsil
epithelial cells as compared to Detroit 562 cells. Only genes expressing log2-fold
changes with p-values <0.05, as determined by the Westfall-Young step down
permutation algorithm, were considered significant and included in Tables 6.1
and 6.2. To further understand the relative transcriptional shifts taking place in
the bacteria co-cultured with palatine tonsil epithelia, we classified these
differentially expressed genes according to the COGs (Clusters of Orthologous
Groups of proteins) database. This classification system predicts function based
upon phylogenetic relationships and assigns genes to the broad categories of
basic cellular processes (Tatusov 2000). While nearly 40% of our gene list
belonged to uncharacterized phage or had otherwise unknown / predicted
functions, the remaining COGs list includes a range of functions from regulation
of virulence, to lipid transport and metabolism, to control of the cell cycle. We
found that the majority of the significantly affected genes in our study were up
regulated (58%, 45/78) as compared to control (Tables 6.2 and 6.3).
Interestingly, while most COGs contained genes that were either up- or downregulated, fourCOGs included genes that were only up-regulatedted: (1) lipid
transport and metabolism; (2) post translational modifications, protein turnover,
and chaperones; (3) cell well / membrane / envelope biogenesis; and (4)
nucleotide transport and metabolism. We note thatof the down-regulated genes
across all COGs, approximately 64% were of unknown function and/ or were
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phage-associated, leaving the consequence of these shifts in expression difficult
to speculate until more information is collected on the putative roles of these
genes.

Phage-associated genes
33 of the genes significantly down-regulated during co-culture with the tonsilderived line, 12 (36%) were phage-related. In fact, we found that all of the phage
genes which underwent significant fold changes were downregulated. Although
SF370 contains one inducible (Φ370.1) and three defective (Φ370.2, Φ370.3 and
Φ370.4) integrated prophages, we noted the differential expression of genes
from both inducible and non-inducible phage and the prophage integrated
conjugative elements (ICE)-like region of difference, designated Φ370.RD1,
which putatively encodes a streptin lantibiotic product (Musser 2007).
Among the known phage genes that were differentially expressed, 6 (50%)
encoded structural proteins necessary for bacteriophage assembly. Of note, the
head morphogenesis gene (Spy0681) for inducible SF370 prophage, Φ370.1
was down-regulated, and both the head morphogenesis (Spy1464) and tail fiber
(Spy1441) genes for a non-inducible prophage, Φ370.3, were downregulated.

Virulence-associated genes
We did identify four differentially expressed genes that are known to be
associated with streptococcal virulence: SagA (Spy0738), vrf (Spy0887), pilus
minor subunit (spy0130,) and amrA (Spy0797). Three of these virulence genes
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were observed to be upregulated while the Streptolysin S associated gene A,
SagA, was down-regulated. Interestingly, the largest log2-fold change observed
in our analysis in either the positive or negative directions occurred by virulence
genes. SagA experienced the most highly negative Log2-fold change of -2.20
while the average fold decrease among downregulated genes was only about 1.13 Log2-fold change. Pilus minor subunit spy0130 (also regarded as ancillary
protein 2), however, had an increased relative expression by Log2-fold of 3.2
while the average increase in up regulated genes was 1.46. In addition, the most
significant (lowest p-value) of all differentially expressed genes meeting our
algorithm’s criteria was also Spy0130. The remaining upregulated virulence
genes will be discussed following our further analysis of this data with the
additional context of neighbor gene clustering and its implications.

Based on the known relationship between subgroups of genes being differentially
expressed, preliminary speculation can be made regarding the bacteria’s
adaptive differences between co-culture in UT-SCC-60B versus Detroit 562 cells.
For example, there may be differences in metabolism, indicated by the increase
in gene expression for lipid transport and metabolism mechanisms, concomitant
with the down regulation of two carbohydrate metabolism genes. Alternatively, it
is possible that the bacteria are dividing more in the presence of the tonsilderived monolayer as indicated by the increased expression of cell wall
biogenesis and post-translational modification genes, both of which would require
lipid metabolism and transport.
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As this information is only a snapshot of the bacteria’s transcriptional state a
single moment in time, greater context regarding the prior transcriptional status
would provide a more comprehensive picture of individual genes. Additional
context however may be achievable by incorporating information based on the
expected contribution additional related genes and pathways may play not
represented under our initial analysis

128

Table 6.2. Differential expression of genes following SF370 co-culture
with human tonsil epithelium versus control
Streptococcal genes exhibiting significant changes in expression during
association with palatine tonsil-derived cells compared with bacteria
associated with Detroit 562 (nasopharyngeal) cells. Genes are organized by
Clusters of Orthologous Groups of proteins (COG) classification* as described
in the annotated S. pyogenes SF370 genome.
*Note – “Virulence” designation assigned to known transcriptional regulators of
virulence and any gene encoding established virulent factors / products
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COG Classification

Total

Up-regulated
genes

Down-regulated
genes

Function Unknown
Phage
Translation, ribosomal structure and
biogenesis
Lipid transport and metabolism
Post-translational modification, protein
turnover, chaperones
Nucleotide transport and metabolism
Virulence*
Carbohydrate transport and
metabolism
Inorganic ion transport and
metabolism
cell wall / membrane / envelope
biogenesis
Amino acid transport and metabolism
Replication, recombination, and repair
Cell cycle control, cell division
Energy production and conversion
General function prediction only

17
12
9

8
0
7

9
12
2

7
6

7
6

0
0

4
4
3

4
3
1

0
1
2

3

2

1

3

3

0

2
2
2
1
1

1
0
1
0
1

1
2
1
1
0

Total

78

45

33
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Table 6.3 Streptococcal genes exhibiting significant changes during association with UTSCC-60B monolayers compared to association with Detroit 562.
Genes rank is ordered by highest significance (lowest p-value calculated using Westfall-

a

Young permutations).
Locus tag, COG designation, and gene function / product designations from the

b

annotated SF370 genome. Phage-associated genes have been highlighted in purple.
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p-Value
Ranka

Locus Tagb

Gene
Nameb

COG Designationb
virulence

Known or proposed function /
product
Minor Pilin subunit; Links pilus to
cell wall (AP2)
Stand-alone regulator.
Repression of speB via RopB
Stand-alone regulator. Activation
of Mga regulon
(sagA) streptolysin S associated
protein

(WestfallYoung)

Log2-Fold
Change

0.00E+00

3.62

0.00E+00

1.49

5.20E-03

1.05

3.06E-02

-2.20



30 S ribosomal protein S10

2.00E-04

2.62



50S ribosomal protein L1

3.40E-03

1.90

1.07E-02

1.05

1.63E-02

1.31

50S ribosomal protein L28

2.02E-02

1.54

30S ribosomal protein S1

3.87E-02

1.24

tmRNA-binding protein

1.90E-03

-0.88



ribosomal biogenesis GTPase

2.82E-02

-1.01



tRNA (guanine-N(1)-)methyltransferase

2.95E-02

1.14



1

M1_Spy_0130

5

M1_Spy_0887

vfr

virulence

34

M1_Spy_0797

amrA

virulence

66

M1_Spy_0738

sagA

virulence

8

M1_Spy_0047

rpsJ

31

M1_Spy_0461

rplA

43

M1_Spy_0886

engB

49

M1_Spy_1770

gatB

55

M1_Spy_1888

rpmB

74

M1_Spy_0913

rpsA

26

M1_Spy_0504

smpB

64

M1_Spy_1161

rgbA

65

M1_Spy_0849

trmD

33

M1_Spy_1755

Transcription

MarR family [REGULATOR]

4.40E-03

1.25

41

M1_Spy_0503

Transcription

exoribonuclease R

8.50E-03

-0.81

Smf family DNA processing
protein

2.90E-03

-1.19

mutator protein / Oxidative
damage repair enzymes

4.25E-02

-1.18

aminotransferase

0.00E+00

1.37

tRNA (uracil-5-)methyltransferase

8.00E-03

1.05

27

M1_Spy_1163

smf

76

M1_Spy_1510

mutT

3

M1_Spy_0288

csdA

39

M1_Spy_1173

gid

Translation, ribosomal
structure and biogenesis
Translation, ribosomal
structure and biogenesis
Translation, ribosomal
structure and biogenesis
Translation, ribosomal
structure and biogenesis
Translation, ribosomal
structure and biogenesis
Translation, ribosomal
structure and biogenesis
Translation, ribosomal
structure and biogenesis
Translation, ribosomal
structure and biogenesis
Translation, ribosomal
structure and biogenesis

Replication,
recombination, and
repair
Replication,
recombination, and
repair
Post-Translational
modifications, protein
turnover, chaperones
Post-Translational
modifications, protein
turnover, chaperones
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ribosome biogenesis GTPbinding protein YsxC
aspartyl/glutamyl-tRNA
amidotransferase subunit B


















56

M1_Spy_0885

clpX

61

M1_Spy_1374

nrdH

69

M1_Spy_0287

7

M1_Spy_0850

11

M1_Spy_1464

sufD

Post-Translational
modifications, protein
turnover, chaperones
Post-Translational
modifications, protein
turnover, chaperones
Post-Translational
modifications, protein
turnover, chaperones
Post-Translational
modification, protein
turnover, chaperones

ATP-dependent protease ATPbinding subunit

2.04E-02

0.90

glutaredoxin

2.52E-02

1.86

ABC-type transport system
involved in Fe-S cluster
assembly

3.32E-02

1.01

thioredoxin reductase

2.00E-04

1.89

Phage - structural

(Φ370.3) Head morphogenesis

2.00E-04

-1.34



2.00E-04

-1.35








14

M1_Spy_1465

Phage - structural

(Φ370.3) putative structural
protein

38

M1_Spy_0945

Phage - UNKNOWN

(Φ370.2) hypothetical protein

7.20E-03

-1.05



50

M1_Spy_1487

Phage - UNKNOWN

(Φ370.3) hypothetical protein

1.65E-02

-0.92



67

M1_Spy_1442

Phage - UNKNOWN

(Φ370.3) hypothetical protein

3.09E-02

-1.05



71

M1_Spy_1075

Phage - UNKNOWN

(Φ370-RD.1) hypothetical
protein

3.50E-02

-1.11



18

M1_Spy_1441

Phage - structural

(Φ370.3) Tail fiber gene

5.00E-04

-1.06



30

M1_Spy_0681

Phage - structural

(Φ370.1) Head morphogenesis

3.30E-03

-0.98



53

M1_Spy_1457

Phage - structural

1.78E-02

-1.01



57

M1_Spy_0661

Phage - structural

2.09E-02

-0.72



29

M1_Spy_1438

Phage - pathogenesis

(Φ370.3) Muramidase

3.00E-03

-1.10



21

M1_Spy_0943

Phage - Lysogeny

(Φ370.2) Lysogeny

6.00E-04

-1.15



6

M1_Spy_2206

guaB

1.20

M1_Spy_1378

nrdF.2

2.00E-04

1.65

24

M1_Spy_1375

nrdE.2

1.40E-03

1.40

72

M1_Spy_0894

deoD2

inosine 5\'-monophosphate
dehydrogenase
ribonucleotide-diphosphate
reductase subunit beta
ribonucleotide-diphosphate
reductase subunit alpha
purine nucleoside
phosphorylase

2.00E-04

9

Nucleotide transport and
metabolism
Nucleotide transport and
metabolism
Nucleotide transport and
metabolism
Nucleotide transport and
metabolism

3.69E-02

0.78

13

M1_Spy_1751

fabK

Lipid transport and
metabolism

trans-2-enoyl-ACP reductase II

2.00E-04

1.66

(Φ370.3) putative structural
protein
(Φ370.1) putative structural
protein
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16

M1_Spy_1749

19

M1_Spy_0880

28

M1_Spy_1747

44

M1_Spy_0881

48

M1_Spy_1745

60

M1_Spy_1746

23

M1_Spy_1240

52

M1_Spy_0319

75

M1_Spy_1242

62

Lipid transport and
metabolism
Lipid transport and
mvaS.1
metabolism
Lipid transport and
accB
metabolism
Lipid transport and
mvaS.2
metabolism
Lipid transport and
accC
metabolism
Lipid transport and
fabZ
metabolism

3-ketoacyl-ACP reductase

fabG

4.00E-04

1.45

5.00E-04

1.23

3.00E-03

1.57

1.11E-02

1.17

acetyl-CoA carboxylase biotin

1.56E-02

1.77

(3R)-hydroxymyristoyl-ACP
dehydratase

2.35E-02

1.37

1.20E-03

1.09

1.74E-02

-1.57

4.09E-02

1.00

3-hydroxy-3-methylglutarylcoenzyme A
acetyl-CoA carboxylase biotin
carboxyl carrier protein subunit
3-hydroxy-3-methylglutaryl-CoA
synthase








Inorganic ion transport
and metabolism
Inorganic ion transport
and metabolism
Inorganic ion transport
and metabolism

phosphate uptake regulatory
protein
ABC transporter substrate
binding protein
phosphate transporter ATPbinding protein

M1_Spy_0867

General function
prediction only

ABC transporter ATP-binding
protein

2.60E-02

0.87

10

M1_Spy_1193

Function unknown

hypothetical protein

2.00E-04

-1.08

12

M1_Spy_2153

Function unknown

hypothetical protein

2.00E-04

1.71

15

M1_Spy_1591

Function unknown

hypothetical protein

3.00E-04

-1.44

17

M1_Spy_1736

Function unknown

hypothetical protein

5.00E-04

1.64

20

M1_Spy_1460

Function unknown

hypothetical protein

5.00E-04

-1.64



32

M1_Spy_1731

Function unknown

hypothetical protein

4.20E-03

-1.02



36

M1_Spy_0796

Function unknown

hypothetical protein

6.20E-03

1.34

37

M1_Spy_0439

Function unknown

hypothetical protein

6.70E-03

1.01

40

M1_Spy_1940

Function unknown

hypothetical protein

8.00E-03

2.23

42

M1_Spy_1290

Function unknown

hypothetical protein (signal
peptide)

1.01E-02

1.39

46

M1_Spy_1482

Function unknown

hypothetical protein

1.31E-02

-1.24



51

M1_Spy_0382

Function unknown

hypothetical protein

1.74E-02

-0.70



phoU

pstB2
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54

M1_Spy_1263

Function unknown

small membrane integral protein

1.86E-02

-0.94

59

M1_Spy_0604

Function unknown

hypothetical protein

2.30E-02

0.67

68

M1_Spy_1945

Function unknown

hypothetical protein

3.14E-02

1.90

70

M1_Spy_1530

Function unknown

hypothetical protein

3.36E-02

-0.78



73

M1_Spy_1405

Function unknown

hypothetical protein

3.75E-02

-1.71



78

M1_Spy_1192

Energy production and
conversion

citrate lyase synthetase

4.77E-02

-0.60



22

M1_Spy_1897

Small conductance
mechanosensitive channel

8.00E-04

1.23

25

M1_Spy_0794

glycosyl transferase

1.80E-03

0.87

47

M1_Spy_1358

murZ

UDP-N-acetylglucosamine 1carboxyvinyltransferase

1.52E-02

1.50

2

M1_Spy_2185

gidA

Cell cycle control, cell
division

tRNA uridine 5carboxymethylaminomethyl
modification enzyme

0.00E+00

2.42

77

M1_Spy_1730

hit

Cell cycle control, cell
division

Diadenosine tetraphosphate
hydrolase

4.35E-02

-0.79

35

M1_Spy_1854

glpF.2

glycerol uptake facilitator protein

5.80E-03

1.23

58

M1_Spy_1711

2.22E-02

-1.66



63

M1_Spy_1399

2.75E-02

-1.02



4

M1_Spy_1506

0.00E+00

2.26

45

M1_Spy_1542

1.20E-02

-1.21

citC

nagB

cell wall / membrane /
envelope biogenesis
cell wall / membrane /
envelope biogenesis
cell wall / membrane /
envelope biogenesis

Carbohydrate transport
and metabolism
Carbohydrate transport
and metabolism
Carbohydrate transport
and metabolism
Amino acid transport and
metabolism
Amino acid transport and
metabolism
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PTS system galactose-specific
transporter subunit IIA
N-acetylglucosamine-6phosphate isomerase
amino acid ABC transporter
ATP-binding protein
Dipeptidase (glutathionemediated detox)















6.2.2 Applying neighbor clustering algorithms reveal additional insights on S.
pyogenes gene expression profiles
“GenomeCrawler is a dynamic windowing (“GenomeCrawler”) algorithm that
sequentially steps through the microarray data and identifies clusters of adjacent
genes exhibiting similar fold changes in expression. Neighbor clustering was
designed to identify expanded groupings of potentially related genes from our
array data by incorporating two reliable predictors of genes that share common
function or regulation, namely physical proximity and similar expression profiles
GenomeCrawler applies a separate permutation algorithm, using the sum of
each gene’s t-statistics to calculate adjusted P values for each cluster.” We
applied the algorithms to our microarray data set and then visually inspect the
resulting clusters, omitting those incongruent with the neighbor cluster definition
as described in the Methods section.

A number of different sized clusters containing the same gene(s) remained
following initial visual curating. To avoid overlapping cluster groups, we curate
clusters and chose the most significant grouping containing the largest number of
members A total of 55 clusters containing 216 genes were identified by this.
Clusters ranged in grouping sizes from including 2 to 32 genes. (Table 6.4)

In some cases, resulting clusters identified previously described or predicted
operons (i.e. Spy0127 – Spy 130). In others, our analysis identified novel
groupings of genes, which may indicate functional relationships not previously
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known. Of the 78 individual genes we identified in our initial analysis as
undergoing significant differential expression, 62 (78%) were components of
significant clusters whereas 16 remained un-grouped. In approximately 25% of
the resulting groupings (n = 14), we identified significance gene clusters, even
though none of the cluster members had initially identified as undergoing
significant log2-fold changes in expression. In such clusters, our algorithm
revealed that the combined contributions of the non-significant gene fold changes
resulted in a significant cluster. Ryan et al initially coined this concept of
“significance by combined gene contributions” in their published work employing
the Genome Crawler algorithm (Ryan 2007).

A nearly equivalent number of clusters were up regulated (29) as were down
regulated (26). We identified eight significantly down-regulated phage gene
clusters, which accounting for 30% of all gene clusters with noted decreases in
expression.

Using a previously described scheme for organizing neighbor clustering analysis
data (Ryan 2007), we qualitatively subdivided our clusters into three categories
based on the availability of functional information on their gene content. Twentythree (42%) of our 55 neighbor clusters were designated as Type I clusters,
composed of genes that have been functionally defined either in the annotated
genome or in subsequent published reports. Twenty-seven (49%) were
designated Type II clusters containing both known and unknown genes. Finally, 5
137

(.09%) were categorized as Type III, which contained only unknown genes.
(Table 6.4)
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Table 6.4 Qualifying neighbor clusters identified in the S. pyogenes SF370 genome
by GenomeCrawler analysis of palatine tonsil epithelia – associated bacteria versus
nasopharyngeal – associated microarray data. Type I gene clusters – contain only
genes of known function (highlighted in shades of yellow). Type II gene clusters –
combination of both genes of known and unknown function (highlighted in shades of
green). Type III gene clusters – contain only genes of unknown function (highlighted
in shades of blue)
Locus (Spy) numbers and common gene names are as designated in the annotated

a

SF370 genome. Genome function designations are also from annotated genome.
Fold change P values calculated by Cyber-T and Westfall-Young permutations as
previously described. Bold Log2Fold indicate downregulation ( - ) change in
expression ratios between palatine tonsil epithelia – associated streptococci versus
control nasopharyngeal –associated streptococci. Astericks indicates individual gene
not scored as significant as p<0.05.
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Start

Stop

Spy0047
-

Spy0078

Function / COGa

Translation,
ribosomal structure,
and biogenesis

p-valueb
(Cluster)

Cluster

Member

Gene
Namea

1.00E-04

Spy0047

rpsJ

Spy0049

rplC

Spy0050

rplD

Spy0051

rplW

Spy0052

rplB

Spy0053
Spy0054

rpsS

Spy0055

rplV

Spy0056

rpsC

Spy0057
Spy0058

rplP

Spy0059

rpmC

Spy0060

rpsQ

a

30S ribosomal protein
S10
50S ribosomal protein
L3
50S ribosomal protein
L4
50S ribosomal protein
L23
50S ribosomal protein
L2
30S ribosomal protein
S19
50S ribosomal protein
L22
30S ribosomal protein
S3
50S ribosomal protein
L16

Spy0062

rplX

Spy0063

rplE

Spy0064

rpsN

Spy0065

rpsH

Spy0066

rplF

Spy0067
Spy0068

rplR

50S ribosomal protein
L29
30S ribosomal protein
S17
50S ribosomal protein
L14
50S ribosomal protein
L24
50S ribosomal protein
L5
30S ribosomal protein
S14
30S ribosomal protein
S8
50S ribosomal protein
L6
50S ribosomal protein
L6

Spy0069
Spy0070

rpsE

30S ribosomal protein
S5

Spy0071

rpmD

Spy0072

rplO

50S ribosomal protein
L30
50S ribosomal protein
L15

Spy0073

secY

putative preprotein
translocase

Spy0061

Intracellular
trafficking and
scretion

Description / Gene
Product
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p-value

c

(Indiv.
genes)

∆

Log2
Fold

2.00E-04

2.62

0.1109*

2.28

0.3993*

2.34

0.4364*

1.22

0.2411*

1.54

0.7039*
0.1009*

1.30
1.12

0.1605*

1.28

0.3367*

1.79

0.1226*
0.1373*

0.94
1.12

0.6973*

1.35

0.2557*

1.17

0.2004*

1.35

0.7391*

1.57

0.4231*

1.12

0.0945*

1.43

0.7465*

1.48

0.2186*

1.36

0.3756*
0.3446*

1.37
1.81

0.56*
0.5687*

1.51
1.72

0.8102*

0.49

1*

0.01

1*

0.06

Nucleotide transport
and metabolism

Spy012
7-

Spy0130

virulence

7.00E-04

Spy0074

adk

Spy0075

infA

Spy0076

rpmJ

Spy0077

rpsM

Spy0078

rpsK

Spy0127

SipA1

Spy0128
Spy0129

Spy028
5-

Spy0290

Spy0130

Post-Translational
modification,
protein turnover,
chaperones

Amino acid transport
& metabolism
Energy production
and conversion

Spy031
9-

Spy0321

Inorganic ion
transport and
metabolism

SrtC1

Spy0285

sufC

Spy0287

sufD

Spy0288

csdA

putative ABC
transporter (ATPbinding protein)
ABC-type transport
system involved in Fe-S
cluster assembly
putative
aminotransferase

Spy0327

ntpJ

similar to NifU protein
conserved hypothetical
protein
ABC transporter
substrate binding
protein
putative ABC
transporter (ATPbinding protein)h
putative ABC
transporter (permease
protein)
K+ transport systems,
NAD-binding
component
V-type Na+ -ATPase
subunit J

Spy0460

rplK

Spy0461

rplA

Spy0289
Spy0290
0.0134

Spy0319
Spy0320
Spy0321

Spy032
6-

Spy046
0-

Spy050
3-

Spy0327

Spy0461

Spy0505

Inorganic ion
transport
Translation,
ribosomal structure,
and biogenesis

Transcription

0.0329

0.0155

0.0042

adenylate kinase
putative translation
initiation factor IF-1
50S ribosomal protein
B
30S ribosomal protein
S13
30S ribosomal protein
S11
putative signal
peptidase I
major pilus (shaft)
subunit
pilus associated
sortase C1
pilin minor subunit / cell
wall linker

Spy0326

Spy0503
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50S ribosomal protein
L11
50S ribosomal protein
L1
putative
exoribonuclease R /
RNAse

0.9893*

0.35

0.8102*

0.49

1*

0.01

1*

0.06

0.9893*

0.35

0.7331*

1.38

0.553*

2.46

0.9934*

0.93

0

3.62

0.2725*

0.83

0.0332

1.01

0

1.37

0.2108*

1.22

0.445*

1.34

0.0174

-1.57

0.3305*

-1.50

0.367*

-1.14

0.0655*

0.76

0.3148*

0.94

0.4118*

1.98

0.0034

1.90

0.0085

-0.81

Spy051
1-

Spy075
5-

Spy084
9-

Spy0513

Spy0761

Spy0852

Translation,
ribosomal structure,
and biogenesis
Post-Translational
modification, protein
turnover, chaperones
Amino acid
transport and
metabolism
Energy production
and conversion

Energy production /
conversion

Translation,
ribosomal structure,
and biogenesis
Posttranslational
modification, protein
turnover, chaperones
General function
prediction only

Spy0504
Spy0505
0.0407

Spy109
7-

Spy0881

Lipid transport and
metabolism

Spy1100

Coenzyme transport
and metabolism

Spy0511

gloA

Spy0512

0.0088

0.0016

Spy0513

pepQ

Spy0755

atpB

Spy0756

atpF

Spy0757

atpH

Spy0758

atpA

Spy0759

atpG

Spy0760

atpD

Spy0761

atpC

Spy0849

trmD

0.021

0.0019

-0.88

putative glutamine
cyclotransferase

0.128*

-0.78

0.7264*

-0.73

0.1863*

-0.84

0.2885*

-0.75

0.8932*

0.39

0.6166*

0.52

0.348*

0.70

0.593*

0.86

0.1905*

0.78

0.3601*

0.79

0.0874*

0.73

0.0295

1.14

0.0002

1.89

0.8808*

1.26

0.05

1.16

0.0005

1.23

0.0111

1.17

0.7809*

-0.36

putative
lactoylglutathione lyase
putative NAD(P)H-flavin
oxidoreductase
putative XAA-PRO
dipeptidase; X-PRO
dipeptidase
putative protontranslocating ATPase a
subunit
putative protontranslocating ATPase,
subunit b
putative protontranslocating ATPase,
delta subunit
putative protontranslocating ATPase,
alpha subunit
putative protontranslocating ATPase,
gamma subunit
putative protontranslocating ATPase,
beta subunit
putative protontranslocating ATPase,
epsilon subunit
putative tRNA
(guanine-N1)methyltransferase

Spy0852

apbA

Spy0880

mvaS.1

Spy0881

mvaS.2

Spy1097

folE

GTP cyclohydrolase

Spy0851

0.005

tmRNA-binding protein

putative thioredoxin
reductase
probable regulatory
protein
putative 2dehydropantoate 2reductase
putative 3-hydroxy-3methylglutarylcoenzyme A
putative 3-hydroxy-3methylglutarylcoenzyme A synthase
(HMG-CoA synthase)

Spy0850

Coenzyme transport
and metabolism
Spy088
0-

smpB
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Spy116
1-

Spy124
0-

Spy125
4-

Spy135
8-

Spy137
4-

Spy137
8-

Spy174
5-

Spy1163

Spy1243

Spy1257

Spy1359

Spy1375

Spy1379

Spy1749

Translation,
ribosomal structure,
and biogenesis
Replication,
recombination and
repair

Inorganic ion
tansport and
metabolism

Defense
mechanisms

Cell wall/membrane
biogenesis
Coenzyme transport
and metabolism
Post-Translational
modification, protein
turnover, chaperones
Nucleotide transport
and metabolism
Nucleotide transport
and metabolism
Inorganic ion tansport
and metabolism
Lipid Transport and
metabolism

0.0066

0.0055

0.0333

0.0332

0.0055

0.0159

Spy1098

folP

Spy1099

folQ

Spy1100

folK

Spy1161

Predicted GTPases

Spy1162

rnh

Spy1163

smf

Spy1240

phoU

Spy1241

pstB

Spy1242

pstB2

Spy1243

pstC

Spy1254

Spy1255

SalY?

Spy1257

SalX?

Spy1358

murZ

Spy1359

metK

Spy1374

nrdH

Spy1375

nrdE.2

Spy1378

nrdF.2

Spy1379
0.0019

Spy1745
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dihydropteroate
synthase
dihydroneopterin
aldolase
hydroxymethylpterin
pyrophosphokinase

accC

putative ribonuclease
HII
putative DNA
processing protein (Smf
family)
putative phosphate
uptake regulatory
protein
phosphate ABC
transporter (ATPbinding protein)
putative phosphate
ABC transporter (ATPbinding protein
putative phosphate
ABC transporter
COG577: ABC-type
antimicrobial peptide
transport system,
permease component
COG1136: ABC-type
antimicrobial peptide
transport
system,ATPase
component
putative UDP-Nacetylglucosamine 1S-adenosylmethionine
synthetase

0.4987*

-0.52

0.1257*

-0.58

0.1925*

-0.57

0.0282

-1.01

0.4548*

-0.59

0.0029

-1.19

0.0012

1.09

0.8424*

0.48

0.0409

1.00

0.2706*

0.89

0.473*

-0.65

0.1656

-0.84

0.4026

-0.96

0.0152
0.7516*

-0.07

0.0252

1.86

0.0014

1.40

putative glutaredoxin
putative ribonucleotide
reductase alpha-chain
ribonucleotide
diphosphate reductase
small subunit
putative chloride
channel protein

0.0002

1.65

0.9943*

0.49

acetyl-CoA carboxylase
biotin

0.0156

1.77

Spy175
1-

Spy1758

Lipid Transport and
metabolism

1.40E-03

Spy1746

fabZ

Spy1747

accB

(3R)-hydroxymyristoylACP dehydratase
acetyl-CoA carboxylase
biotin carboxyl carrier
protein subunit

Spy1749

fabG

Spy1751

fabK

Spy1753

acpP

Spy1754

fabH

Spy194
0-

Spy209
2-

Spy028
1-

Spy035
8-

Spy1941

Lipid Transport and
metabolism
Post-Translational
modification, protein
turnover, chaperones
Translation,
ribosomal structure,
and biogenesis
Translation,
ribosomal structure,
and biogenesis

Spy2093

Translation,
ribosomal structure,
and biogenesis

Spy1772

Spy0282

General function
prediction only

Spy0367

Cell wall/membrane
biogenesis
General function
prediction only
Function unknown
Cell wall/ membrane/
envelope biogenesis

0.0101

0.0424

0.0312

2.00E-04

0.014

1.37

0.003

1.57

3-ketoacyl-ACP
reductase

0.0004

1.45

putative trans-2-enoylACP reductase II

0.0002

1.66

0.5995*

0.58

0.3849*

0.96

0.0044

1.25

0.1324*

0.93

0.0163

1.31

0.1124*

1.07

0.3028*

0.90

0.008

2.23

0.9493*

0.85

0.1349*

1.85

0.1684*

2.05

0.8124*

0.68

0.4895*

0.71

0.1413*

0.53

0.9308*

0.36

0.9301*

0.47

putative acyl carrier
protein
fabH putative betaketoacyl-[ACP]
synthase III
[REGULATOR]
MarR family

Spy1755

Spy177
0-

0.0235

Spy1758

phaB

Spy1770

gatB

Spy1771

gatA

Spy1772

gatC

putative enoyl CoA
hydratase
aspartyl/glutamyl-tRNA
amidotransferase
subunit B
Glutamyl-tRNA Gln
amidotransferase
subunit A
Glu-tRNA Gln
amidotransferase
subunit C

Spy1941

cysS

hypothetical protein
cysteinyl-tRNA
synthetase

Spy2092

rpsB

Spy2093

tsf

Spy0281

mecA

Spy0282

rgpG

Spy1940

Spy0358
Spy0359
Spy0361
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glr

30S ribosomal protein
S2
putative elongation
factor TS
putative negative
regulator of genetic
competence
possibly involved in
regulation of genetic
competence
putative membrane
spanning protein
Uncharacterized protein
conserved in bacteria
glutamate racemase

Nucleotide transport
and metabolism
General function
prediction only
Multifunctional
Replication,
recombination and
repair

Spy037
9-

Spy043
9-

Spy056
7-

Spy065
8-

Spy0382

Spy0441

Spy0569

Spy0667

Xanthosine
triphosphate
pyrophosphatase

Spy0362
Spy0363
Spy0364
Spy0365

XerD

Function unknown

Spy0366

scpA

Transcription
Posttranslational
modification, protein
turnover, chaperones

Spy0367

scpB

Spy0379

pflC

0.0129

Energy production
and conversion

Spy0380

function unknown

Spy0382

function unknown
Lipid transport and
metabolism
General function
prediction only
General function
prediction only
General function
prediction only
Intracellular
trafficking and
secretion

0.0052

Phage

0.0022

Spy0439
Spy0440

fabG

Spy0441
0.0493

Spy0567
Spy0568
Spy0569
Spy0658
Spy0659
Spy0660
Spy0661
Spy0663
Spy0664
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ftsY

phosphoesterase
CBS domain
site-specific tyrosine
recombinase XerD-like
protein
segregation and
condensation protein A
segregation and
condensation protein B
pyruvate-formate lyase
activating enzyme
Exopolyphosphatase;
Possible adhesin
(intrageneric
coaggregation-relevant
adhesin)
conserved
streptococcal
hypothetical protein
hypothetical protein
3-ketoacyl-ACP
reductase
NAD-dependent
oxidoreductase
Predicted hydrolases of
the HAD superfamily
Predicted hydrolases of
the HAD superfamily
putative signal
recognition particle
(docking protein)
(Φ370.1) putative Crolike protein, phage
associated
(Φ370.1) hypothetical
protein, phage
associated
(Φ370.1) hypothetical
protein, phage
associated
(Φ370.1) hypothetical
protein, phage
associated
(Φ370.1) hypothetical
protein, phage
associated
(Φ370.1) hypothetical
protein, phage

0.5768*

0.53

0.6548*
0.5062*

0.48
0.61

0.5139*

0.67

0.5124*

0.47

0.6457*

0.53

0.2173*

-1.27

0.4667*

-0.70

0.0174

-0.70

0.0067

1.01

0.0645*

1.18

0.1238*

1.10

0.2834*

0.90

0.7443*

0.63

0.3685*

0.49

0.3003*

-0.67

0.6513*

-0.67

0.3359*

-0.73

0.0209

-0.72

0.9237*

-0.51

0.6749*

-0.61

associated

Spy0665
Spy0666
Spy0667
Spy068
0-

Spy0681

Phage

0.0073

Spy0680

Spy0681

Spy079
1-

Spy0798

Cell wall/membrane
biogenesis

1.00E-04

Spy0791

rgpEc

Spy0792

rgpFc

Spy0793

Spy087
3-

Spy088
3-

Spy0875

Spy0887

Function unknown

Spy0794
Spy0796

virulence regulator

Spy0797

Function unknown

Spy0798

Function unknown

two component
system
two component
system
Coenzyme transport
and metabolism
Function unknown

0.0179

1.00E-04

amrA

Spy0873

Spy0874

sptR

Spy0875

sptS

Spy0883
Spy0884

dyr
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(Φ370.1) hypothetical
protein, phage
associated
(Φ370.1) replication,
phage associated
(Φ370.1) hypothetical
protein, phage
associated
(Φ370.1) Head
morphogenesis, phage
associated
(Φ370.1) Head
morphogenesis
(Portal protein), phage
associated
putative
glycosyltransferase possibly involved in cell
wall localization and
side chain formation of
rhamnose-glucose
polysaccharide
conserved hypothetical
protein - possibly
involved in cell wall
localization and side
chain formation of
rhamnose-glucose
polysaccharide
phosphoglycerol
transferase related;
alkaline phosphatase
superfamily
putative glycosyl
transferase
hypothetical protein
[REGULATOR]
Activation of Mga
regulon
predicted membrane
protein
conserved hypothetical
protein
(sptR-sptS) Important
for persistence in
human saliva;
Activation of spd, speB,
sic, has, and complex
carbohydrate utilization
pathways
putative dihydrofolate
reductase
hypothetical protein

0.1435*

-0.63

0.2469*

-0.59

0.3414*

-0.63

0.0575*

-0.91

0.0033

-0.98

0.6189*

0.46

0.1973*

0.65

0.1907*

0.85

0.0018
0.0062

0.87
1.34

0.0052

1.05

0.0598*

1.29

0.1163*

-0.57

0.5299*

-0.37

0.0749*

-0.54

0.8166*
0.0767*

0.40
0.88

Posttranslational
modification / prottein
turnover
General function
prediction only

Spy089
4Spy091
6-

Spy0895

Spy0917

Spy119
2-

Spy1193

Spy140
2-

Spy1405

Spy142
5-

Spy1429

virulence regulator
Nucleotide
transport and
metabolism
General function
prediction only
Function unknown
Posttranslational
modification,
protein turnover,
chaperones
Energy production /
conversion
Function unknown
Cell wall/membrane
biogenesis
Function Unknown
Function Unknown

0.0191

0.0461

Spy145
7-

Spy1442

Spy1465

Phage

Phage

`

clpX

Spy0886

engB

Spy0887

vfr

Spy0894

deoD2

ATP-dependent Clp
protease subunit X
conserved hypothetical
GTP-binding protein
[REGULATOR]
Repression of speB via
RopB; No DNA binding
activity
putative purine
nucleoside
phosphorylase

0.0204

0.90

0.0107

1.05

0

1.49

0.0369

0.78

Spy0895

histidine protein kinase

0.1079*

0.95

Spy0916

hypothetical protein

0.623*

-0.88

0.0746*

-1.00

0.0477
0.0002

-0.60
-1.08

Spy0917

Glutathione Stransferase
putative citrate lyase
synthetase (citrate (pro3S)-lyase ligase)
hypothetical

0.0035

Spy1192
Spy1193

0.008

Spy1402
Spy1404
Spy1405

hypothetical protein
hypothetical protein
hypothetical protein

0.1363*
0.0678*
0.0375

-1.58
-1.54
-1.71

0.0279

Spy1425

hypothetical protein

0.232*

-1.84

0.1341*

-2.07

0.6725*

-0.48

0.003

-1.10

0.0005

-1.06

0.0309

-1.05

0.0178

-1.01

0.0005

-1.64

0.3555*

-1.17

0.1166*

-1.26

0.0002

-1.34

General function
prediction only
Carbohydrate
transport and
metabolism
Spy143
8-

Spy0885

citC

Spy1427

0.0053

2.00E-04

Spy1429
Spy0143
8
Spy0144
0
Spy0144
1
Spy0144
2
Spy0145
7
Spy0146
0
Spy0146
2
Spy0146
3
Spy0146
4
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gpmA

putative transcriptional
regulator ?
putative
phosphoglycerate
mutase
(Φ370.3) Muramidase
(flagellum-specific)
(Φ370.3) putative holin
(Φ370.3) Tail fiber gene
(Φ370.3) - phage
associated
(Φ370.3) putative
structural protein
(Φ370.3) - phage
associated
(Φ370.3) - phage
associated
(Φ370.3) - phage
associated
(Φ370.3) Head
morphogenesis

Spy0146
5
Spy148
6-

Spy151
0-

Spy152
9-

Spy154
1-

Spy1487

Phage

Spy1511

Replication,
recombination and
repair

Spy1530

Carbohydrate
transport and
metabolism

Spy1547

Function unknown
Amino acid
transport &
metabolism

0.0161

0.0479

0.0203

0.0022

Spy0148
6
Spy0148
7
Spy0151
0
Spy0151
1
Spy0152
9
Spy0153
0
Spy1541

mutT

glcK

arcC

Spy1542
Spy1543
Spy1544

arcB

Spy1546
Spy1547
Spy173
0-

Spy173
3-

Spy1731

Spy1736

Cell cycle control,
cell division
Function unknown

0.0068

Transcription

0.0088

Lipid metabolism

Spy194
4-

Function unknown
Translation,
ribosomal structure,
and biogenesis

hit

0.0002

-1.35

0.1819*

-1.04

(Φ370.3) Lysogeny

0.0165

-0.92

putative mutator protein

0.0425

-1.18

hypothetical protein

0.7238*

-0.68

glucose kinase
conserved hypothetical
protein

0.1806*

-0.56

0.0336

-0.78

0.1302*

-1.00

0.012

-1.21

0.3614*

-1.45

0.1573*

-1.72

0.1856*

-1.93

0.0584*

-1.90

0.0435
0.0042

-0.79
-1.02

0.2927*

0.62

0.9782*

0.54

0.2225*

1.13

0.0005

1.64

putative carbamate
kinase
Dipeptidase
(glutathione-mediated
detox)
predicted membrane
protein
putative ornithine
transcarbamylase
hypothetical protein
arginine deiminase /
[VIRULENCE]
Activator of SpeB
putative cell-cycle
regulation histidine triad
[REGULATOR] Cell
envelope-related
repressor
Acetyltransferase,
including N-acetylases
of ribsomal proteins
hypthetical / COG802:
Predicted ATPase or
kinase

Spy1733
Spy1734

General function
prediction only
General function
prediction only
Spy1946

Spy1730
Spy1731

sagP /
(arcA)

(Φ370.3) putative
structural protein
(Φ370.3) putative
repressor - phage
associated

Spy1735
Spy1736
0.0083

Spy1944

cysE

serine acetyltransferase

0.0553*

1.29

0.0314

1.90

pnpA

hypothetical protein
putative polynucleotide
phosphorylase, alpha
chain

0.1783*

1.45

Spy1945
Spy1946
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Spy211
2-

Spy2114

Spy218
5-

Spy2186

Spy220
9-

Spy2211

Translation,
ribosomal structure,
and biogenesis
Replication,
recombination and
repair
Function unknown
Cell cycle control,
cell division
Function unknown
Function unknown
Nucleotide
transport and
metabolism

0.0199

Spy2112
Spy2113
Spy2114

9.00E-04

Spy2185
Spy2186

0.0486

Spy2209
Spy2210

Function unkown

Spy2211

Spy060
3-

Spy0604

Function unknown

0.033

Spy0603
Spy0604

Spy094
5-

Spy0947

Phage

0.0054

Spy0945
Spy0946
Spy0947

Spy095
6-

Spy0963

Phage

0.0122

Spy0956
Spy0957
Spy0958
Spy0959
Spy0960
Spy0961
Spy0962
Spy0963
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gidA

conserved hypothetical
protein
Predicted
endonuclease involved
in recombination
hypothetical protein
tRNA uridine 5carboxymethylaminome
thyl modification
enzyme
hypothetical protein
conserved hypothetical
protein
ABC transporter, ATPbinding protein
predicted membrane
protein
Hypothetical protein
(signal peptide)
hypothetical protein
(Φ370.2) hypothetical
protein, phage
associated
(Φ370.2) putative P1type antirepressor,
phage associated
(Φ370.2) hypothetical
protein, phage
associated
(Φ370.2) hypothetical
protein, phage
associated
(Φ370.2) hypothetical
protein, phage
associated
(Φ370.2) hypothetical
protein, phage
associated
(Φ370.2) hypothetical
protein, phage
associated
(Φ370.2) hypothetical
protein, phage
associated
(Φ370.2) hypothetical
protein, phage
associated
(Φ370.2) hypothetical
protein, phage
associated
(Φ370.2) hypothetical
protein, phage
associated

0.3502*

-0.57

0.1506*
0.1451*

-0.63
-0.63

0
0.3646*

2.42
1.68

0.1952*

1.05

0.9766*

0.23

0.1319*

1.07

0.5017*
0.023

1.08
0.67

0.0072

-1.05

0.0799*

-0.99

0.0692*

-0.98

0.9042*

-0.79

0.2373*

-0.95

0.5753*

-0.80

0.2934*

-1.00

0.0994*

-0.98

0.8586*

-0.54

0.9604*

-0.60

0.4782*

-0.66

Spy107
5-

Spy215
3-

Spy1077

Phage

0.0447

Spy1075
Spy1077

Spy2154

Function unknown
Function unknown

0.0045

Spy2153
Spy2154
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(Φ370-RD.1)
hypothetical protein,
phage associated
(Φ370-RD.1) putative
methyl transferase,
phage associated
conserved hypothetical
protein
Hypothetical protein
[transmembrane]

0.035

-1.11

0.7174*

-0.97

0.0002

1.71

0.2017*

1.09

6.2.3 SF370 pili play a significant role during adherence and invasion during coculture with HPTE and tonsil tumor-derived cell lines
Among the notable Type I clusters identified, neighbor cluster Spy0127 –
Spy0130 encoding the pilus forming operon within the GrAS FCT-2 (Fibronectin
and Collage binding and T antigen) pathogenicity region was significantly up
regulated in comparison with our control bacteria associated with Detroit cells.
Previously, our lab determined this cluster was indeed an operon through in silico
analysis and reverse transcription of deletion mutants (Ryan 2007). These
findings were concurrently examined and verified by others. (Abbot 2007,
Manetti 2007). Ryan et al observed in their microarray studies that this cluster
was upregulated during adherence to Detroit 562 monolayers as compared to
control bacteria that were associated but not yet adhered. In our work presented
here, we see a significant upregulation of the pilus operon, which indicates a role
for the pili in preparation for, or subsequent adherence to, the tonsillar cells. Our
finding that there is a significant increase in transcription of this operon as
compared to the control (Detroit 562 cells) suggests that the pili, or transcription
of one or all genes may be even more important to adherence to the bacterium’s
target tissue (the tonsil) as compared to a proximal cell type (Detroit cell), We
tested this hypothesis in studies with the pili knock-out mutant presented later in
this work.

Our finding that the pili operon genes are significantly upregulated at the
association stage with tonsillar epithelial cells as compared to Detroit cells
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suggests that pili may contribute to the tropism for tonsillar cells, if we assume
that the mechanisms for adherence to the two cell types are the same.
Increased expression during association may simply indicate earlier gene
activation in the tonsil environment than in the Detroit 562 environment, or it
might indicate the expression of more total number of pili being synthesized and
organized at the bacterial cell surface. Since the mechanism for adherence to the
tonsillar cell types has yet to be explored, this leads to a new avenue for
research into the question of tropism.

To confirm the effect of pili on interactions with our tonsil epithelial cells, we used
a previously characterized deletion mutant of the pilus-associated sortase C1
gene,ΔSpy0129, (Ryan 2007) in our standard adherence and invasion assay.
This SF370 mutant is deficient in proper pili production and cell-surface
presentation. As was demonstrated with Detroit 562 cells (Abbot 2007, Ryan
2007), we found that the adherence of the pili-mutant to both primary and tumorderived tonsil epithelial cells was significantly decreased, (Figure. 6.1) Of note,
adherence was not completely abolished by the absence of pili, indicating that
other adhesins likely contribute to adherence, albeit to a lesser degree than the
pili.

We also assayed strain SF370 in invasion assays using both tonsillar cell lines.
We report here that invasion capacity by strain SF370 is significantly decreased
as compared to Detroit 562 cells. (Figure. 6.2)
152

Figure 6.1. ∆Spy0129 deletion decreases Streptococcal adherence across all
epithelial monolayers
ΔSpy0129 mutant was created and verified as apiliated as previously
described (Ryan 2007). Detroit 562, UT-SCC-60A, UT-SCC-60B, and HPTE
cell monolayers were grown to ~95% confluence on Falcon® 24-well tissue
culture plates. Wells were inoculated with either ΔSpy0129 or parental strain
SF370SMR (Wild Type, SF370 SMR) at Multiplicity of Infection 100:1 in DMEM
without serum. Associated bacteria were removed with PBS and colony
forming units (cfu) were counted on blood agar as described in the methods.
Results are the mean  standard deviation of at least three independent
experiments performed on separate days in triplicate. Statistical significance
(reported as p value) was determined by Student’s t-test. Asterisks indicates p
< 0.0001
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120.00%

*
*

Adherence
(as a % of Inoculum)

100.00%

*
80.00%

60.00%

40.00%

20.00%

0.00%

SF370 SMR
(WT)

ΔSpy0129

UT-SCC-60A

SF370 SMR
(WT)

ΔSpy0129

UT-SCC-60B
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SF370 SMR
(WT)

ΔSpy0129

HPTE

Figure 6.2. Internalization of M type 1 ΔSpy0129 mutant is greatly decreased
ΔSpy0129 mutant was created and verified as apiliated as previously
described (Ryan 2007). Detroit 562, UT-SCC-60A, UT-SCC-60B, and HPTE
cell monolayers were grown to ~95% confluence on Falcon® 24-well tissue
culture plates. Wells were inoculated with either ΔSpy0129 or parental strain
SF370SMR (Wild Type, SF370 SMR) at Multiplicity of Infection 100:1 in DMEM
without serum. Associated bacteria were removed by vigorous washing with
PBS and subsequently treated with Antibiotics cocktail (Penicillin 100ng / µL+
Gentamicin 100ng / µL) and PlyC (0.05U / well). Monolayers were washed
with PBS and cfu’s were counted on blood agar as described in the methods.
Results are the mean  standard deviation of at least three independent
experiments performed on separate days in triplicate. Statistical significance
(reported as p value) was determined by Student’s t-test. Asterisks indicates p
< 0 .0001
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Internalized GrAS (as % of Adherent)

1.40%

*

1.20%
1.00%
0.80%
0.60%

*
p < 0.005

0.40%
0.20%
0.00%

SF370 SMR
(WT)

ΔSpy0129

Internalized GrAS (% of Inoculum)

DETROIT-562

SF370 SMR
(WT)

ΔSpy0129

UT-SCC-60A

SF370 SMR
(WT)

ΔSpy0129

HPTE

*

0.70%
0.60%
0.50%
0.40%
0.30%

*

0.20%
0.10%
0.00%

SF370 SMR
(WT)

ΔSpy0129

DETROIT-562

SF370 SMR
(WT)

ΔSpy0129

UT-SCC-60A
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SF370 SMR
(WT)

ΔSpy0129

HPTE

6.3 Discussion
6.3.1 Regulatory systems

GrAS transcription is regulated through the concerted action of 13 conserved
‘two-component’ signal transduction systems (TCS, containing a sensor kinase
and a response regulator) and >60 ‘stand-alone’ transcription factors (named due
to their ability to independently regulate transcription). Between our individual
gene and cluster analyses, we identified one two-component system, sptR-sptS
(Spy0874-Spy0875), which has been shown to be important for persistence in
adult whole saliva. The role of this TCS during persistence in human saliva
involves linking central metabolic processes with the production of a broad range
of putative and known virulence factors (Shelburne 2005).

We were also able to identify five putative and known regulators. The first, amrA
(Spy0797) is so named for “activation of mga regulon” expression locus A. It was
found to be directly involved with regulating this locus during knockout
experiments, but the mechanism of this regulator remains unknown. Based on
sequence homology, Ribardo et al also predicted that amrA may be a membrane
protein involved in the transport of a polysaccharide component during bacterial
cell wall production in addition to its modulatory role of mga. We additionally
identified the regulator, vfr (Spy088) named for virulence factor regulator. The
function ascribed has been to serve as a repressor of SpeB via RopB. The
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putative cell wall envelope regulator, Spy1733 and the MarR Family regulators
Spy1755, were identified in our analysis although their functions are currently
unknown. All of the stand-alone regulators were up regulated in our analysis. The
upregulation of vfr is consistent with our assumed mechanisms for adherence, as
the bacteria would want to suppress SpeB from cleaving surface adhesins. The
expression of amrA is consistent with its COG designation for cell wall
biogenesis, as many other genes associated with this function were similarly
upregulated. The mga locus, and associated virulence factors, showed no effect
in our analysis so it is possible this regulator may plays dual functions when
being expressed. As the mechanism for it’s regulation of mga continues to be
explored, it will be interesting to consider if our finding reflects such a dual role.

While virulence potential may not be fully described for all the identified TCS and
regulatory systems, the direction of their expression change generally appears to
be decreasing expression of enzymes that would disarm the bacterial surface
proteins necessary for adhesion (vrf and sptR-sptS) as well as affecting
metabolic strategies based on sensing environmental sources of nutrients
(Spy1755 and sptR-sptS).
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6.3.2 Complex carbohydrate vs lipid and secondary metabolic pathways for
energy

As was apparent from our initial analysis of individual genes (Table 6.1), the
neighbor cluster data identified additional significantly regulated genes that were
associated with COG designations Lipid Transport and Metabolism (14 out of 14
genes with this COG), cell wall, membrane biogenesis (7/8), and post
translational modification and protein turnover (7/10) were up regulated. This is in
contrast to complex carbohydrate utilization pathways, which were mostly
downregulated, an observation that is consistent with the downregulation of the
SptR-SptS TCS.

While it is clear the microenvironment of the tonsillar monolayer would not
necessarily be rich in available carbohydrate sources, the increased expression
of lipid transport and metabolism genes may be a unique feature induced by the
tonsil epithelium monolayer. Juncosa et al reported no significant change in
SF370 expression of the SptR-SptS TCS either during co-culture with pharyngeal
conditioned media or following 2.5h associated with Detroit 562 monolayers
(Juncosa 2012). Inversely, this TCS was reported as upregulated in SF370,
which were adhered to Detroit 562 cells (Ryan 2007).

To try to understand these observations in the broader context, we were drawn to
the previously described mevalonic acid pathway, which has been linked to lipid
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transport, and has recently been proposed as part of a model for bacterial
persistence within the tonsil niche in vivo (Shea 2010). This pathway converts
acetyl-CoA to isopentenyl-pyrophosphate (IPP), a short-chain phospholipid
produced by GrAS that is identical to IPP produced by host epithelial cells and γ
/δ T cells. . A potential role relating the mevalonic acid biosynthesis pathway
and the host T cell anergy / proliferation axis was proposed by Shea et al 2010
during their longitudinal microarray-based study in macaques. This group was
interested in the “interactome” between GrAS transcripts and their influence
on concomitant host gene expression or vice versa. Throughout the stages of
macaque infection, they found significant activation of mevalonic pathway
enzymes correlating with host cell stress response and T cell regulation. In our
analysis, we saw an upregulation of mevalonic pathway genes mvaS.1
(Spy0880) and mvaS.2 (Spy0881) as well as the differential regulation of a
number of other lipid metabolic pathways during association with tonsillar cells.
We plan to continue these studies to determine if any such gene clusters play a
role in persistence within the tonsillar environment.
The mevalonic acid operon (Spy0880-Spy0881) is positioned directly
downstream of the sptR-sptS TCS. Although Shea and colleagues hypothesized
that expression of the melavonic acid genes, the activity of the sptR/sptS twocomponent system, and consequent production of IPP, promoted enhanced
GrAS survival in the oropharynx, they concede that additional information is
needed on the exact role of the IPP stimulated γ/δ T cells (Shea 2010).
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Recently, a sptR deletion mutant was created in the SF370 background
(Shelburne 2005). This knockout resulted in an increase in gene expression
within the FCT operon. In particular, the major shaft subunit (Spy0128)
responsible for GrAS pilus length and stability was up regulated (Shea 2010). Pili
expression was accompanied by downregulation of the sptR-sptS regulon. We
observed a similar expression profile in our data: namely, the downregulation of
the sptR-sptS TCS and the concomitant upregulation of pili genes with
downregulation of nearly all differentially expressed carbohydrate metabolism
associated genes (Tables 6.2 and 6.3). The similarities between our system and
the SptR knockout simply reconfirm the proposed role of this TCS on regulating
the expression of particular genes.
6.3.3 Phage-related genes

A survey of the known phage genes that were down-regulated (in both gene
cluster and individual gene analyses) are consistent with previous reports from
our lab on streptococcal association and adherence to Detroit 562 cells at a 2.5
hour incubation time point. The specific downregulation of Φ370.3 -encoded
muramidase and holin may indicate a decreased release of the phage, which
would lyse the bacteria and prevent adherence to the target cell. The
experiments reported by Juncosa et al mirror our Detroit cell control conditions,
demonstrated a relative down-regulation of all prophage genes in these cells as
well compared to bacteria in fresh media. Taken together, the data presented
here indicate that in the tonsil environment, streptococci are further repressing
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expression of these phage genes beyond the downregulation already described
for the Detroit cell environment. It will be interesting to study why and how phage
genes are so actively repressed in the tonsillar environment.

The high number of phage-associated genes that have unknown or hypothetical
functions indicates how little is known about the role of phages in GrAS
pathogenesis. This is despite the fact that phage ORFs have been shown to
account for up to 74% of the variability in a GrAS genome (Banks 2004) and
undoubtedly play a large role in all forms of infection.

6.3.4 Final Comment
In this chapter, we investigated the relative global transcriptional differences
exhibited by a single representative “throat specialist” emm pattern strain of
streptococci when exposed to nasopharyngeal versus palatine tonsil-derived
epithelium. It is clear that in vivo, this non-motile bacterium successfully infects
the human palatine tonsil, entering either a carrier state or initiating a focal
disease. Our previous studies have demonstrated that streptococci undergo
adaptive transcriptional responses to the changing environment. Our current
study, however, is the first demonstration of streptococcal tissue-specific
responses between two anatomically relevant locations that would naturally be in
contact with the pathogen. We have shown that the bacteria produces a unique
response with features such as increased early activity of the GrAS pili encoded
operon and a unique metabolism shift. These observations, though limited in
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scope with what may be interpreted, surely offers the foundation for asking more
precise questions about streptococcal pathogenesis and its mechanisms
underlying this apparent tissue predilection.
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§7.0 STREPTOCOCAL EPITHELIAL INTERNALIZATION
7.1 Introduction

S. pyogenes causes invasive disease, finding access to deep tissues of its host,
to cause necrotizing fasciitis, abscesses, and disseminated sepsis. Although
historically regarded as an extracellular mucosal pathogen, recent laboratory and
clinical observations made over the past 20 years have challenged the earlier
assumption of this pathogen’s obligate extracellular status. Noting similarities
between group A streptococci and the gram positive Listeria monocytogenes,
including internalin, which shares structural similarities to streptococcal surface
proteins, LaPenta and colleagues sought to explore streptococcal internalization
properties through in vitro modeling of upper airway streptococcal infection. In
1994, they reported that group A streptococci are internalized by cultured human
epithelial cells, which are a non-phagocytic cell type, at frequencies as high as
Listeria in certain strains (LaPenta 1994). With these findings, they were among
the first to propose that entry into epithelial cells might serve as an initial step
towards tissue invasion. Since this report, models of GrAS invasion and
subsequent dissemination have been expanded to include paracellular and
transcellular mechanisms.
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7.1.1 Paracellular Invasive Dissemination
In the paracellular model, S. pyogenes interact with epithelial cell surface
receptors, inducing changes in either epithelial or endothelial morphology to form
gaps between an otherwise continuous tissue layer. Cywes et al demonstrated a
CD44-dependent mechanism for GrAS binding that induced appreciable
cytoskeletal rearrangements in human keratinocytes leading to membrane
ruffling and disruption of intercellular junctions. In their model, extracellularly
bound CD44 transduces an intracellular signal for Rac1-mediated actin
polymerization. This event in turn results in local movement of the cell membrane
to form lamellipodia and open intercellular junctions with neighboring cells
permitting a paracellular entry point for invasive GrAS (Cywes 2001). Pancholi et
al has additionally proposed a mechanism where the fibrinolytic digestion of
intercellular junctions by proteolytically active plasminogen may enhance GrAS
pericellular penetration through pharyngeal cell monolayers, as mediated by
streptococcal enolase, SEN (Pancholi 2003).
7.1.2 Transcellular Invasion

In a transcellular model, the GrAS is internalized by epithelial cells and
subsequently reemerges from the cells, presumably via the basolateral surface.
Most transcellular models require a eukaryotic extracellular matrix “bridging
molecule”, either fibronectin or collagen. One such model depends on binding of
M protein to fibronectin which bridges the bacteria to alpha5beta1 integrin
(Cleary, 2000) leading to a phosphatidylinositol 3-kinase (PI3K) (Purushothaman
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et al., 2003)-dependent signaling cascade for cytoskeletal rearrangement and
subsequent ingestion of streptococci (Dombek 1999). Similarly, in another model
Sfbl is the main factor required for attachment and invasion using fibronectin as
its bridging molecule and the alpha5beta1 integrin as cellular receptor. The
mechanism of uptake in this model is characterized by the generation of large
membrane invaginations at the bacteria-cell interface without evidence of actin
recruitment or cellular injury (Molinari 2000).

The virulence factor Sfb1is not present in all invasive strains, like in the well
characterized clinical isolate A8 strain (Molinari 2000). Alternatively, during
transcellular invasion by A8, a proteinaceous moiety was described, which does
not interact with alpha5beta1 or need any known bridging molecule. Bacterial
attachment stimulates elongation and massive recruitment of neighboring
microvilli, fusing to surround streptococcal chains, eventually engulfing the
bacteria (Molinari 2000). Furthermore, not all integrin-mediated transcellular
invasion necessarily requires a bridging molecule as shown by Caswell et al. in
2007 in their Scl1-dependent internalization model utilizing a M41 strain with
HEp-2 epithelial cells. They were able to demonstrate direct interactions between
the surface expressed Scl1 and the alpha2beta1 integrin that facilitated
internalization (Caswell 2007).

With the evolution of presumably many routes to the interior of human epithelial
cells, many question the limit to the transiency this otherwise extracellular
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bacterium necessarily must exhibit in transcellular models. Osterlund et al. were
able to move beyond in vitro observations of potentially a laboratory artifact by
providing clinical evidence of streptococcal internalization. In their study, they
reported the presence of viable intra- and extracellular streptococci on excised
tonsil tissues using electron microscopy and immunohistochemistry.
Convincingly, they found intracellular S. pyogenes in pharyngeal epithelial cells in
13 of 14 patients with tonsillitis (93%). Furthermore, intracellular S. pyogenes
were found in macrophage-like cells in eight (73%) and in epithelial cells in four
(36%) tonsils from 11 asymptomatic S. pyogenes carriers. This observation led to
the expanding of the suggestion that the tonsil may contain an intracellular
reservoir of S. pyogenes that mediates recurrent infection by evading nonpenetrating antibiotics (Osterlund 1997, Cue 2000). Multiple groups have since
contributed additional evidence towards a potential intracellular niche for the
pathogen by demonstrating S. pyogenes intracellular survival for up to 7 days, in
vitro across numerous immortalized human epithelial lines grown in an antibiotic
supplemented medium. In some cases, the ability of viable S. pyogenes to be
externalized and establish an extracellular infection has been assessed upon the
removal of the extracellular antibiotic (Osterlund 1997).

As different GrAS strains may utillize differing mechanisms for epithelial
internalization, different host cells also engage a range of intracellular pathways
when infected by streptococci. Among the numerous factors suggested that may
influence these pathways are the serotype(s) of the invading streptococci,
167

environmental stresses, input signals, and the mounted bacterial transcriptional
response. To better understand the disparate mechanisms at play, several
groups have investigated the intracellular pathways required for the uptake (or
active invasion) process, from phenotypic (Pancholi 1997) (Wang 2006)
(Nakagawa 2006) and global transcriptional perspectives (Argawal 2012) (Klenk
2007) of both the host and pathogen.

7.1.3 Potential Role of Autophagy

Nakagawa et al reported that intracellular S. pyogenes are initially visualized in
HeLa cell endocytes and then readily escape via Streptolysin O (SLO) to gain a
replicative niche in the cytoplasm. The process for bacteria escape from these
endocytes subsequently stimulates autophagy, a fundamental cellular
homeostatsis pathway in the intracellular degredation and recycling pathways.
Nearly 80% of cytomplasmic streptococci eventually become trapped in
autophagosome-like compartments as determined by fluorescence microscopy.
These compartments then become degraded upon fusion with lysosomes lending
the investigators to conclude that autophagy plays a protective role during
streptococcal infection (Nakagawa 2004).
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7.1.4 Host Cell Response to Invasion

On the epithelial side, Klenk and colleagues noted in HEp-2 cells 86 genes that
were differentially transcribed following being co-cultured with a M49 GrAS strain
including genes for cytoskeleton proteins, transcription factors and apoptosisrelated factors (Klenk 2005). In addition, apoptosis was phenotypically observed
in his and other studies following streptococcal invasion, albeit by different
apoptosis mechanisms in an often serotype-dependent manner (Tsai 1999,
Klenk 2005, Klenk 2007, Argawal 2012). If the epithelium has been transiently
damaged by previous or ongoing microbial infection, then Streptococcal
infectivity may gain direct access to tonsillar interior. Because of the close
proximity of non-epithelial cell types to the tonsil surface and crypt epithelium (ie.
lymphocyte follicles, fibroblasts, PMNs, and monocytes), apoptosis may assure
the dissemination of released streptococci to interact in these associated
invasive niches. Wang et al demonstrated that GrAS interactions with human
primary tonsil fibroblasts stimulated an increase in TGF-Beta, which in turn was
able to signal pharyngeal epithelium to upregulate the expression of alpha5beta1 integrins at its surface in vitro. They then provided evidence for a proposed
mechanism where increased alpha5-beta1 integrins on the epithelial monolayer
leads to increased bacterial invasion when inoculated with GrAS through
intracellular signaling (Wang 2006).
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As presented in sections 5 and 6, we show that our representative throat
specialist M type 1 S. pyogenes strain demonstrates a significantly divergent
invasiveness phenotypes based on anatomic origin of epithelial cell. As has been
established in the literature, internalization and intracellular fate depends on
serotype and potentially tissue-type distinctions. In order to better understand the
implications of the intracellular GrAS phenotype, in the context of our study,
strain SF370 was co-cultured with three of our human epithelial cell lines (Detroit
562, UT-SCC-60A, and UT-SCC-60B). After permitting the pathogen to adhere
and become internalized by the host cells we employ novel methods to prohibit
bacteria re-emergence. Additionally, immunofluorescence microscopy provides
us with preliminary data as the ground work for future studies investigating
intracellular mechanisms underlying intracellular GrAS survival.
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7.2 Results
7.2.1 Streptococcal viability following internalization may be epithelial cell typedependent

We employed a novel strategy for maintaining an intracellular bacterial
population following co-culture with human oral epithelial monolayers as
described in the Methods. Two anti-reemergence PlyC solutions (with- or without
Tannic Acid [T.A.]) were applied to monolayers and viability of intracellular
bacteria was assessed at times points over the course of 24 hrs. Our initial time
point (T0), represented the baseline number of internalized bacteria for each
monolayer, based on the number of bacteria internalized following the start of the
2.5h co-culture. Consistent with what has been demonstrated in earlier chapters,
our representative M type 1 strain of GrAS was preferentially internalized by the
UT-SCC-60B epithelial monolayer (p < 0.0001). Following 2 h of selective antireemergence pressure, the enumeration of total recovered intracellular GrAS
from the tonsil-derived epithelial monolayers revealed an increase by nearly 6X
that of the baseline recovered amount, irrespective of T.A. treatment. The
number of bacteria recovered from the Detroit 562 monolayers only increased an
insignificant amount in the T.A treated wells and decreased in the PlyC-only
treated wells (Figure7.1). The number of viable bacteria declined significantly by
the 16h post-infection time point (T16). At this time, the number of bacteria
recovered from the UT-SCC-60B monolayer had returned to near its baseline,
maintaining this level of intracellular viability up to 24 h post infection. During this
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same time, our ability to recover viable bacteria was just barely above
undetectable.
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Figure 7.1. S. pyogenes intracellular viability is cell type dependent
M type 1 strain SF370 in serum-free DMEM (~1x 108 CFU) was co-cultured with UTSCC-60B and B) Detroit 562 epithelial cell monolayers for 120 min at 37ºC.
Associated bacteria were removed by vigorous washing with PBS and subsequently
treated with antiamidase lysin PlyC (0.05U / well) only (solid bars) -or- PlyC with the
exocytosis inhibiting agent, Tannic Acid (striped bars) as described in Methods. Tx=
Xhrs post initiation of PlyC selective pressure against bacterial reemergence. Data
presented is from a representative experiment of duplicate wells plated in triplicate.
Difference between Detroit 562 and UT-SCC-60B cell types at every (conditionmatched) time point is highly significant (p < 0.000) as determined by student t-test.
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7.2.2 Intracellular Compartment of internalized Streptococci

Increased internalization is likely of no benefit to the pathogen if they are
immediately destined to be cleared by the activities of lysosome-mediated
degradation or similarly deleterious intracellular pathways. Our experiments
demonstrate GrAS increased adherence and internalization capacity during coculture with tonsil-derived epithelium. To gain an appreciation for the fate of
internalized streptococci in our tonsil tumor epithelial cell system, we performed
microscopy-based co-localization studies using markers from known pathways
implicated in streptococcal intracellular persistence in non-phagocytic cells. We
focused principally on the UT-SCC-60 A and UT-SCC-60B epithelial cells in light
of the pronounced sustained intracellular viability as compared to Detroit 562
cells (Figure 7.1).

As many of the integrin-mediated mechanisms proposed as routes for GrAS
intracellular entry, ultimately enter bring the bacterium into the cell’s endocytic
pathway, we first sought to identify whether the bacteria was found along
vesicles associated with this process. Early endosomes are the first location
within the endocytic pathway and is likely to reflect recently endocytosed debris
and microorganisms. Consistent with this mode of transcellular entry, we
consistently observed S. pyogenes in association with clustered groups of
vesicles staining positively for the Early Endosome Antigen 1 (EEA1) (Figure
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7.2A). We were also able to find GrAS co-localized within these vacuoles
providing evidence suggestive that intracellular S. pyogenes within the UT-SCC60A and UT-SCC-60B epithelium at least in part are engaged with this process.

Nakagawa et al have proposed that GrAS escape from endosomes into the
epithelial cell cytoplasm, which stimulates autophagy. They’ve gone on to show
that intracellular S. pyogenes is captured by LC3-positive autophagosome-like
vacuoles and degraded upon fusion of these compartments with lysosomes in
HeLa cells (Nakagawa 2004). Using LC3 as an important marker for autophagy,
we observed apparent co-localization of SF370 with LC3-positive vesicles with
relatively similar frequency of distribution across the cell as was seen with the
early endosomes (Figure 7.3).
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Figure 7.2 S. pyogenes co-localizes with Early Endosomes at 2.5h post infection.
Fluorescence micrographs of GrAS-associated Early Endosomes in UT-SCC-60A
epithelial monolayers following co-culture with strain SF370. Extracellular bacteria
were removed by antibiotic and lysin treatment. Monolayers were fixed,
permeabolized and stained as described in Methods. DNA was labeled with DAPI
unless otherwise noted. A) Early Endosome are visualized by anti-Early Endosome
Antigen-1 (EEA1)-FITC mAb (green). B) S. pyogenes was labeled with PlyCB-Alexa
554. C-D) White arrow indicates S. pyogenes co-localizes with EEA1-positive
compartment. Images taken originally at 40X. White box demarcates the area
digitally magnified x10 in D)
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Figure 7.3 S. pyogenes also co-localizes with Autophagosome marker at 2.5h post
infection.
Fluorescence micrographs of LC3 distribution (green) in UT-SCC-60B epithelial
monolayers following co-cultured with strain SF370. Extracellular bacteria were
removed by antibiotic and lysin treatment. Monolayers were fixed, permeabolized
and stained as described in Methods. DNA was labeled with DAPI unless otherwise
noted. A). LC3-positive vacuoles were visualized using α-LC3-FITC mAb (green).
B.) S. pyogenes was labeled with PlyCB-Alexa 554(red). C-D.) White arrow
indicates S. pyogenes colocalizes with LC3-positive compartment. E. Early
Endosomes were visualized by anti-Early Endosome Antigen-1 (EEA-1)-FITC mAb
(green). Images taken originally at 40X. White box demarcates the area digitally
magnified x7 in D).
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7.3 Discussion:
Depending on the S. pyogenes strain, the bacteria are killed within the vacuole,
survive in a resting or even multiplying state, or leave the early phagocytic
vacuole towards the cytosol, where they again either rest or multiply
(Kreikemeyer 2004). In our study, once the S. pyogenes are internalized, they
often remained viable and continued multiplying during the initial hours following
invasion, possibly indicative of an amenable intracellular replicative niche. While
GrAS that were internalized by UT-SCC-60B cells continued growing most
markedly, we later saw an equally marked drop, likely demonstrative of some
intracellular killing process. Importantly, however, we note sustained viability of
internalized bacteria was evident in our tonsil-derived epithelial system for at
least 24hrs.
The intracellular status of GrAS could protect the bacteria from antibiotics and
host defense mechanisms. It appears to be a prerequisite for GrAS persistence
in host tissues, which in the case of tonsillar epithelium leads to recurrent
infections or an asymptomatic carrier status. As patients with persistent GrAS are
the only source for GrAS transmission in non-epidemic settings continued
exploration of the underlying mechanisms of GrAS adherence and internalization
processes may inform our strategies to address moving forward to effectively
interfere with these processes.
We also report here our use of PlyC in suspension with minimal media to provide
the selective pressure against streptococcal reemerge from an otherwise
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transient intracellular niche. This transiency is a necessary final requirement of
the proposed theory for an intracellular sanctuary, or reservoir, as a cause for
recurring infection. The classic experimental set up for measuring intracellular
viability continuously exposes the epithelial monolayer with antibiotic solutions
(Osterlund 1995, Marouni 2004). These experiments, however, may not account
for bacterial recalcitrance due to microcolony and / or biofilm formation (Marnetti
2007). We have shown in earlier studies the ability for PlyC to effectively sterilize
the monolayer surface as confirmed by microscopy (see section 5). Numerous
studies have supported the sterilizing capacity of PlyC against streptococcus spp
providing significant support for the effectiveness of this narrow spectrum agent
for a broad range of uses. To our knowledge, this is the first reported use of the
phage lysin, PlyC (Fischetti 1971), for the purpose of applying a selective
pressure against reemerging pathogens to investigate intracellular viability.

182

§8.0 CONCLUSIONS
This study has extended our lab’s continued work on the transcription shifts
observable in S. pyogenes from initial contact with host factors in suspension
(conditioned media), to transient contact / association with neighboring epithelial
cells (Detroit 562), to transient contact / association with palatine tonsil epithelium
(UT-SCC-60B), to adherence with nasopharyngeal (Detroit 562) surface. It is
clear that in vivo, the GrAS must experience adaptive transcriptional changes at
every step of infection as shown convinsingly by our model. The bacteria may
also adhere to non-tonsil tissues in the pharynx, particularly during asymptomatic
carriage of the pathogen in the nasopharynx. While we have discovered
numerous unique qualities that may be unique to the stage of infection modeled,
improvements in models and annotation will only provide us the opportunity to
ask even more precise questions. As there currently doesn’t exist a deposited
tonsil cell line availbale through AT-CCL, our new UT-SCC-60A and UT-SCC60B tonsil epithelial model has been shown to be an affective surrogate for the
more precious HPTE cells, mirroring effects during our in vitro experiments
performed in parallel. We believe these tools will prove helpful to study this
uniquely human disease process that is otherwise difficult to study in unnatural
host animal models or otherwise poorly representative tissue lines.
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APPENDIX

APPENDIX4.1. Immunofluorescence (IF) staining for epithelial and fibroblast
markers
Confocal microscopy images of cultured Detroit 562, UT-SCC-60A, UT-SCC-60B
and Human Primary Tonsil Epithelial Cell (HPTEC) monolayers labeled with a
mouse or rabbit antibody against keratins k8/18 (A, B), k19 (not shown),
pankeratin (C,D), and vimentin (not shown). Secondary Alexa558-labeled goat
antibody against either mouse or rabbit was applied for visualization by
fluorescence.
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Appendix 6.1 Dye swap microarray between streptococci “associated”
with Detroit 562 (nasopharyngeal) or UT-SCC-60B (palatine-tonsil)
epithelial monolayers Eight biological replicate experiments incorporating
dye swaps [17] were performed to account for both biological and technical
variability. Fluorophore-labeled cDNA samples were hybridized to custom
arrays and scanned with an Agilent High-Resolution C Microarray Scanner at
5 μm per pixel resolution. The resulting images were processed using the
GenePix Pro program. Panel (A) represents “standard” arrays with cDNA from
GrAS associated with Detroit 562 is labeled with Cy3, while cDNA from GrAS
associated with UT-SCC-60B is labeled with Cy5. Panel (B) is the opposite
dye confirmation.
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§A8. Supplementary Chapter. IDENTIFYING STREPTOCOCCAL BINDING
PARTNERS WITH HUMAN ORAL EPITHELIUM
A8.1 Introduction
The interactions between group A streptococcus with its human host has been
extensively studied. In 2000, Cunningham reviewed at least 11 streptococcal
adhesins and potential virulence factors that have been shown to bind host cell
receptors in some direct fashion. Bacterial lipoteichoic acid (LTA), an
amphipathic molecule, appears to account for approximately 60% of adhesion to
epithelial cells via electrostatic interactions with positively charged host
extracellular matrix components such as fibronectin (Hasty 1996, Cunningham
2000). Hasty and Courtney initially describes the action of LTA as the first step in
their proposed 2-step model for streptococcal adherence. By this same model, it
follows that the remaining 40% of the adhesion process is left to commence
following LTA-mediated attachment, likely conferring receptor specificity with
greater avidity. Their theory hinges on the idea of adhesin-host multiplicity where
this interaction would require that multiple binding partners be engaged working
in concert to promote GrAS adherence to the epithelial surface. Hasty and
Courtney’s two step mechanism may in part explain the ability for GrAS to
interact and possibly attach to numerous cell types in vitro, at times in lieu of
natural anatomic relevance to the bacterium.

Several extracellular host cell proteins have been implicated in as the pathogen’s
receptors or surface moiety principally involved in conferring specific attachment
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and / or internalization by group A streptococci including: fibronectin, fibrinogen,
collagen, vitronectin, a fucosylated glycoprotein, and integral membrane proteins
including CD46, the membrane cofactor protein on keratinocytes, and CD44, the
hyaluronate- binding receptor on keratinocytes. While it is undisputed by the
evidenced presented to argue the case for these numerous adhesins playing
significant roles in GrAS adherence in the respective models tested, deciphering
relative significance for site specific pathogenesis remains a challenge for
researchers to rectify.
Questions surrounding the contextual significance of one receptor/ligand pair
over another have resulted in much contention in the field regarding definitive
mechanisms. For example, the importance of CD46 as a cellular receptor for
group A streptococci is uncertain. While CD46 binds M protein through factor Hlike repeats, transfection of L cells with cDNA encoding human CD46 failed to
increase binding of group A streptococci (Abbot 2007). Additionally, Abbot et al.,
recently confirmed that tonsil epithelium was replete with CD44 receptors (Abbot
2007), described by Cunningham to be the host receptor for the hyaluronic acid
capsule of S. pyogenes. Abbot's group, however, noted that a ΔhasA capsule
deficient SF370 strain did not alter adherence capabilities in their ex vivo tonsil
system contradicting the relative importance of this described hyaluronic capsule
– CD44 interaction as significant towards explaining the enhanced adherence
phenotype seen clinically and in vitro towards the surface of the palatine tonsil.
We have described in previous chapters observations that demonstrate
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significantly different adherence and invasion phenotypes by M type 1 GrAS
strain SF370 during co-culture with nasopharyngeal and tonsil epithelium.
Notably, the streptococcal adherence efficiency to our palatine tonsil derived
tumor lines was statistically indistinguishable from human primary tonsil
epithelium. Although purely circumstantial, we may speculate from these
observations the possibility of retained similar surface topographies between our
primary and tumor tonsil cell lines. Therefore, our UT-SCC-60A, UT-SCC-60B
and HPTE cell cultures may provide contextually-applicable epithelial sources
that may augment and facilitate the discovery of novel receptors earlier
investigators missed due to sample limitations when exploring whole tonsil
tissues or intrinsic inadequacies of the existing non-palatine tonsil cell in vitro
models. Our described experimental findings from relevant tissue-specific
association and adherence may also allow us to prioritize such exploration by
key receptor-ligand pairs consistent with the gene expression profile during
association at the tonsil surface.
To better understand the implications of our previous results, we have begun
studies to describe host-pathogen interaction. Preliminarily, we sought to test our
ability to identify the corresponding protein binding partner(s) between our tumor
cell lines and a known streptococcal surface adhesins. We hypothesize that
streptococci likely interact with unique surface proteins on UT-SCC-60B as
compared to Detroit 562 cells, which may account for observed differences in
adherence. This chapter provides our preliminary results, and introduces our
data-informed future plans for additional screens to elucidate the cellular basis of
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tonsil tissue tropism.

A8.2 Results
A8.2.1 Identification of epithelial cell wall proteins that bind recombinant group A
streptococcal M6 protein
Our earlier described studies have consistently demonstrated that Streptococcus
pyogenes M type 1 strain SF370 adhere to tonsil epithelial cells with greater
efficiency than the Detroit 562 nasopharyngeal cell type. Due to the novelty of
using UT-SCC-60A and UT-SCC-60B cells to model streptococcal
pharyngotonsillitis, however, their cell surface receptor distribution remains
largely uncharacterized in the context of any host-pathogen interaction. As a
means to determine similarities between these tonsil tumor cell lines and the
otherwise well characterized Detroit 562 cell line, we decided to test a GrAS
adhesin known to have multiple defined epitopes on epithelial cells. Possibly the
quintessential classic determinant of streptococcal virulence, M protein has been
extensively studied by our lab and others as an important adhesion and invasion
during streptococcal colonization of epithelial cells. Previous studies on the
mechanism of M protein adherence have been conducted over the decades
across numerous cell types yielding a cadre of putative receptors (Cunningham
2000, Nobbs 2009). Our lab recently highlighted the ability of recombinant M type
6 (rM6) protein to bind glucosaminoglycans (GAGs) and sialic acid containing cell
surface proteins (Ryan 2001) during Detroit 562 epithelial cell adherence. Similar
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to M type 1 strain SF370, the M type 6 is a member of the emm type pattern A-C
described as a throat tropic.

Based on our expansive experience with M protein and the availability of purified
recombinant protein material, we used M type 6 protein our initial probe (or “bait”)
protein to perform comparative co-immunoprecipitation experiments. These
studies would determine whether different “M6 protein – human epithelial
receptor” complexes might be distinguishable between epithelial cell membrane
associated proteins from nasopharyngeal and palatine tonsil cells.

Prior to the co-immunoprecipitation, we conducted preliminary co-culturing
experiments using M type 6 strain D471 and the M6 isogenic knockout strain
JRS75 respectively with Detroit 562, and UT-SCC-60B epithelial cell monolayers.
As had been shown previously by our group and others, during co-culture with
Detroit 562 cells, adherence was drastically diminished in the isogenic M6 protein
knockout strain versus the wild type D471 strain. The adherence to the UT-SCC60B was similarly decreased in the absence of M protein although variability
between independent experimental replicates in the wild type will necessitate that
repeat experiments be performed to assess statistical significance (data not
shown).

Our co-immunoprecipitation experiments were performed as detailed in the
methods. Briefly, recombinant M type 6 (rM6) protein was incubated with
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epithelial surface proteins in mixed suspension from each respective cell line to
encourage potential protein-protein interactions and identify natural binding
partners. Protein complexes were captured by the 10.B6 mAb (α-M protein)
bound to packed protein G beads. After washing away unbound proteins, rM6
protein with accompanying complexes were eluted from the protein G beads, and
analyzed by SDS-PAGE.

We observed two unique protein bands at 30kD and 80kD, respectively,
putatively representing components of complexes between Detroit 562 surface
proteins and the streptococcal rM6 protein (Figure 8.1). These bands have yet to
be analyzed by mass spectrometry for protein identification. Based solely on the
molecular weights, however, these bands may indeed prove to be novel M
protein binding partners as their weights are inconsistent with some of the known
M protein ligands including: filamentous actin (MW = 42kD); CD46 (MW = 56 –
66 kD); and the fibronectin (MW = 240kD)-α5β1 integrin (MW > 115kD)
complex. This list of M protein receptors is not meant to be exhaustive (see Table
1.2), however, and final confirmation of identity will need to be performed by
more rigorous LC-MS/MS analysis.

It may be significant that bands from known M protein binding partners were not
evident following SDS-PAGE analysis. Based on the literature, it is evident that
more M protein – host interactions with the Detroit 562 cells would be expected
than what we observed following our co-immunoprecipitations. Notably, the UT193

SCC-60B cell surface proteins did not elute with any observable proteins in
complex with the rM6 protein. We recognize a number of technical
considerations that may account for these results. One observation is the low
concentration of epithelial cell membrane associated proteins and rM6 protein in
flow through / wash lanes 5 and 8 (Figure 8.1). Additionally, it is unclear whether
there is observable rM6 protein in our eluted lanes (4 and 7), as the band at ~50
kDa may be the degraded heavy chain portion of our mAb, 10B6. Since we only
used coomasie to visualize our bands, there is the possibility that we were
unable to see fainter bands more readily observable following silver staining. In
future iterations of this experiment, we may add more epithelial cell proteins as
well as rM6 protein into our initial suspension to promote more interactions and
potentially stronger banding patters. We may also consider a more stringent
elution buffer or procedure to confirm our bound complexes do not remain in the
column.

Our co-immunoprecipitation, though preliminary, would qualify as the first time
the UT-SCC-60B cell line has been probed for M protein binding potential and
may reflect something novel about their surface topography. We also note,
however, that recombinant M type 1 protein may yield a more impressive yield of
protein – protein complexes.
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Figure A8.1. Identification of binding complexes between epithelial cell membraneassociated proteins (CMAP) and recombinant M6 protein. Detroit 562 and UT-SCC60B human epithelial CMAPs were placed in suspension with recombinant M6 protein.
Protein-protein complexes were then affinity purified using a μMACSTM protein G
MicroBeads column conjugated to 10.B6 (α-M protein) mAb. M protein-CMAP
complexes were resolved by SDS-PAGE and stained with 0.1% (w/v Coomasie). Lane
1) Bands at 75, 100, 150, and 250kDa determined to be “carryover” dye from MW
ladder. Lane 4) Green arrow: putative D562 – rM6 complex #1, White arrow: suspected
rM6 +/- 10.B6 mAb heavy chain, Red arrow: putative D562 – rM6 complex #2, Blue
arrow: suspected 10.B6 mAb light chain.
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A8.2.2 Click Chemistry metabolically labels newly synthesized streptococcal
proteins
We have reported on comparative genomic and mutagenesis studies to revela
bacterial genes that are important for infection, but their precise biochemical
mechanisms and temporal expression patterns are difficult to measure or truly
speculate as a result of posttranslational regulation. Direct biochemical analysis
of bacterial proteomes during infection may be a useful measure to elucidate
these mechanisms informed by microarray transcriptome analysis. New
strategies for selectively enriched bacterial proteins from host proteomes during
infection have recently been described, including the use of non-natural amino
acids to distinguish bacterial proteins from the host. (Grammel 2010).

For example, Azide functionalized methionine surrogate, Azidohomoalanine
(AHA) (Fiigure 8.2A) has been shown to be incorporated into the bacterial
proteome by endogenously expressed methionyl-tRNA synthetase (MetRS) in
Escherichia coli. The azide group is able to survive cellular metabolism and
remains available to be subsequently reacted with a secondary reporter such as
Alkyne-Rhodamine (Alk-Rho) detection tag by Cu1-catalyzed Azide-Alkyne
Cycloaddition, also called “Click Chemistry”. This selective tagging can occur in
mixed bacteria-host lysate solution and resolved by SDS-PAGE and in-gel
fluorescence scanning.

197

To our knowledge, the ability of the streptococcal endogenous translational
apparatus to incorporate alkyne- / azide-functionalized non-natural amino acids
has yet to be tested. Additionally, the subsequent use of Click Chemistry to
selectively label bacterial proteins during infective processes has yet be exploited
for the study of streptococcal virulence.

As our first step towards utilizing these new tools, we successfully demonstrated
S. pyogenes incorporation of Azidohomoalanine (AHA) (Figure 8.2). In our initial
experiments, we added unlabeled streptococcal cell wall protein in excess to a
well and resolved the band using SDS-PAGE. Previous investigators have
reported levels of autofluorescence as a source of background signal and
confounding noise during in-gel fluorescence analysis post Click Chemistry
reactions. Similar to these previous reports, we also observed faint
autofluorescence at 580nm, although the observed background remained
distinguishable from AHA + Alk-Rho labeled samples (Figure 8.3C). Significantly,
we also note that low expressing proteins that proved difficult to visualize by
normal coomasie stain may be better analyzed with metabolic labeling and in-gel
fluorescence (Figure 8C).
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Figure A8.2. In-Gel Fluorescence distinguishes metabolically labeled
Streptococcal proteins using Click Chemistry. A) Structures of methionine
(Met) and azidohomoalanine (AHA). S. pyogenes.was cultured in THY media to
late log phase, and then diluted into methionine-free minimal media
supplemented with AHA. Protein Bacteria were lysed and extracted cell wall
fractions were either (B) directly resolved by SDS-PAGE or (C) reacted with the
clickable fluorophore Alkyne-Rhodamine (Alk-Rho) via Cu1-catalyzed azidealkyne cycloaddition (“Click Chemistry”) immediately before resolving on SDSPAGE. Resulting gels were visualized with 1% (w/v) Coomasie stain (CM) or by
In-Gel fluorescence scan (Fluor) at 580nm. AHA/Alk-Rho samples were
compared to normal treated samples.

199

A

Size
kD

C

B

CM

Fluor

CM

200

Fluor

A8.3 Discussion
Most of our current methods to determine protein-protein interactions between
host and pathogens, including our co-immunoprecipitation, require that one of the
proteins in the pair be a known entity. This has limited the field to consider the
current scope of known adhesins when searching for binding partners. Numerous
reports have demonstrated that M protein binds multiple eukaryotic proteins in
human serum and on macrophages, fibroblasts, and keratinocytes. Our
preliminary search for unique interactions between tonsil cell surface proteins
only captured identifiable interactions with the Detroit 562 cell line. Additional
analysis of the two resulting bands on SDS-PAGE may offer insight on
differences in streptococcal interactions between these neighboring epithelial
surfaces, although this remains to be determined. Moving forward, however, we
plan to modify our exploratory search in a more directed manner informed by our
microarray and adherence phenotype data.

One area of immediate intended focus is on establishing tissue-specific roles for
the components of the highly upregulated operon Spy0127 – Spy130. Our coculture phenotype and transcriptional expression data support that pili are
important during GrAS strain SF370 association with –, adherence to –, and
invasion of – tonsil epithelial cells. Recently reported adherence studies using
purified recombinant S. pyogenes pilus ancillary proteins encoded by Spy0125
(rSpy0125) and Spy0130 (rSpy0130) have shown that both of these SF370 pili
subunits bind Detroit 562 (Manetti 2007) and HaCaT cell lines as well as intact
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human tonsil epithelium (Smith 2010). Smith et al subsequently assigned subunit
Spy0125 as the principle pili adhesin based on the ability for anti-rSpy1025 sera
to inhibit adherence to tonsil epithelium (Smith 2010). Their report was unable to
determine pili – host epithelial binding partners, leaving the exact mechanism for
their observed adherence properties yet to be described. We would like to use
these recombinant pili subunits, rSpy1025 and rSpy0130, and corresponding
anti-sera to repeat co-immunoprecipitation and immobilized ligand assays
comparing binding partners from UT-SCC-60A, UT-SCC-60B, HPTE, and Detroit
562 cell lysates.

As our M protein experiments may reveal, there may be tissue-specific or even
bacterial –serotype differences in the engagement of particular bacterial
adhesion-surface receptor complexes. This idea may be supported by Bessen et
al’s recent characterization of throat tropic members of the emm pattern types AC. The heterogeneity of genes imply horizontal gene transfers and mutations
account for a convergence of adaptation for this oral niches, quite possibly by
numerous mechanisms (Bessen 2011).
Though not fruitful as of yet, metabolically labeled proteins able to be visualized
through Click Chemistry is a safe means of tagging epithelial proteins for
experiments that are less linked to identifying the protein of interest at the onset.
Our lab has recently attempted mixing epithelial cell membrane associated
proteins with metabolically labeled, Mitomycin C-killed, intact bacteria in a
suspension that encourages naturally-occurring protein-protein complexes to
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form. Using the same principles of our earlier co-imunoprecipitation column, this
has allowed for an unbiased approach to identifying binding partners (not
shown). We may consider pre-incubating the bacteria in tonsil-conditioned media
to assure expression of relevant surface proteins likely present within the
intended tonsil niche. While elution methods may have so far presented a
challenge in capturing all host-pathogen complexes formed during coimmunoprecipitation, crosslinking receptor-bound complexes using DTSSP (3,3´dithiobis[sulfosuccinimidylpropionate]), as well as using Click Chemistry may
provide us stronger results in the future.
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